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Abstract 
Aims: The importance of inflammation in the development of joint damage and 
subsequent functional limitation, together with the increasing awareness that clinical 
assessment is insensitive at detecting synovitis, has led to the use of modem imaging 
modalities such as ultrasonography (US) in rheumatology. This with an emphasis on 
improved detection of synovitis and earlier, more effective therapeutic intervention. 
The aim of this thesis was to investigate the role of US in routine practice, by 
validating its role in diagnosis, prognosis and therapeutic intervention, across a 
range of common rheumatological clinical scenarios. 
Methods: Construct validity for US-detected synovitis III knee arthritides was 
examined by comparIson with clinical assessment and arthroscopy. In order to 
examine the benefits of US-guided joint injections, the accuracy of guided shoulder 
injections was observed. As well, the efficacy of US-guided corticosteroid injections 
in hip osteoarthritis and predictors of outcome were also assessed. The sensitivity of 
US over clinical examination was assessed in a cohort of rheumatoid arthritis 
patients with low disease activity levels. The diagnostic and therapeutic predictive 
value of US-detected synovitis in inflammatory hand pain was examined in a large 
cohort. Finally the clinical utility of US at altering diagnosis and management in 
clinical rheumatology practice was prospectively examined. 
Results: For detection of knee synovitis, using arthroscopy as the gold-standard, US 
had higher sensitivity (98 vs 85%) and specificity (75 vs 25%) than clinical 
assessment. Kappa values for inter- and intra-reader reliability of US were 0.71 and 
0.85 respectively. In the shoulder US-guided injections were 100% accurate, but 
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55% had evidence of extrabursal contrast limited to the tissue planes adjacent to the 
bursa. Outcome following hip injection was poor, but synovitis without osteophytes 
on US was the best predictor of short term benefit. In rheumatoid arthritis patients in 
clinical remission, the majority satisfying established remission criteria, US detected 
gray-scale and power Doppler (PD) synovitis in 85% and 60% patients respectively. 
The kappa value for inter-reader reliability was 0.60 for gray-scale, and intra-reader 
reliability was 0.60 for gray-scale and 0.62 for PD. Most inflammatory hand pain 
patients without clinical evidence of an inflammatory arthritis had US synovitis 
(55%); and US (p<O.OOI), but not clinical, synovitis was significantly associated 
with response to parenteral corticosteroid therapy. The site-specific diagnosis (53%) 
and management (53%) was altered in most patients referred for US in a routine 
clinic. 
Conclusion: Ultrasonography is now well validated in synovitis detection in small 
and large joints, and this has substantial implications for the accurate and early 
diagnosis of inflammatory arthritis, as well as in monitoring outcomes to therapy in 
rheumatoid arthritis. Ultrasonography can aid prognosis as well as improving 
placement of guided intra-articular therapies. This work has demonstrated that US 
has a significant role to play in rheumatology practice. 
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Chapter 1 
1.1 Introduction 
Our department in Leeds has undertaken pioneering work which has 
contributed to further understanding of the role of synovitis in the development of 
joint damage and subsequent function limitation. The department has become 
particularly noted for its work in the early diagnosis of inflammatory arthritis and its 
aggressive management with a view to reducing joint damage. The use of imaging 
techniques such as Ultrasonography (US) and Magnetic Resonance Imaging (MRI) 
has been at the forefront of early diagnosis. My colleague, Richard Wakefield, 
developed the US service with support from radiology colleagues, before I joined 
the group and much of the work in this thesis is a result of collaboration with these 
people. 
Rheumatologists like other physicians have always used the patient's history, 
clinical assessment and laboratory investigations as central to formulating a 
diagnosis. In the past, x-ray was the main imaging modality used to visualise 
changes in bony structures. With technological advances other modalities such as 
computed tomography (eT), US and MRI were developed allowing rheumatologists 
to view not only bone but also other articular structures and soft tissue. Thirty years 
ago diagnostic US machines were expensive and cumbersome, using gantry systems 
that produced coarse, static images although in the last decade systems improved 
and use has become more widespread. 
Manufacturers seeing the potential of US, have in recent years thrown their 
considerable financial weight behind improving the technology that drives its use, 
and massive advances in technology have dramatically changed how US is used as a 
diagnostic tool in clinical practice. These changes include the development of faster 
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mlcroprocessors, digital imaging systems, and high frequency linear-array 
transducers so that today we have machines that are fully portable, including some 
that are hand-held, and capable of high resolution real-time gray-scale and Doppler 
Imagmg. 
The increasing portability and ease of use of US, accompanied with the 
realisation that clinical assessment is insensitive and unreliable (Eberl, Fasching et 
a1. 1976; Hauzeur, Mathy et a1. 1999), has led to increasing calls for use in day to 
day practice as an extension of the rheumatologists' assessment (Manger and 
Kalden 1995; Grassi and Cervini 1998; Wakefield, Gibbon et al. 1999; Backhaus, 
Burmester et al. 2001). Advances continue at such a fast rate that often by the time 
independent scientific research into a particular modality has taken place; newer 
'better' modalities are in vogue. Examples of more recent advances include the 
development of Colour and tissue harmonics, microbubble contrast agents, extended 
field of view imaging and 3D imaging all still in the early phases of validation as an 
investigative tool. 
Despite this relative lack of validation the role of US in Rheumatology 
practice has continued to expand and practice has evolved so that for most 
rheumatologists US has two sometimes overlapping roles. First is the every day use 
for clinicians as an extension of physical examination to aid clinical diagnosis, and 
second as an objective outcome measure used in studies. With improved training 
programmes and also the cost of high quality, research capable, machines falling; 
the use of US as an objective measure of disease activity and response to treatment, 
previously used mainly in research units, is becoming more widespread by 
rheumatologists in their daily practice. 
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Chapter 2 
2.1 History, Clinical Utility and Validity 
2.2 History of Ultrasonography 
To appreciate the changes that US has undergone in the last few decades we 
need to have some idea of its history. 
2.2.1 Bats and Bells 
The first time the concept of high-frequency US had been lauded was in the 
late 1700's when an Italian biologist Lazzaro Spallanzi demonstrated that bats 
navigated in the dark using echo reflection from high frequency sound (inaudible to 
humans) they emitted. The next phase in the history of US started with the 
measuring of distance under water with SONAR (Sound Navigation and Ranging). 
In the early 1800's a Swiss Physicist Jean-Daniel Colladon used an underwater bell 
to determine the speed of sound in waves. Work spread to try and define the 
fundamental physics of sound vibrations, with one of the earliest publications from 
Lord Rayleigh (England) in 1877 entitled "The Theory of Sound" where a sound 
wave was first described as a mathematical equation. High frequency sound waves 
were probably first generated by another Englishman Francis Galton in 1876. 
2.2.2 Piezoelectricity 
Around the same time (1880) another breakthrough was made by Pierre and 
Jacques Curie in Paris when they demonstrated that when certain quartz crystals 
were put under mechanical stress they generated an electric charge. They later 
confirmed the findings of the Nobel Physicist Gabriel Lippman, that the reciprocal 
effect of mechanical stress being produced when a voltage difference was applied 
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across a crystal was also true; they called this phenomenon piezoelectricity. It was 
now possible to use a single crystal to generate and receive sound in the frequency 
range of millions of cycles per second (megahertz) namely "ultrasound", a quality 
which to this day remains central to the working of modem transducers. 
2.2.3 Ships and Submarines 
The invention of the diode and triode allowed for the electronic 
amplifications required to develop ultrasound instruments. The sinking of the 
Titanic in 1912 led to the development of underwater sonar systems which were first 
used for the purpose of underwater navigation and judging water depth. The first 
patent for underwater echo ranging sonar was filed at the British Patent Office by 
English meteorologist Lewis Richardson one month after the sinking of the Titanic. 
The French physicist Paul Langevin has been accredited with developing the 
hydrophone, subsequently widely used in naval navigation, using a transducer made 
of a variety of thin quartz crystals glued between two steel plates with a resonant 
frequency of 150 KHz. The hydrophone underwent further improvements and was 
subsequently used to monitor German U-boats in World War I. The German U-boat 
UC-3 on the 23rd April 1916 was the first known submarine sunk after detection 
using the hydrophone. 
2.2.4 SONAR 
The first working sonar system was designed and built in the United States 
by Canadian Reginald Fessenden in 1914. Fessenden had almost a decade earlier 
used his research in sound waves to send a radio transmission of music to ships on 
the Atlantic. The Fessenden sonar was able to detect an iceberg underwater from 2 
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miles away, although with the low frequency, it could not prec isely resolve its 
direction. By the mid 193 0s, many ocean liners were equipped with some form of 
underwater sonar using the same technique developed by Fessenden of using an 
electromagneti c coil to emit sound before switching to a rece iver mode to listen for 
echoes. 
2.2.5 Reflectoscope and "Medical Ultrasound" 
Another equally important development was the construction of ultrasonic 
metal fl aw detectors in the 1930's to check for flaws on metal hulls of ships then for 
tanks and aircraft wings. Floyd Firestone (no link with Firestone tyres) produced hi s 
patented supersonic refl ectoscope in 1941. 
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All these developments were the precursors for what led to ultrasound waves 
being used in the medical setting. Gohr and Wedekind from the Medical University 
of Koln are accredited as being the first to discuss the possibility of diagnostic 
ultrasound in their paper "Der Ultraschall in der Medizin" published in 1940. 
Figure 2.2 Der Ultraschall in der Medizin 
The Austrian Karl Dussik, a neurologist at the University of Vienna is 
widely accepted as the first physician to have employed ultrasound in Medical 
diagnosis. His paper published in 1942, based on his research on transmission 
ultrasound investigation of the brain, is accredited as the first paper using ultrasound 
in Medicine. In the 1950's Ian Donald, then Professor of Midwifery at the 
University of Glasgow, leading a team of clinicians and engineers established 
ultrasound as a clinically useful imaging modality in gynaecology and obstetrics . 
6 
MD Thesis- Dr Zunaid Karim 
Their first major publication appeared in 1958 and contained the first 
ultrasound images of the foetus ever published (Donald I 1958). This image from 
the British Musculoskeletal Ultrasound Society (BMUS) archive is one of his 
earli est on record . 
Figure 2.3 Early Foetal US 
2.2.6 B-mode scanning 
Donald and his colleague Tom Brown went on to build the prototype of the 
worlds first compound B-mode contact scanner on the frame of a hospital bed-table 
(Figure 2.4) with the transducer operating at 2.5 MHz in 1957 (BMUS archive). 
Figure 2.4 Early B-mode scanner 
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A compound sector technique was used to build up a two-dimensional image 
with gray scaling. The images were taken from different points in contact with the 
abdomen (Figure 2.5) and information was then used to build an echo pattern, from 
the skin through to the bowel (Figure 2.6). Initially machines like this were 
manually operated, but later machines were automated. 
Figure 2.5 Compound Sector Technique 
Figure 2.6 Early Abdominal US 
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2.2.7 Musculoskeletal Ultrasonography 
In the US Holmes and Howry experimented with water tanks to achieve 
acoustic coupling (1956) and are accredited with one of the first images in 
Musculoskeletal Medicine (Howry 1955), an image ofthe normal neck (Figure 2.7). 
Figure 2.7 Normal Neck 
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Figure 2.8 Volunteer in gun turret 
This image from the BMUS (Figure 2.8) archive demonstrates how the 
volunteer was submerged in degassed water in a disused B29 gun turret and scanned 
through 360 degrees. 
2.2.8 Diasonograph 
The Oiasonograph was designed and built by the same Tom Brown and 
Fleming in 1963. The early design of the Oiasonograph envisaged a matching 
examination couch (Figure 2.9), 
Figure 2.9 Diasonograph- The plan 
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although considerations of cost forced a compromise usmg a standard hospital 
trolley (Figure 2.10). 
Figure 2.10 Diasonograph- Reality 
The Diasonograph used a heavy gantry because of the need for a stable 
scanning platform weighing in at one ton lending itself to the nickname of the 
'Dinosaurograph'! By the mid ' 70s linear array real-time systems had been 
developed which were much smaller and easier to use (Figures 2.11, 2.12). 
Figure 2.11 Linear array real-time 
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Figure 2.12 Linear array in practice 
Advances in technology at all levels of the US pathway in recent years have 
led to marked improvements in the images that we see on our screens today (Figures 
2.13 , 2.14). 
Figure 2.13 Modern image: Image of foetus 
Figure 2.14 Modern image 1: Image of foetus 
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2.2.9 Ultrasonography or Ultrasound? 
The term Ultrasonography has been used by European groups involved in 
musculoskeletal 'ultrasound' and our imaging group has taken on this term although 
in the current literature both terms are used, often interchangeably. 
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2.3 Technological developments in Ultrasonography 
The textbook definition of US is energy generated by sound waves of 20,000 
or more vibrations per second. The endpoint of this for an US machine is a 
transducer which gives off sound waves which are then reflected back in varying 
degrees from organs and tissues to the transducer, allowing a picture of what is 
inside the body to be depicted on a screen. 
Advances in technology at all levels of the US pathway have led to marked 
improvements in the images that we see on our screens. Modern systems are fully 
digital which reduces the signal to 'noise' ratio of returning echoes, but also adds 
massive potential in performance related to beam formation, signal processing, 
image display and storage. Changes in transducer technology has not only allowed 
for better signalling, but also the use of different signalling techniques resulting in 
some of the most significant advances in applications for US and US quality 
(Whittingham 1997). 
2.3.1 Transducers 
Components 
A usual transducer consists of, from the surface in, a protective layer, a lens, 
matching layers, an active ferro- or piezoelectric material, and a backing block. 
Transducers convert one form of energy to another. Piezo 'actuators' convert 
electrical energy to radiofrequency which is why they are referred to as motors. 
Piezo 'sensors' convert radiofrequency into electrical energy which is why they are 
referred to as 'generators'. In most cases, the same crystal can be used to perform 
either task. Transducers are limited by the range of frequencies over which they 
work mainly due to the loss of sound when converting from electrical energy to 
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radiofrequency, which is why we still have different transducers for different uses. 
One way of documenting the range of frequencies they work over is the bandwidth 
defined as the width of the frequency response (the transducer efficiency versus 
frequency relationship) at half maximum transducer output. 
Signal Transmission 
Improvements in methods and materials used in the transducer such as novel 
ways of using multiple layering of ceramics around the new piezoelectric materials 
all reduce the amount of energy lost in this conversion. This cuts the requirement for 
multiple transducers of varying frequencies but is also essential for using harmonic 
imaging, discussed later. The use of better piezoelectric materials alongside 
improvements in transducer design, digitalisation and analysis of received echoes 
has resulted in much higher frequency transducers that unlike previous transducers 
maintain penetration and resolution. The main limitation of the very high frequency 
transducers is the low penetration power of the ultrasonic beam. Twenty MHz 
transducers have an axial resolution power of 0.038 mm, but do not allow an 
assessment of structures deeper than 1.5 cm (Grassi and Cervini 1998). This now 
allows US examination of the skin, eye but also allows measurement of flow 
(O.5mmls) in small 100-300 urn diameter vessels. 
Digitalisation 
Manipulation of sound waves, both transmitted and received, as a result of 
digitalisation has reduced sound loss, but also allowed for new methods of sending 
signal. Examples include altering the waveform and duration of single pulses; or 
using multiple pulses or beams which allows for better resolution, but also greater 
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bandwidth. The introduction of contrast and 3D imaging that require a thinner more 
unifoml image slice thickness has led to the development of transducers with 
multiple parallel rows of elements (Figure 2.15) (Claudon, Tranquart et at. 2002), 
a b 
Figure 2.15 Transducer- Multiple parallel rows (a) 
and also those that uses a concave lens with crystals that resonate at different 
frequencies, the outer aspect which resonates at lower frequencies focuses on the 
deeper tissues and the inner aspect which focuses on closer tissue resonates at higher 
frequencies which maintains clear focus at all levels (Figure 2.16) (Claudon, 
Tranquart et at. 2002). 
Figure 2.16 Transducer- Concave lens 
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Signal Reception 
There have been huge advances in how transducer signal is received as well, 
and non-linear or hannonic imaging, first noted with contrast agents, is central to 
many of these advances. These are higher frequency signals which develop because 
US passes through compressed and non compressed tissue at different speeds and 
results in slight distortions that build up the further it goes into tissue. This means 
that tissue hannonic intensity is virtually zero at the skin, but as the US wave passes 
through tissue higher intensity is generated until attenuation of the US signal 
overcomes this when it reduces, resulting in a lower intensity. This is important 
because a lot of image distortion with linear imaging occurs at the skin and in this 
setting tissue hannonics are used to our advantage by using filters to remove the 
original transmitted signal. The remaining hannonic signal has less distortion and 
signal clutter, because this is usually caused by superficial structures like skin and 
fat, giving better image quality. 
2.3.2 Doppler 
Doppler uses reflected US waves to evaluate blood as it flows through a 
blood vessel. The original US wave is sent from the transducer and bounces off 
tissues including blood cells and the movement of blood cells causes a change in 
pitch of the reflected US (called the Doppler effect). This is the reason why the 
sound from an ambulance siren changes when it passess by. Information from the 
reflected sound wave is then digitally processed to provide an image that represents 
the flow of blood through the blood vessels. These graphs or pictures can be saved 
for future review or evaluation. 
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Colour and Power Doppler 
Colour and power Doppler have been used for almost a decade in rheumatology, 
mostly by Wolfgang in the early days. Colour Doppler uses standard US methods to 
produce a picture of a blood vessel, but in addition, the Doppler sounds are 
converted into colours that are overlaid on the image of the blood vessel and that 
represent the speed and direction of blood flow through the vessel. Power Doppler 
(PD) is different in that whereas CD assesses flow in vessels, PD displays the 
amplitude of the spectral density of the Doppler signal and is determined by the 
amount of blood present and not flow, making it better for assessing low velocity 
flow in smaller vessels. 
2.3.3 Harmonics, inverted pulse modes and Gray-scale flow imaging 
Other advances have been the addition of harmonic and inverted pulse modes, 
particularly beneficial with contrast bubbles. Gray scale flow imaging is a method 
used to estimate flow in b-mode. This is achieved by measuring back scatter from 
two encoded sequences emitted very close together. Any blood flow will lead to 
change in signal and the resulting subtracted image is attributed to movement. 
2.3.4 Extended field of view 
Extended field of view imaging uses information regarding the position of the 
probe taken from the US images themselves as the probe is moved along a structure 
to construct a single landscape view (Figure 2.17) (Claudon, Tranquart et al. 2002). 
Using electromagnetic sensors to judge movement of the transducer has allowed so 
called 3D imaging, and adding to this technology using consecutive updates of these 
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3D images (between 4-16 cycles/sec) has created real time 4D images (4-D Kretz 
machine) . 
Figure 2.17 Extended field of view 
2.3.5 Microbubbles 
Mode of action 
Microbubbles are less than 10 urn in diameter and work by resonating in the 
US beam, rapidly contracting and expanding in response to the pressure changes of 
the sound wave, and by helpful coincidence vibrate particularly strongly at the high 
frequencies used for diagnostic US. This oscillation makes them several thousand 
times more reflective than normal body tissues and means that they show up very 
clearly on US scans. In this way they enhance both gray scale images and flow 
mediated Doppler signals. This oscillation also means that multiple harmonic 
signals or overtones, just as with a musical instrument, are produced. 
Ultrasonography machines can be tuned to "listen" to these harmonics, producing 
strong preferential imaging of the microbubbles, increasing sensitivity of flow in 
very small vessels, so you can see capillaries with a diameter of +/- 100um 
(Blomley, Cooke et at. 2001). 
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Potential treatment delivery 
This selective excitation can also be used to destroy microbubbles relatively 
easily, an effect that can be useful both in imaging and in emerging therapeutic 
applications. Microbubbles can potentially carry treatment and be activated at a 
particular site by using high frequency US beams at that site. This would usually 
require high acoustic power, substantially beyond that pennitted for imaging, but the 
power needed is greatly reduced when microbubbles are present, because 
microbubbles lower the amount of energy necessary for cavitation; the process in 
which extreme oscillations induced by US pulses lead to microbubble collapse. 
It is these technological advances that have pushed the boundaries of use of 
US in many aspects of a rheumatologists practice. 
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2.4 Changes in the use of Ultrasonography with time 
Ultrasonography has come a long way from its first practical uses of judging 
water depth and locating submarines. This change in practice has occurred primarily 
because improvements in technology have allowed the machines to become more 
patient and user-friendly and also led to better quality information being gathered. 
2.4.1 Improvements in image quality 
In rheumatology practice, initial use was mainly confined to larger joints 
such as the hip (Koski, Anttila et al. 1990; Koski and Isomaki 1990), knee (Aisen, 
McCune et al. 1984; van Holsbeeck, van Holsbeeck et al. 1988; Rubaltelli, Fiocco et 
al. 1994; Ostergaard, Court-Payen et al. 1995), shoulder (Cicak, Matasovic et al. 
1992; Alasaarela and Alasaarela 1994; van Moppes, Veldkamp et al. 1995), and 
elbow (Aisen, McCune et al. 1984; van Holsbeeck, van Holsbeeck et al. 1988; 
Koski 1990; Koski, Anttila et al. 1990; Cicak, Matasovic et al. 1992; Koski 1992; 
Alasaarela and Alasaarela 1994; Rubaltelli, Fiocco et al. 1994; Ostergaard, Court-
Payen et al. 1995; Fiocco, Cozzi et al. 1996). With the improvements in transducer 
technology, high-frequency transducers (22-10 MHz) with a smaller footprint size 
became available which allowed for high resolution imaging of superficial structures 
such as the small joints of the hands and feet, and tendons, but also improved image 
quality of larger, deeper structures such as the rotator cuff and hip joint. The smaller 
footprint size allowed for better access and manoeuvrability between the small joints 
and machines have also become more portable lending to their use in the outpatient 
and ward setting. 
2.4.2 Early treatment improves outcome 
Another key reason for the increased use of US (and also MRI) has been the 
growing awareness that early diagnosis with early initiation and aggressive 
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treatment of inflammatory arthritis leads to better long-term clinical and radiological 
outcomes (Emery 1994; Egsmose, Lund et al. 1995; Emery and Salmon 1995; 
Boers, Verhoeven et al. 1997; Landewe, Boers et al. 2002; O'Dell 2002). Both US 
and MRI are now routinely used in many early arthritis clinics to look for the 
presence or absence of inflammation and damage in soft-tissue, tendons and joints. 
The technological improvements previously described allow for quantification of 
inflammation and damage, accurate diagnosis and direct therapy when appropriate 
and advances in three-dimensional software potentially allow for estimation of 
volume (Ribbens, Andre et al. 2003; Terslev, Torp-Pedersen et al. 2003). Sequential 
assessments allow for monitoring of response to therapy by measuring change in 
inflammation and also by measuring progression of damage. Being directly able to 
visualise structures has also contributed to a better understanding of disease 
pathogenesis (Kane, Greaney et al. 1999; Mc Gonagle, Gibbon et al. 1999; 
McGonagle, Conaghan et al. 1999; McQueen, Stewart et at. 1999; Balint, Kane et 
al. 2002; D'Agostino, Said-Nahal et al. 2003). 
2.4.3 Advantages of Ultrasonography 
Ultrasonography has the advantage over arthroscopy, traditionally used as a 
means of directly visualising structures within the joint and obtaining tissue samples 
for histological analysis, of being non-invasive. Ultrasonography, unlike x-ray and 
CT, is able to visualise soft-tissue structures and also lacks ionising radiation. 
Ultrasonography can also be used to guide aspiration and injection of joints, tendon 
sheaths and bursae, and can assess multiple structures in multiple planes at the same 
sitting. Due to the real time image acquisition and lack of physical restriction to the 
patient US is also able to assess real time or 'dynamic' movement of structures, and 
has the advantage of the patient being able to see in real time the structures being 
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assessed. This can allow the clinician to demonstrate and explain the nature of an 
underlying problem, or reassure the patient if structures are normal. Compared with 
MRl, US is relatively inexpensive and is easy for patients to tolerate making it 
particularly useful for repeated assessments. 
Other imaging modalities such as x-ray, CT and MRl can be used by 
technicians using a system of protocols so that a specific image and image 
acquisition technique is used to assess a particular structure or if used to detect a 
particular type of pathology. The nature of image acquisition with these modalities 
also allows for repeat assessments, and images from different assessments are easily 
comparable. This also allows for investigations to be performed away from 
clinicians, by a less expensive technician, and images transmitted to them at another 
site. The restrictions due to cost and ionising radiation with x-ray, CT and MRl 
remain. 
2.4.4 Disadvantages of Ultrasonography 
The disadvantage of US is that is requires an operator that is trained to 
maximise the quality of images acquired and also understand the complex anatomy 
and functional anatomy of structures that are being visualised. Whilst using US in 
the outpatient or ward setting is helpful in that information, giving an earlier more 
accurate diagnosis, is immediately available to the clinician this needs to be weighed 
against the time taken away from regular outpatient duties and the costs associated 
with this. Due to the inability of US to penetrate bone it requires direct access to any 
structure it needs to visualise so has limited ability to detect pathology such as bone 
erosions or cartilage loss particularly in complex joints. Unlike MRl, US cannot 
detect pathology within bone such as bone oedema. Despite these potential 
limitations the use of US by rheumatologists as an additional clinical tool in the 
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assessment of patients with rheumatological conditions has increased (Manger and 
Kalden 1995; Grassi and Cervini 1998; Backhaus, Burmester et al. 2001; Wake field, 
Brown et al. 2004). 
2.4.5 Publications with use of Ultrasonography in Rheumatic Conditions 
The increasing number of publications in recent years relating to the use of 
US in rheumatological practice reflects the growing use and critical evaluation of 
this technique. The are now publications relating to the use of US in conditions such 
as Rheumatoid Arthritis (RA) (Grassi, Tittarelli et al. 1993), spondyloarthropathy 
(SpA) (Lehtinen, Taavitsainen et al. 1994), osteoarthritis (OA)(Aisen, McCune et al. 
1984) (McCune, Dedrick et al. 1990), regional pain syndromes (Manger and Kalden 
1995), tendonitis (Grassi, Tittarelli et al. 1995; Nazarian, Rawool et al. 1995; 
Grassi, Filippucci et al. 2000), bursitis (Nazarian, Rawool et al. 1995), synovial 
cysts (Andonopoulos, Yarmenitis et al. 1995), Sjogrens disease (Makula, Pokorny et 
al. 1996), systemic sclerosis (Ihn, Shimozuma et al. 1995), temporal arteritis 
(Schmidt, Kraft et al. 1995), Tietze's syndrome (Martino, D'Amore et al. 1991), 
amyloid (Kay, Benson et al. 1992), Behcets disease (Ozdemir, Atilla et al. 1995) and 
rib fractures (Mariacher-Gehler and MichelI994). 
2.4.6 Ultrasonography is out ofthis world 
In a clear demonstration of just how much US has taken off Fincke and 
colleagues used remote assistance to train non physician crew members to perform 
US of the shoulder in space (Fincke, Padalka et al. 2005). 
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2.5 Validity and Reliability of Ultrasonography 
The increasing use of US in clinical practice has inevitably led to increased 
publications surrounding this matter but also for calls to investigate the true validity 
and reliability of US findings (Ostergaard and Wiell 2004). The knowledge that 
early diagnosis coupled with aggressive initiation of treatment, is essential to long 
term outcome in many patients with musculoskeletal conditions, has led to keen 
scrutiny of imaging modalities to assess their practical role in improving patient 
outcome. There are different types of validity depending on whether the tool being 
assessed is seen to have the capability of demonstrating a particular feature, whereas 
other types of validity include a comparison with a gold standard. 
2.5.1 Definitions of Validity 
Face Validity 
This term is applied when a modality such a US appears to measure what it 
is supposed to measure. Ultrasonography is able to directly visualize structures such 
as synovium and tendons, has excellent image quality and spatial resolution and is 
capable of demonstrating certain features such as thickness of synovium, blood flow 
and potentially volume. This demonstrates face validity or 'credibility'. 
Content Validity 
Content validity suggests comprehensiveness, that is, the modality being 
assessed is able to cover all aspects of what is being measured. For example with the 
synovium US is able to detect different features of the synovium as mentioned 
above. Ultrasonography however cannot penetrate bone so it can be argued that 
when assessing bone erosions, whilst there is no doubt that US has face validity, 
because of incomplete access to all the bony structures (example intra-bony 
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pathology such as bone oedema) it may not have complete content validity. For 
synovitis however this is not the case. 
Criterion Validity 
Unlike face and content validity which is more subjective, criterion validity 
is the degree to which the modality being assessed reflects a 'gold standard.' There 
are two types of criterion validity, concurrent validity and predictive validity. 
Concurrent validity 
This term is applied when the modality that is being assessed is compared 
against a gold standard assessing the same pathology. In the case of US, an example 
would be, US-detected synovitis compared with synovitis detected by MR!. This is a 
more objective measure of validity and much of the publications discussed below 
fall into this category. 
Predictive validity 
This is described when the modality being assessed is compared against a 
future gold standard outcome. A simple example of this would be where US-
detected synovitis is compared against progression of radiographic damage or 
functional impairment in the future. 
Construct validity 
Construct validity describes consistency with theoretic concepts for example 
that US-detected synovitis is related to other measures of synovitis. 
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Discriminant validity 
This is sensitivity to change and is applied when the modality can detect 
clinically important changes. This requires that there must be a change over time 
(e.g. reduction in synovitis), and that the modality (e.g. US) must be able to reliably 
detect any change. 
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2.6 What features can Ultrasonography detect? 
Accurate detection of synovitis is important for the assessment of systemic 
disease activity, which in turn leads to appropriate treatment. In addition the use of 
newer, more expensive and often more toxic, systemic therapies when clinical 
assessment demonstrates apparent increased disease activity has important cost 
implications. The detection of synovitis, tenosynovitis and enthesitis has an 
important role in patient management and in our unit, with referral for guided 
therapy, has been the commonest reason for referral to US. The presence of erosions 
has diagnostic and prognostic implications for many musculoskeletal conditions. 
This literature review concentrates on these areas attempting to separate the 
evidence by pathology, region of interest and validity. 
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2.6.1 Synovitis and Effusion 
Mep in RA with controls; comparison with clinical assessment 
In recent years there have been a number of studies describing changes seen 
in patients with RA. Grassi and colleagues (Grassi, Tittarelli et at. 1993) evaluated 
the ability of high frequency US (13 MHz) to detect pathological changes in the 
symptomatic MCP joints of 20 subjects with RA using 20 healthy subjects as 
controls. Ultrasonography detected soft-tissue or bone pathology in all RA patients. 
Sixteen patients with RA (80%) had intra articular soft tissue abnormalities; 7 
patients had synovial thickening without joint effusion, 8 patients had synovial 
thickening and joint effusion, and 1 patient had joint effusion without synovial 
thickening. Loss of definition of articular cartilage in the MCP joint was observed in 
17 patients (85%), and 16 (80%) had bone erosions. Regarding tendon disease; 9 
patients (45%) showed widening of the flexor tendon sheaths, with marginal 
irregularities of the extensor tendons in 7 (35%) and flexor tendons in 8 (40%) 
patients. Extensor tendon rupture was observed in 2 patients (10%). The authors 
concluded that US assessment of the MCPs detected more pathology than 
conventional x-ray and suggested a role for US in the assessment of the soft-tissue 
in RA patients. This was one of the first papers to suggest the role of US at 
improving detection of soft-tissue and bone pathology in RA and also used healthy 
controls to demonstrate that the changes described in RA patients did not occur in 
the healthy population. This study did not however include any comparison with any 
accepted gold-standard treatment, so does not demonstrate criterion validity. 
Mep, wrist in RA with controls; comparison with clinical assessment 
Lund and colleagues performed a similar study but with more RA patients 
(29) and less healthy subjects (10) as controls. In addition to the previous study of 
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Grassi & colleagues they also examined the wrist, and findings were also correlated 
with disease activity which was assessed clinically (Lund, Heikal et al. 1995). 
Synovial abnormalities were confirmed to be most commonly identified in the 
rheumatoid hand and wrist (p < 0.01) compared with healthy controls. They 
observed significant differences in synovial abnormalities between the inactive and 
mildly active disease groups as well as the active and mildly active disease groups 
(p < 0.01). This study added to the literature by demonstrating that US findings of 
synovitis differed in patients with different disease activity states. Whilst US 
findings were compared with clinical disease activity, this is not true concurrent 
validity; because most authors would argue that a clinical assessment of disease 
activity, whilst commonly used in clinical practice, is not a gold standard. 
PD in finger and wrist in RA; comparison with clinical assessment 
In this study Qvistgaard and colleagues performed US including PD on 18 
patients with RA (Qvistgaard, Rogind et al. 2001). The subjectively most inflamed 
joint was assessed (Mep, PIP or wrist) with US and was repeated following 
injection with Levovist; other measurements included ESR and HAQ. 
Measurements of synovial area and thickness (gray-scale), vascularisation 
(power/colour Doppler), and indices of the intra- and extra-synovial arterial flow 
(spectral Doppler) were recorded. The mean fraction of the synovium, vascularised 
in the patients was 0.15, and the mean indices ofpulsatility and resistance were 1.92 
and 0.70. The estimated vascular fraction correlated with the ESR, and the relative 
index of pulsatility correlated with both ESR and HAQ. The relative indices of 
pulsatility, an estimate of an abnormally low resistance to vascularisation, correlated 
with both ESR and HAQ. The authors concluded that US is a reliable tool for 
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estimating the size of the joint space and the synovial activity measured by the 
degree of vascularisation and pattern of flow. 
CD in MCP, PIP RA with controls; comparison with clinical assessment 
This study by Hau & colleagues (Hau, Schultz et al. 1999) assessed the Mep 
and PIP joints of patients with rheumatoid arthritis comparing them with healthy 
controls. A total of 120 normal joints and 153 RA joints (21 active, 39 moderately 
active and 93 inactive) were assessed. They confirmed that healthy joints had no 
detectable synovitis. In the RA group synovitis did not correlate clearly with disease 
activity; 67% of inactive joints, 82% of moderately active joints, 52% of active 
joints. Vascularisation performed better with significant differences in the joints of 
all RA sub-groups compared with those of health subjects (p<O.OOI). There were 
also significant differences in the RA sub-groups; inactive versus moderately active 
RA (p<0.02) and inactive versus R active (p<0.05). This study demonstrates that US 
is better than clinical assessment for monitoring RA. 
MCP, PIP, DIP in arthritis; comparison with MRI and scintigraphy 
A study by Backhaus and colleagues (Backhaus, Kamradt et al. 1999) was 
the first to compare US with clinical assessment, MRI and bone scintigraphy in 60 
patients with RA, OA and arthritis associated with connective tissue disease. 
Fourteen joints in one hand were compared with MRI and scintigraphy. Synovitis on 
US was defined as an anechoic or hypoechoic area in the joint space. This study 
demonstrated that clinical assessment, US and MRI were all significantly more 
sensitive than x-ray at detecting inflammatory changes in patients with low grade x-
ray damage (Larsen grades 0-1), and that US detected more synovitis than MRI. 
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There was good correlation with the detection of synovitis using US with MRI and 
scintigraphy. This is one of the first studies to demonstrate concurrent validity 
where US-detected synovitis was compared with MRI and bone scintigraphy. It is 
also one of the few studies published where US was demonstrated to have detected 
more synovitis than MRI. 
PD in Mep RA with controls; comparison with MRl and clinical assessment 
This important study by Szkudlarek and colleagues used good methodology 
to compare PD findings with MRI in RA patients and healthy controls (Szkudlarek, 
Court-Payen et al. 2001). Findings with MRI were separated by the relative speed of 
enhancement post contrast injection. PD US was positive in 16/18 RA MCP joints 
that were quickly enhancing, and falsely positive in only one slowly enhancing RA 
MCP joint, leading to an overall sensitivity and specificity of PD US of 88.8% and 
97.9%. This relatively small study provides evidence of concurrent validity. 
PD with contrast in RA; comparison with MRl 
This study by Magarelli and colleagues (Magarelli, Guglielmi et al. 2001) 
evaluated the role of Levovist during PD US assessment. Forty patients with 
synovitis were assessed before and after Levovist injection, MRI was performed to 
assess validity. Following contrast injection PD US synovitis enhanced in 
comparison to asymptomatic joints in the same patient. PD US and MRI findings 
were the same in all cases. This is a landmark study with each PD US assessment 
correlating with subsequent MRI assessment providing good support of concurrent 
validity. 
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Wrists, shoulders, knees in RA. Response to treatment; comparison with clinical 
assessment 
This study assessed US in detecting response to therapy (fenbufen) in 6 RA 
patients, comparing it with swollen (SJC) and tender joint counts (TJC) (Spiegel, 
Spiegel et al. 1987). They revealed statistically significant differences between TJC 
and SJC, and between TJC and US findings (P less than 0.05 by kappa test statistic), 
but no difference between US findings and SJC (P greater than 0.05). Repeat 
assessment at 6 months revealed high concordance between improvement in SJC 
and US improvement (P less than 0.01). The authors concluded that clinical 
assessment of Joint swelling is accurate and like US can provide objective 
measurement of response to therapy. This study is important because it is one of the 
earliest to compare US counts with standard joint counts. 
PD in Mep with response to therapy; comparison with clinical assessment 
This study by Stone and colleagues used PO US to assess response following 
administration of corticosteroid (Stone, Bergin et al. 2001). There was significant 
improvement in findings with PO US as well as other clinical indices (ESR, VAS). 
Effusion in thumb base OA with controls 
Iagnocco and colleagues performed a control study (lagnocco and Coari 
2000) to document the range of joint distension in the thumb base (carpometacarpal 
joint) used high-resolution US (l0 MHz) to measure distance within the joint space 
in 20 joints in healthy, and 57 joints in OA thumb base OA, subjects. The values 
obtained by measuring the distance between the apex and the base of the joint cavity 
triangle was significantly increased (p<O.OO 1) in OA joints compared with normals. 
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They concluded that the presence of effusion is highly likely if the distance, as 
measured in their study, is greater than 3.33 mm (mean+2 SO). This study is one of 
the few looking at the thumb base, using a standard assessment to detect effusion but 
also setting a limit of distension above which effusion is likely. 
Shoulder in RA; comparison with clinical assessment and x-ray 
In a study assessing the ability of US in providing additional information to 
clinical examination and x-ray in RA patients with shoulder pain Alasaarela and 
colleagues (Alasaarela and Alasaarela 1994) examined 44 RA patients (88 
shoulders) They demonstrated that US detected many soft tissue lesions (in 
relatively early RA disease) when no radiological changes were noted. The most 
common US finding was subacromial-subdeltoid bursitis in 61 shoulders (69%) of 
35 patients. Other findings demonstrated were; glenohumeral joint synovitis in 51 
shoulders (58%) of 32 patients, biceps tendonitis in 50 shoulders (57%) of 29 
patients, and degenerative changes in the supraspinatus tendon in 29 shoulders 
(33%) of 20 patients. They also noted that symptoms and clinical findings were non-
specific and had little association with US findings. This study demonstrated that 
there is a poor sensitivity of clinical examination at detecting soft-tissue in the 
shoulder, but also that US was able to detect significant pathology in a cohort of 
patients with relatively early RA without x-ray changes. Whilst an interesting 
comparison, this is perhaps an unfair reflection on plain radiography because its 
primary use is to assess changes in bone texture or cortical irregularity, not to detect 
soft tissue changes. This study, whilst not comparing US against any gold standard, 
demonstrates the clinical utility of US in detecting significant changes in patients 
with relatively early RA, with relatively few symptoms. 
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Shoulder in arthritis; comparison with MRI 
Alasaarela and colleagues (Alasaarela, Takalo et al. 1997) evaluated 30 
patients with chronic arthritis and painful shoulders (31) with US; the findings were 
then compared with MRI. Ultrasonography was similar to MRI at detecting 
effusions in the subacromial-subdeltoid bursa, biceps tendon sheath and 
glenohumeral joint, but MRI was more sensitive at detecting synovitis. They 
concluded that US was a helpful tool in investigating the painful shoulder and 
suggested that because US is easily available and relatively inexpensive, it should be 
the first line imaging modality for soft-tissue problems of the shoulder with the 
proviso that for some with rotator cuff pathology both modalities may be required. 
This study demonstrates concurrent validity for US in the detection of effusions in 
the subacromial-subdeltoid bursa, biceps tendon sheath and glenohumeral joint. It is 
not clear whether this study, when assessing the shoulder for synovitis used an 
axillary view because many investigators would argue that the classic anterior and 
posterior approach for assessing the glenohumeral joint for synovitis, and effusion, 
is not as sensitive as the axillary view (Koski 1991). 
Shoulder in arthritis; comparison with surgery 
This study assessed 20 inpatients with arthritis one day before their shoulder 
operation (Alasaarela, Leppilahti et al. 1998). Changes in the subacromial-
subdeltoid bursa, biceps tendon and tendon sheath, rotator cuff, and glenohumeral 
joint were recorded and compared with findings at operation. Compared with 
findings at surgery, US had a sensitivity of 93% and a specificity of 83% for the 
detection of effusion/hypertrophy in the subacromial-subdeltoid bursa. For 
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effusionlhypertrophy in the biceps tendon sheath US had a sensitivity of 100% and a 
specificity of 83%. Synovial effusionlhypertrophy was detected by US and at 
operation in all of the 12 glenohumeral joints that were evaluated at surgery. They 
concluded that US is a reliable method in experienced hands for the evaluation of 
inflammatory changes of an arthritic shoulder, with the warning that in advanced 
stages of rheumatoid shoulder joints, however, US is less useful, because destructive 
bone changes and tendon ruptures change the nonnal anatomy and restrict shoulder 
motions, limiting the visibility of US. This study is important because it confinns 
the concurrent validity of US comparing it with the gold standard of findings at 
surgery, although for the detection of glenohumeral effusion the numbers are small. 
Acromioclavicular joint distension,· comparison with x-ray, eT, MRI 
Alasaarela & colleagues (Alasaarela, Tervonen et at. 1997) assessed 63 
healthy volunteers (126 AC joints) and 32 patients (33 joints) with chronic arthritis 
US was to used to define the nonnal range of capsular distension and width of the 
AC joint. It was also compared with x-ray, CT and MRI for the detection of bony 
changes and soft tissue lesions. The mean distance of the joint capsule from the bone 
rim was 2.2 mm +/- standard deviation (SD) 0.5 mm in 21-32-year-old control 
subjects and 2.9 +/- 0.7 mm in 37-81-year-old control subjects. The mean width of 
the joint space was 4.1 +/- 0.9 mm and 3.5 +/- 0.9 mm in the same control groups, 
respectively. In detecting soft tissue changes in arthritic AC joints MRI was better 
than US, whereas regarding bony surface changes, CT was the best method and 
radiography was least sensitive but quite specific. When the distance of the joint 
capsule from the bone rim was < 3 mm on US, there was no synovial hypertrophy or 
effusion on MRI scans allowing the authors to conclude that US is useful for 
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excluding inflammation in the AC joint. This study is important because, using a 
standardised assessment; it defined a limit below which it is unlikely that there is 
any inflammation. This study demonstrates concurrent validity because US is 
compared with 'gold-standard' imaging modalities. 
Hip effusion in early RA 
This study of patients with rheumatoid arthritis of less than 5 years duration 
included 76 patients and also (Eberhardt, Fex et al. 1995)documented patient 
symptoms and clinical findings. This study revealed that 13176 patients had US 
pathology (effusion/synovitis) bilateral in 9 patients. There was poor correlation of 
clinical signs with US findings; 7/13 patients with US pathology were 
asymptomatic, the remaining 6/13 had mild symptoms and 6/63 with normal US had 
symptoms. There was no difference in demographic, clinical, and laboratory 
findings in patients with and without hip synovitis. They concluded that hip disease 
occurs early in RA, US detects changes, and that there is poor correlation between 
clinical assessment and US findings. They added that US, rather than signs or 
symptoms, could identify patients with hip joint involvement and provide a rationale 
for early treatment. This study again demonstrates the clinical utility of US in testing 
patients with early disease, many of whom were asymptomatic. 
Hip effusion; comparison with clinical assessment and x-ray 
In an early study US was used to assess 50 patients with RA (100 hips) and 
compared with clinical assessment and x-ray (Koski 1989). In this study 15 patients 
had US-detected effusion; defined as a distance between the joint capsule and bone 
of more than 7 mm (14), and or a difference between the two sides of more than 1.5 
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mm (1). Clinical assessment was deemed as poor because in 5/15 cases the hips 
were asymptomatic, and routine clinical examination was abnormal in only 2 cases. 
X-ray was normal in 11115 hips. The authors concluded that US hip in RA was more 
sensitive than x-ray for detecting abnormalities. This study demonstrates clinical 
utility, but does not confirm concurrent validity. X-ray was used in this study, but it 
is not a gold-standard for the detection of synovitis of effusion. 
Hip effusion; comparison with surgery 
In one of the earlier studies assessing US ability to detect synovitis or joint 
effusion Koski and colleagues (Koski, Anttila et al. 1990) measured distance 
bem:een the neck of the femur and the capsule of the hip joint in 75 patients, 88 hips 
in total, prior to joint aspiration. All patients had chronic inflammatory joint disease, 
and had hip joint symptoms or signs. In addition, 10 other hips were assessed prior 
to non-replacement surgery of the joint. The study demonstrated that the US 
distance between neck of femur and capsule was 7 mm or greater in the majority of 
hips with synovial fluid following joint aspiration (29/33), and with evidence of 
synovitis or intra-articular effusion during open surgery (7/9). This study concluded 
that both joint effusion and synovitis without effusion can increase the anechoic 
distance between the neck of femur and the joint capsule. As a result of this work 
the value of an upper limit of normal of 7mm hip distension is still used by many 
today. This study despite the lack of controls demonstrates that US has true 
concurrent validity being compared with positive joint aspiration and findings of 
synovitis or effusion during surgery. 
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Knee effusion; comparison with clinical assessment 
This study compared US with clinical examination for the detection of knee 
effusion in 50 patients (Hauzeur, Mathy et al. 1999). Using complex methodology, 
with different study arms assessing sensitivity of examination and correlation, they 
demonstrated clinical detection of effusion had 79% and 32% sensitivity and 
specificity respectively. Agreement was moderate (kappa = 0.508) but statistically 
significant (p<O.OOI) between the clinical and US examinations, agreement was 
slightly weaker (kappa = 0.446, P = 0.032) between the 2 investigators for clinical 
examination, but strongly related (kappa = 0.902) between the 2 investigators for US 
examination. This study demonstrates that clinical assessment is poor compared 
with US, and that US has good inter-observer reliability. 
Knee synovitis; comparison with MRI 
Ostergaard and colleagues (Ostergaard, Court-Payen et al. 1995) assessed 
the ability of US to detect findings in the knee of patients with arthritis using MRI as 
a gold standard. There were 20 subjects; 13 with inflammatory arthritis of the knee, 
2 with osteoarthritis and 5 healthy controls. Assessments included detection of 
effusion (with volume estimation), Baker's cysts, synovial membrane and cartilage 
thickness. Ultrasonography correctly identified 12/12 joint effusions and 5/5 Baker's 
cysts detected on MRI. It also detected synovial thickening in the suprapatellar 
recess in 8/14 (57%) cases. Quantitative MR- and US-estimates of effusion, 
synovial membrane and cartilage thicknesses were taken and Spearman correlation 
coefficients were 0.87, 0.86 and 0.82, respectively. The authors concluded that US 
was reliable at demonstrating joint effusions and Baker's cysts, but insensitive for 
demonstration of synovial membrane and bone erosions. They added that 
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measurement of synovial membrane thickness, when identifiable, was precise as 
was measurement of cartilage thickness, but that the clinical value was limited, 
because the weight-bearing areas were inaccessible. This study demonstrates 
concurrent validity for the detection of effusions, Baker's cysts, and also for US -
estimates of effusion and synovial membrane thickness. 
Knee synovitis in RA response to therapy; comparison with thermography and 
clinical assessment 
A study by van Holsbeeck and colleagues assessed 20 patients with 
longstanding rheumatoid arthritis (including knee involvement) but did not use 
controls (van Holsbeeck, van Holsbeeck et al. 1988). Knee synovitis was assessed 
using US thennography and clinical assessment scores, before and after 
intraarticular corticosteroid. In all patients synovitis, and for all modalities, 
regressed following injection of intra-articular corticosteroid. The quantity of 
synovial fluid, measured with US 10 days post injection of corticosteroid, correlated 
best with the patients clinical assessment. The degree of synovial thickening 
measured by US reduced to a maximum 3 months after corticosteroid injection. This 
study demonstrates the clinical utility of US at detecting changes following 
corticosteroid injection, but does not provide concurrent validity because most 
authors would not include thermography as a 'gold-standard' for detecting synovitis 
in the knee. 
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Knee synovitis in Inflammatory Arthritis response to therapy; comparison with 
arthroscopy 
In a later study US was compared with findings at arthroscopy as the gold 
standard (Rubaltelli, Fiocco et al. 1994). This study validated the ability of US to 
detect, localise, and identify patterns of synovitis in patients with RA and psoriatic 
arthritis (PsA). In some patients US was repeated after synovectomy as well to 
detect any changes in location and pattern of synovitis. Ultrasonography was 
performed in a total of 12 patients with RA (13 knees) and 13 patients with PsA (14 
knees) using an electronic linear transducer (7.5 MHz) or a mechanical sector 
transducer (10 MHz). Arthroscopy was performed within a week of US to document 
synovitis in 3 areas; supra-, medial- and lateral patellar recesses. Thirteen knees 
were also reassessed by US 2 months after synovectomy. A significant correlation 
was found between US and arthroscopic synovial thickness in the suprapatellar (P < 
0.02) and medial peripatella recesses (P < 0.02), the sites of maximal synovial 
proliferation in our patients. Three distinct patterns of synovial proliferation were 
confirmed by arthroscopic examination: villonodular thickening in 12 knees; 
uniform thickening in 8 knees, and overlapping thickening in 7 knees. They 
concluded that US was a valid tool to localise and detect patterns of synovitis, but 
that there were no specific difference in pattern of synovitis between RA and PsA. 
This study confirmed the concurrent validity of US-detected synovitis with 
arthroscopy as the gold standard. There was no histological analysis which most 
authors would argue is the ultimate gold standard in the assessment of synovitis. 
This study however, demonstrates the clinical utility of US at detecting, not only 
changes in degree of synovitis following therapy (in this case arthroscopic 
synovectomy) but also the ability of US to detect different patterns of synovitis. 
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Knee response to therapy; comparison with clinical assessment 
The same group went on to correlate in the long-term clinical with US 
findings following arthroscopic knee synovectomy (Fiocco, Cozzi et al. 1996). At 
entry to the study arthroscopic findings were used to confirm findings at us. 
Assessment had been taken at the outset of the study prior to arthroscopy thereafter 
at 2, 6 and 12 months after synovectomy or otherwise at relapse of synovitis up to 2 
years post synovectomy. Information collected included synovial thickness and 
effusion detected by US, as well as clinical findings. After synovectomy, the clinical 
index and both US joint effusion and synovial thickness were significantly reduced, 
whereas US patterns of synovial proliferation did not show significant changes. 
Clinical and US findings were significantly correlated in all follow-up 
measurements and US joint effusion was significantly increased in the group of 
patients who relapsed compared to non-relapsers following synovectomy. The 
authors suggest that at 12 months the probability of reaching maximum 
improvement in US-detected joint effusion and synovial thickness as an outcome 
was 99% and 58% respectively; whereas the probability of achieving remission was 
72%. They concluded that US findings are accurate, that US can be used to monitor 
response (only validated with clinical findings), and effusion at presentation 
predicted relapse following synovectomy. This study is limited in that the findings 
at follow up assessments with US were compared against clinical findings, however 
this study does suggest that US can be used to predict relapse following 
synovectomy. Relapse however, as assessed clinically, is not a true gold standard 
outcome which would preclude most from concluding that this confirms predictive 
validity. 
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PD in knee arthritis with controls; comparison with clinical indices 
This study compared PD US with clinical indices in 22 patients with 8 
healthy volunteers as controls (Giovagnorio, Martinoli et at. 2001). Presence or 
absence of hypervascularity, synovial thickening, effusion, and Baker's cysts were 
recorded. Disease activity was measured by laboratory indices of inflammation such 
as ESR, CRP. There were significant differences in ESR (P= 0.039), and other 
indices in patient groups defined by presence or absence ofvascularity, leaving the 
authors to suggest that PD US is able to demonstrate synovial hyperaemia and 
correlates with indices of inflammation like ESR. 
PD in knee arthritis; response to therapy 
In this descriptive study Newman and colleagues used PD US in patients 
with arthritis before and after joint aspiration and intraarticular corticosteroid 
injection (Newman, Laing et al. 1996). They reported a decrease in synovial 
perfusion in all eight knees, with improvement of symptoms in seven of the eight 
cases. This descriptive study gives 'credibility' or face validity for the role of PD 
US in monitoring change to therapy. 
PD in knee synovitis; comparison with histology 
This important study assessed the validity of PD US at detecting changes 
compared with histological analysis in 20 patients following total knee replacement 
(Schmidt, Volker et at. 2000). Patients were scanned independently by 2 clinicians 
with different equipment. All 9 patients with histological changes of synovial 
proliferation had PD changes detected by US with 1 observer, and the other detected 
changes in 8/9 knees with synovitis. They confirmed that CD and PD US detected 
small intraarticular vessels equally, and concluded that PD and CD US were 
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valuable for the detection of low-grade synovitis In the knee. This study 
demonstrates concurrent validity with a true gold-standard. 
Another important study evaluated the role of PD US in the diagnosis of 
synovial hypertrophy of the knee joint comparing findings with histological findings 
of synovial membrane vascularity (Walther, Harms et al. 2001). 23 patients 
undergoing arthroplasty of the knee joint had US performed prior to arthroplasty and 
vascularity of the synovial membrane was classified semi-quantitatively using PD 
US. Synovial tissue obtained during the arthroplasty was assessed for vascularity of 
synovial tissue, graded qualitatively. Both qualitative grading systems were 
controlled by analysing PD US images and histological samples using a digital 
image evaluation system. The correlation between the qualitative PD US results and 
the qualitative grading of vascularity by the pathologist was 0.89 by Spearman's rho 
(P < 0.01). Using the digital image evaluation system there was significant 
correlation between PD US images and analysis of synovial tissue. The authors 
concluded that PD US is a reliable, diagnostic method for qualitative grading of 
synovial vascularity. This study provides true gold-standard concurrent validity with 
PD US compared with histology to detect synovitis. 
Knee effusion predicts relapse 
I have already described the methods of Fiocco and colleagues in this study 
which assessed whether findings immediately post synovectomy predicted relapse 
(Fiocco, Cozzi et al. 1996). They demonstrated that US joint effusion was 
significantly increased in the group of patients who relapsed compared to non-
relapser's following synovectomy. This study suggests that US can be used to 
predict relapse following synovectomy. It might be argued however that relapse as 
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assessed clinically, is not a true gold standard outcome which would preclude the 
conclusion that this confirms true predictive validity. 
Baker's cysts; comparison with MRl 
This study by Ward and colleagues assessed 36 knees in patients with 
suspected Baker's cysts (Ward, Jacobson et al. 2001). Baker's cyst on MRI was 
defined as fluid signal between the semimembranosus and medial gastrocnemius 
tendons. Using MRI as the gold standard US rightly diagnosed Baker's cysts in all 
21 patients with evidence on MRI. Ultrasonography also incorrectly diagnosed two 
other knees as having Baker's cysts, which in fact were a meniscal cyst and a 
myxoid liposarcoma. A retrospective review of US images revealed that when 
hypoechoic or anechoic fluid was present between the semimembranosus and 
medial gastrocnemius tendons there was a hundred percent accuracy in diagnosis. 
The authors conclude4 that US is a sensitive tool for detecting Baker's cysts but to 
avoid incorrectly diagnosing other pathology, the presence of fluid between 
semimembranosus and medial gastrocnemius tendons should be a prerequisite to US 
diagnosis. 
Ankle effusion; comparison with x-ray and MRI 
In this cadaveric study Jacobson and colleagues assessed the sensitivity of 
US, MRI and x-ray at detecting effusions in the ankle (talotibial) joint (Jacobson, 
Andresen et al. 1998). Increasing volumes of fluid were injected into the ankle 
before imaging was performed with the ankle in dorsi-flexion, neutral, and plantar 
flexion. X-ray detected fluid within the anterior aspect of the ankle joint in the 
neutral position after 5ml of fluid was injected, and US detected fluid also in the 
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anterior aspect with the ankle in neutral and plantar flexion after 2ml of fluid was 
injected. Fluid was detected by MRI after 1 ml of fluid was injected, in the anterior 
aspect with the ankle in neutral and plantar flexion, and the posterior aspect with the 
ankle in dorsi-flexion. The authors concluded that US was more sensitive than x-ray, 
but less sensitive than MR!, at detecting effusions in the ankle. They also suggested 
that the position of the ankle impacted not only on the ability to detect effusion but 
also on the location where effusion is most likely to be detected. This study 
demonstrates concurrent validity for US and also suggests an examination technique 
to improve detection of joint fluid. 
Response to therapy in RA; comparison with scintigraphy 
In a study of patients with RA receiving radiation synovectomy US was 
compared with technetium scintigraphy as a measure of monitoring response (Gratz, 
Gobel et al. 1999). Twenty patients had radiation synovectomy in 36 joints, and 
bone scintigraphy assessments were performed at baseline, and after I, 2, and 5 
months. Reductions in blood pool activity were seen, and US after 3 and 6 months 
demonstrated a mean reduction in synovial swelling. The reduction in US-detected 
synovial swelling at 3 and 6 months was 1.67 and 4.38 mm respectively in the knee 
joint, 0.88 and 1.93mm in the larger joints (shoulder, elbow, hand, talo-
tibiaVsubtalar), and 0.53 and 1.76 mm respectively in the finger joints. The best 
results clinically were observed in the finger joints. The authors concluded that there 
was a strong correlation between the reduction of blood pool activity, synovial 
swelling, and improvement of pain. This study provides a comparison with 
scintigraphy, but this is not generally accepted as a gold-standard assessment, so 
does not confer concurrent validity. 
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Grassi and colleagues performed high-resolution US (HRUS) on finger 
tendons of 20 patients with RA describing their findings (Grassi, Tittarelli et al. 
1995). Most, 18 patients (90%) had tendon abnormalities; 16 (80%) had widening of 
the flexor tendon sheath, 12 (60%) had loss of the normal fibrillar pattern, with 
irregularity of the flexor and extensor tendon margins seen in 50% and 30% 
respectively. Significant loss of tendon structure consistent with tear was seen in 
10%. This study helps confirm the face validity that HRUS was able to visualise 
fine structures like the extensor tendons, without assessing true concurrent validity. 
Finger extensor tendon partial rupture in RA; comparison with MRI and surgery 
This study included 21 patients with RA and established extensor 
tenosynovitis undergoing surgical inspection, and compared HRUS and MRI with 
surgical findings (Swen, Jacobs et al. 2000). For partial tears, sensitivity and 
specificity were 0.27 and 0.83 for MRI, and 0.33 and 0.89 for HRUS, respectively. 
Positive and negative predictive values were 0.35 and 0.78 for MRI, and 0.50 and 
0.80 for HRUS, respectively. Accuracy was 0.69 for MRI and 0.75 for HRUS. The 
authors concluded that HRUS performed better than MRI at detecting partial 
extensor tendon ruptures, although HRUS (and MRI) was not sensitive enough to 
allow for the assessment of partial extensor tendon rupture. 
Finger tenosynovitis in arthritis; comparison with MRI and scintigraphy 
A study by Backhaus and colleagues (Backhaus, Kamradt et al. 1999) was 
the first to compare US with clinical assessment, MRI and bone scintigraphy in 60 
patients with RA, OA and arthritis associated with connective tissue disease. 
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Fourteen joints in one hand were compared with MRI and scintigraphy. This study 
demonstrated that clinical assessment, US and MRI were all significantly more 
sensitive than x-ray at detecting inflammatory changes in patients with low grade x-
ray damage (Larsen grades 0-1), and that US-detected tenosynovitis correlated with 
findings on MRI. There was also correlation between extensor tendon tenosynovitis 
and scintigraphy. This is one of the first studies to demonstrate concurrent validity 
where US-detected tenosynovitis was compared with MRI and bone scintigraphy. 
Dactylitis in PsA; comparison with x-ray 
In a descriptive study Kane and colleagues described US features of 
dactylitis (25 digits) in 17 patients with PsA (Kane, Greaney et al. 1999). They 
described flexor tenosynovitis in 96% (24/25), joint synovitis in 52% (13/25), and 
with subcutaneous soft tissue enlargement in all dactylitic digits. They demonstrated 
that narrowing of joint space and periostitis on x-ray correlated with joint synovitis 
on US in that digit. This study confirms the validity of US at detecting joint space 
narrowing and periostitis. The findings of tenosynovitis, joint synovitis and soft 
tissue changes in dactylitic fingers are clinically helpful, but do not provide 
evidence of concurrent validity because the described findings cannot realistically 
be compared with x-ray. 
Elbow effusion; comparison with x-ray and MRI 
This cadaveric study (De Maeseneer, Jacobson et al. 1998) assessed the 
sensitivity of imaging modalities at detecting effusions in the elbow. The authors 
injected increasing volumes of fluid into cadaveric elbows and assessed the ability 
of US, MRI and x-ray to detect effusions. The elbow was assessed in full flexion 
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and extension to see if position improved sensitivity. They documented that in 
flexion fluid initially collected in the posterior elbow and fluid then spread to the 
anterior compartment as larger volumes were injected. X-ray detected fluid in the 
joint with a positive fat pad sign on lateral x-ray in elbow flexion with 5 to 10 ml of 
fluid injected, whereas US over the olecranon fossa with the elbow flexed detected 
fluid with 1 to 3 ml of fluid injected. Magnetic-resonance imaging identified joint 
fluid with only 1 ml of fluid injected, regardless of elbow position. The authors 
concluded that US was more sensitive than x-ray, but less sensitive than MRI, at 
detecting effusions in the elbow joint and suggested US to detect effusions in the 
elbow was best perfonned with the elbow flexed. This study demonstrates 
concurrent validity for US at detecting relatively small amounts of joint fluid. but 
also suggests a specific US technique to improve the sensitivity at detecting joint 
effusions. 
Shoulder in arthritis; comparison with MRI 
Alasaarela and colleagues (Alasaarela, Takalo et a1. 1997) evaluated 30 
patients with chronic arthritis and painful shoulders (31) with US; the findings were 
then compared with MRI. Whilst MRI was better than US at detecting full-thickness 
tears of the supraspinatus tendon. US had greater sensitivity detecting partial-
thickness tears and supraspinatus degeneration. Biceps tendon ruptures were 
visualised equally well by MRI and US. The authors concluded that US was a 
helpful tool in investigating the painful shoulder and suggested that because US is 
easily available and relatively inexpensive, it should be the first line imaging 
modality for soft-tissue problems of the shoulder with the proviso that for some with 
rotator cuff pathology both modalities may be required. This study demonstrates 
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concurrent validity for US in the detection of supraspinatus tendon and bicep tendon 
pathology. 
Rotator cuff tear; comparison with arthrography and surgery 
Swen and colleagues determined the validity of US and arthrography to 
detect rotator cuff tears using findings at surgery as the gold-standard (Swen, Jacobs 
et al. 1998). Twenty-one otherwise healthy patients with non inflammatory 
unilateral chronic shoulder pain due to a possible full-thickness rotator cuff tear had 
US and arthrography performed prior to surgery. Sensitivity for assessment of a full 
thickness cuff tear was 0.86 for US and 0.77 for arthrography. Specificity was 0.88 
for US and 0.92 for arthrography. They concluded that US was a useful and valid 
tool to detect cuff tears. This study demonstrates concurrent validity for US and 
arthrography. 
Rotator cuff tear; comparison with MRI and arthroscopy 
Swen and colleagues performed this study in 21 otherwise healthy patients 
with non inflammatory unilateral chronic shoulder pain due to a possible full-
thickness rotator cuff tear (Swen, Jacobs et al. 1999). Ultrasonography was 
performed by a radiologist and a rheumatologist, blinded to each others findings, 
and MRI was evaluated by 2 radiologists again blinded to each others findings. 
Arthroscopy was performed soon after and confirmed for full-thickness tears the 
sensitivity for US and MRI were both 0.81, whereas specificity was 0.94 for US and 
0.88 for MRI. The positive predictive value was 0.96 for US and 0.91 for MR!, and 
the negative predictive value 0.77 for US and 0.74 for MR!. Accuracy was 0.86 for 
US and 0.83 for MR!. The authors concluded that US was a valid tool to detect full 
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thickness cuff tears. This study demonstrates concurrent validity and also adds the 
assertion that US can be performed by a rheumatologist as well as a radiologist. 
Painful shoulder; comparison with surgery 
This study by Read and colleagues evaluated the accuracy of US for the 
preoperative evaluation of shoulder impingement syndrome, rotator cuff tear, and 
abnormalities of the long head of the biceps tendon in 42 consecutive surgical cases 
(Read and Perko 1998). Ultrasonography detected all of the 10 full-thickness cuff 
tears identified at surgery (sensitivity 1.0, specificity 0.97) but detected only 6 of 13 
partial-thickness cuff tears (sensitivity 0.46, specificity 0.97). A full-thickness tear 
was falsely diagnosed in one case of severe cuff abrasion. Dynamic scan criteria 
correctly diagnosed impingement in 27 of 34 cases (sensitivity 0.79, positive 
predictive value 0.96), and abnormalities of the long head of the biceps tendon were 
accurately diagnosed with the exception of low-grade tendonitis. They concluded 
that US is a sensitive and accurate method of identifying patients with full-thickness 
tears of the rotator cuff, and or long head of biceps tendon pathology, and that 
dynamic US could help confirm, but not exclude, impingement. 
Another similar study assessed 20 inpatients with arthritis one day before 
their shoulder operation (Alasaarela, Leppilahti et at. 1998). Changes in the 
subacromial-subdeltoid bursa, biceps tendon and tendon sheath, rotator cuff, and 
glenohumeral joint were recorded and compared with findings at operation. 
Compared with findings at surgery, US had a sensitivity of 70% and a specificity of 
100% for the detection of biceps tendon rupture. US missed three intraarticular 
biceps tendon ruptures. For effusionihypertrophy in the biceps tendon sheath US had 
a sensitivity of 100% and a specificity of 83%. For rotator cuff tear US had a 
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sensitivity of 83% and a specificity of 57%. US missed two small longitudinal 
rotator cuff tears. Three thin membranous, but intact, rotator cuff tendons were 
classified as full thickness tears by US. The authors concluded that US is a reliable 
method in experienced hands for the evaluation of inflammatory changes of an 
arthritic shoulder, with the warning that in advanced stages of rheumatoid shoulder 
joints, however, US is less useful, because destructive bone changes and tendon 
ruptures change the normal anatomy and restrict shoulder motions, limiting the 
visibility of US. This important study confirmed findings with US as being valid 
when compared to findings at surgery which reaches the ultimate gold standard for 
tendon damage and rupture. 
Achilles tendon pathology; comparison with surgery 
This is one of the earliest studies comparing Achilles tendon pathology with 
surgical findings. Lehtinen and colleagues used a 5 MHz linear array probe to 
examine 30 patients (34 Achilles tendons) with overuse injuries prior to surgery 
(Lehtinen, Peltokallio et al. 1994). Ultrasonography had an overall sensitivity of 
0.96 in the detection of Achilles tendon pathology; US suggested partial Achilles 
rupture in 10 cases, all confirmed at surgery, but missed one seen at surgery. In this 
cohort US was under diagnostic for paratenonitis and over diagnostic for tendonitis, 
with most diagnosed by US as having tendonitis, actually having paratenonitis at 
surgery. The authors conclude that US is a valid tool for the diagnosis of partial 
ruptures. Whilst this study confirms concurrent validity for US detection of partial 
ruptures, the 5 MHz probe would not have had the resolution to clearly differentiate 
between the paratenon and tendon. 
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Posterior tibialis tendon pathology,' comparison with surgery 
In this retrospective study, Miller and colleagues studied 17 patients who 
had US performed prior to posterior tibialis tendon surgery (Miller, Van Holsbeeck 
et al. 1996). US findings of tenosynovitis in 3, partial tears in 4, and complete 
ruptures in 10 tendons were confirmed at surgery. A subset of patients also had MRI 
performed and the authors noted that 2 cases of ruptures were undiagnosed with 
MR!. The authors concluded that US was a reliable tool to assess the posterior 
tibialis tendon, and maybe a valuable tool in planning surgery, but conceded that the 
study was limited because it was retrospective. The findings are however still 
important for patients with inflammatory arthritis, particularly rheumatoid arthritis 
where posterior tibialis tendon disease is common, but also in patients presenting 
with foot and ankle pain. 
Plantar tenosynovitis in inflammatory arthritis with controls; comparison with 
clinical assessment 
This study included 25 patients with inflammatory arthritis and forefoot pain 
with 35 healthy controls, and included clinical findings (Koski 1995). 
Ultrasonography revealed twenty plantar flexor tenosynovitis in 12/25 patients. 
Only 6120 affected digits had a corresponding inflamed MTP, and only 8/20 had 
clinical abnormalities detected on examination. The authors concluded that 
tenosynovitis as well as MTP joint disease can cause forefoot pain. This study 
demonstrates that US is more sensitive than clinical examination, but does not imply 
concurrent validity. 
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Enthesopathy; comparison with clinical assessment 
This early study assessed the lower limbs of 31 patients with 
Spondyloarthropathy (SpA) and compared US with clinical findings (Lehtinen, 
Taavitsainen et al. 1994). Ultrasonography detected enthesitis in 44 entheseal sites 
in 20 patients, whereas with clinical examination enthesitis was diagnosed in 56 
sites in 20 patients. The commonest sites were at the insertions of the Achilles 
tendon and the plantar fascia. Clinical examination frequently misinterpreted bursitis 
around the calcaneum and synovitis, and or pain in the hip and knee joints as 
enthesitis. The authors concluded that US was a valuable tool for detecting 
enthesitis and clinical examination had poor specificity compared with US. 
Plantar fascia 
Kane and colleagues performed a study of 4 patients (5 heels) who had 
failed to respond to non-guided or 'blind' injections (Kane, Greaney et al. 1998). 
Patients had US of their symptomatic and asymptomatic (in 3 patients) heels. 
Ultrasonography confirmed an increased thickness of plantar fascia in symptomatic 
heels compared with asymptomatic heels, loss of distinction of the distal plantar 
fascia borders, and reduced echogenicity of the plantar fascia. They concluded that 
US can effectively diagnose plantar fasciitis. This study is descriptive and, while 
including a relatively small amount of patients, used the asymptomatic side as a 
control. 
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2.6.3 Erosions 
The detection of erosions is important because they form part of the 
diagnostic criteria for some conditions like RA, but also because they have 
prognostic implications for outcome. Much of this thesis concentrates on the 
detection of synovitis and tendon disease more so than erosions, so the literature 
review here concentrates on a few key pieces of research. 
MCP, wrist erosions in RA with controls 
Lund and colleagues performed a study with RA patients (29) and healthy 
subjects (10) as controls assessing the Mep and wrist joints and comparing their 
findings in the 2 groups and also comparing findings with disease activity states 
(Lund, Heikal et at. 1995). Erosions were confirmed to be most commonly identified 
in the rheumatoid hand and wrist (p < 0.01) compared with healthy controls. They 
observed significant differences in erosions between the inactive and mildly active 
disease groups as well as the active and mildly active disease groups (p < 0.0 I). 
Ultrasonographic findings however, of normal and abnormal cartilage as defined did 
not predict normal and disease states. This study added to the literature by 
demonstrating that erosions were seen more frequently in increased disease activity 
states. 
MCP, PIP, DIP erosions in arthritis; comparison with MRI and scintigraphy 
I have already described the methods of this study by Backhaus and 
colleagues (Backhaus, Kamradt et al. 1999). In this study US recorded changes of 
'irregular joint contour' and correlated these with x-ray and MRI, and demonstrated 
that US detected these changes in a significant number of patients, but did not 
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demonstrate any significant correlation between x-ray or MRI, with us. This is one 
of the first studies that assessed the concurrent validity of US-detected 'erosions', 
but is somewhat limited by the definition of 'erosions'. 
Mep in RA; comparison with x-ray and MRI 
This study compared US with x-ray for the detection of erosions in the MCP 
joints of 100 patients with RA and 20 controls (Wake field, Gibbon et at. 2000). A 
sub-group of 25 patients also had MRI performed. Intra-observer reliability of US 
was assessed using video recordings of 55 MCP joint scans of RA patients, and 
inter-observer reliability was assessed by comparing 160 MCP joint scans 
performed sequentially by 2 independent observers. In all RA patients (100) US 
detected significantly more erosions, 127 (56 patients) compared with x-ray 
detecting 32 erosions (26 coincided with US erosions) in 17 patients (P < 0.0001). 
Ultrasonography detected 6.5-fold more erosions than x-ray in early disease, in 7.5-
fold the number of patients, compared with 3.4-fold more erosions than x-ray in late 
disease, in 2.7-fold the number of patients. In the sub-group with MRI, all US 
erosions not visible on x-ray (n = 12) corresponded by site to MRI abnormalities. 
The Cohen-kappa values for intra- and inter-observer reliability of US were 0.75 
and 0.76, respectively. The authors concluded that US is a reliable technique that 
detects more erosions than x-ray, especially in early RA, and that US-detected 
erosions not seen on x-ray corresponded to MRI bone abnonnalities. This study 
provides concurrent validity comparing US with MRI. 
56 
MD Thesis- Dr Zunaid Karim 
Knee; comparison with MRI 
Ostegaard and colleagues (Ostergaard, Court-Payen et al. 1995) assessed the 
ability of US to detect bone erosions in the knee of patients with arthritis using MRI 
as a gold standard. There were 20 subjects; 13 with inflammatory arthritis of the 
knee, 2 with osteoarthritis and 5 healthy controls. Ultrasonography identified only 
3/8 (38%) bone erosions. The authors concluded that US was insensitive for 
demonstration of bone erosions. This study confinns the limited role of US for 
detecting erosions in the knee in that weight bearing areas of the knee are largely 
inaccessible. 
Shoulder in arthritis; comparison with MRI 
I have already described the methods used in this study by Alasaarela and 
colleagues (Alasaarela, Takalo et al. 1997). Ultrasonography was compared with 
MRI in 30 patients with painful shoulders (31). Erosions of the humeral head were 
visualised equally well by MRI and US, but the locations occasionally differed. 
They concluded that US was a helpful tool in investigating the painful shoulder and 
suggested that because US is easily available and relatively inexpensive, it should be 
the first line imaging modality for problems of the shoulder. This study 
demonstrates concurrent validity for US in the detection of erosions. 
Shoulder in RA,· comparison with x-ray, eT and MRI 
Another study compared US with CT, MRI and x-ray at detecting humeral 
head erosions, 26 patients (1 shoulder each) with RA (Alasaarela, Suramo et al. 
1998). Magnetic-resonance imaging detected humeral erosions in 25 (96%) 
shoulders, compared with 24 (92%), 20 (77%) and 19 (73%) for US, CT and x-ray 
respectively. Magnetic-resonance imaging and US were both significantly superior 
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to eT in detecting small erosions, and US was more sensitive than MRI at detecting 
surface erosions on the greater tuberosity. Ultrasonography, eT and MRI detected 
large erosions quite similarly, but x-ray frequently missed small erosions. They 
concluded that US and MRI were more sensitive than traditional x-ray at detecting 
early erosions in the rheumatoid shoulder. This study is important because it 
compares US with the standard technique of x-ray but with the evolving gold 
standard of eT and MRI providing concurrent validity. 
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2.7 US-guided therapy 
With increasing use of US and its ability to clearly visualise structures it was 
no surprise when US started being used to direct therapy to specific areas. This is 
partly related to the fact that with US clinicians are able to visualise the structures 
that they want to direct therapy to, but also able to observe for example 
corticosteroid directly injected into the joint. Techniques for guiding joint injections 
have been published (Ko ski 2000). 
2.7.1 Mep, flexor tendon sheath injections 
Grassi and colleagues have added much to the literature with their 
descriptive and pictorial essays on the use of US-guided therapy in arthritis. While 
not providing any concurrent validity they have led the way in describing techniques 
in Guided injections. In this pictorial essay they describe an US-guided approach to 
local injection of the 3rd Mep joint and flexor tendon sheath in a patient with PsA 
(Grassi, Lamanna et a1. 1999). After determining joint and tendon synovitis they 
proceed to demonstrate the technique for guided injection, confirming placement of 
the needle before injecting corticosteroid. They conclude this is a safe and simple 
method to accurately guide therapy to small joints and tendons. 
2.7.2 Aspiration and injection 
Another review by Grassi and colleagues suggests that US has a clear role to 
play in the aspiration of small fluid collections, and also in the targeting of specific 
lesions (Grassi, Farina et a1. 2001). They conclude that due the ease of learning 
guided needle placement this should be included in the standard training of all 
rheumatologists. 
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2.7.3 US-guided wrist injection; injection site and response to therapy 
Koski has also assessed whether wrist injection is best as a single radio 
carpal or as a combined radio and inter-carpal injection in 50 patients. 
Ultrasonography was used to guide injection, and then monitor response to therapy. 
The combined injection had better outcomes, although clinical assessment (68%) 
recorded more wrists as normal at follow-up compared with US (1O%) (Koski and 
Hermunen 200 I). 
2.7.4 US-guided carpal tunnel release; comparison with conventional surgery 
Ultrasonography has been used to demarcate and guide incision of the flexor 
retinaculum in patients undergoing carpal tunnel release. In this randomised study of 
103 patients comparing US-guided carpal tunnel release with conventional carpal 
tunnel release, similar outcomes were demonstrated with respect to numbness and 
parasthesiae, static two-point discrimination, and electrophysiological findings 
(Nakamichi and Tachibana 1997). The US-guided release group however, had better 
outcomes regarding pain, tenderness of the scar, and key-pinch strength at 3, 6, and 
13 weeks, as well as grip strength at 3 and 6 weeks after surgery. The authors 
concluded that US-guided carpal tunnel release was as effective as conventional 
release but with potential benefits regarding certain key outcomes. This study 
provides concurrent validity for the role of US to guide carpal tunnel release. 
2.7.5 Caudal injections 
Klocke & colleagues (Klocke, lenkinson et al. 2003) demonstrated using 
high resolution real time US, that it is possible to identify the sacral hiatus 
landmarks and subsequently guide needle placement. The authors suggest that this 
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technique, whilst potentially useful in all patients would be particularly useful in 
patients with clinically unreliable anatomic landmarks. In this study there is no 
formal confirmation of placement. 
2.7.6 Iliopsoas abscess 
McAuliffe and colleagues described a case where US was used to guide 
drainage of an iliopsoas abscess (McAuliffe and Clarke 1994). This was followed a 
few years later by Gupta and colleagues (Gupta, Suri et al. 1997) where US was 
used to drain an iliopsoas abscess in 51 patients as an alternative to surgery, with 
only 7 out of 51 patients ended up requiring surgery in the long term. This study 
confirmed a clear clinical utility of US allowing a less invasive guided technique to 
avoid the majority of patients requiring more invasive surgery. 
2.7.7 Plantar fascia 
Kane and colleagues performed a study of 4 patients (5 heels) who had failed 
to respond to non-guided or 'blind' injections (Kane, Greaney et al. 1998). All 
symptomatic heels had US-guided injections. Following injection one patient 
developed a recurrence of symptoms after 6 months, but 3 patients (4 heels) had 
complete relief (mean follow-up 24 months). They concluded that US can 
effectively diagnose and treat plantar fasciitis, suggesting one of the reasons for 
previous lack of response may have been misplacement of 'blind' injection. This 
study demonstrates a clinical utility of US. All patients had previously failed non 
guided or 'blind' injections, with most patients having complete relief at extended 
follow-up. 
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2.8 Reliability of Ultrasonography 
One of the key advantages of US over conventional x-ray and even MRI is 
that is it safe, portable, and capable of multiple examinations at one sitting. With 
modalities like MRI, CT and x-ray standardisation of assessment and storing of 
images is easy and it is also possible to compare saved images with ones taken at a 
later date. Unlike the modalities mentioned above US is operator dependent and has 
lacked evidence confirming reliability. 
2.8.1 Mep, PIP, DIP synovitis and erosions in arthritis 
A study by Backhaus and colleagues (Backhaus, Kamradt et al. 1999) was 
the first to compare US with clinical assessment, MRI and bone scintigraphy in 60 
patients with RA, OA and arthritis associated with connective tissue disease. 
Fourteen joints in one hand were compared with x-ray, MRI and scintigraphy. 
Twenty randomly selected patients of the original 60 had a second blinded reading 
of all 4 modalities. The intra-observer variation coefficient for US was 11 % for 
synovitis and 5% for 'erosions', compared with 12 % and 17% respectively for 
MRI. The intra-observer coefficient of variation for bone scintigraphy was 5%, and 
for x-ray erosions 8%. This is one of the first studies to demonstrate the reliability of 
US, albeit intra-observer only, whilst also comparing this with other imaging 
modalities. 
2.8.2 Gray-scale, PD synovitis in finger and wrist RA 
In this study US including PD was performed on 18 patients with RA 
(Qvistgaard, Rogind et al. 200 I). The subjectively most inflamed joint was assessed 
(MCP, PIP or wrist) by 2 independent observers and included measurement of 
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synovial area and thickness (gray-scale), vascularisation (power/colour Doppler), 
and indices of the intra- and extrasynovial arterial flow (spectral Doppler). The two 
investigators measured the pixel area of the synovial vessels twice. The intra-
observer correlation coefficient of 74 evaluable double measurements was 0.97 
(p<O.OOOI) for investigator 1, and 0.82 (p<O.OOOI) for investigator 2. Inter-observer 
reliability was tested in the first evaluation of the pictures and the correlation 
coefficient between investigators 1 and 2 was 0.81 (n=75, p<O.OOOI). The authors 
concluded that US is a reliable tool for estimating the size of the joint space and the 
synovial activity measured by the degree of vascularisation and pattern of flow. 
2.8.3 Mep erosions in RA 
This study compared US with x-ray and MRI for the detection of erosions in 
the MCP joints of 100 patients with RA and 20 controls (Wakefield, Gibbon et a1. 
2000). Intra-observer reliability of US was assessed using video recordings of 55 
MCP joint scans of RA patients, and inter-observer reliability was assessed by 
comparing 160 MCP joint scans performed sequentially by 2 independent observers. 
The Cohen-kappa values for intra- and inter-observer reliability of US were 0.75 
and 0.76, respectively. The authors concluded that US is a reliable technique for the 
detection of erosions in RA. 
2.8.4 Rotator cuff tears 
This study which determined the validity of US and arthrography to detect 
rotator cuff tears using findings at surgery as the gold-standard (Swen, Jacobs et a1. 
1998), also used 2 operators a rheumatologist and a radiologist to US. The inter-
observer reliability for US was 0.63, compared with 0.52 for MRI, the authors 
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concluding that US is a valid and reliable tool that could be performed by either a 
rheumatologist or radiologist experienced in US. 
2.8.5 Knee effusion; comparison with clinical assessment 
This study compared US with clinical examination for the detection of knee 
effusion 50 patients (Hauzeur, Mathy et al. 1999). Using complex methodology, 
with different study arms assessing sensitivity of examination and correlation, they 
demonstrated that agreement was moderate (kappa = 0.508) but statistically 
significant (p<O.OOI) between the clinical and US examinations, agreement was 
slightly weaker (kappa = 0.446, p = 0.032) between the 2 investigators for clinical 
examination, but strongly related (kappa = 0.902) between the 2 investigators for US 
examination. This study demonstrates that US has good inter-observer reliability. 
2.8.6 PD in knee synovitis 
Schmidt and colleagues in a study of 20 patients assessed the validity of PD 
US at detecting changes compared with histological analysis following total knee 
replacement (Schmidt, Volker et al. 2000). Patients were scanned independently by 
2 clinicians with different equipment. All 9 patients with histological changes of 
synovial proliferation had PD changes detected by US with 1 observer, and the other 
detected changes in 8/9 knees with synovitis. They concluded that both PD and CD 
US had good inter-observer reliability and were valuable for the detection of low-
grade synovitis in the knee. 
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2.9 Summary and aims of this thesis 
This thesis centres on looking at the role of US in daily clinical practice and 
using scientific research sets out to justify its use. 
2.9.1 Format 
Each chapter will be set out in the same format describing the clinical 
relevance of the study then an abstract of the study. The body of the study will have 
an introduction, methods section, results section; and then a discussion followed by 
subsequent studies relevant to the work discussed in the chapter, before a final 
summary. 
2.9.2 Chapter 3 
The construct validity of US at detecting synovitis in the knee will be 
assessed. Clinical examination and US are compared with findings at arthroscopy, 
used as the gold-standard, for the detection of synovitis in the knee. A binary 
(yes/no) and semi-quantitative measure of US synovitis is recorded, and the intra-
and inter-observer reliability of US at detecting synovitis for both these measures is 
assessed. 
2.9.3 Chapter 4 
In chapter 4 the accuracy of US-guided injections to the shoulder sub-
acromial bursa is determined, using contrast mixed with corticosteroid, confirming 
placement with x-ray. 
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2.9.4 Chapter 5 
In chapter 5 the efficacy of US-guided injections in patients with arthritis of 
the hip is documented in an open pilot study. Baseline features with US of 
osteophytes and effusion are recorded, prior to US-guided injection of 
corticosteroid. This pilot study also evaluates whether baseline US features predict 
outcome. 
2.9.5 Chapter 6 
In chapter 6 based on the evidence that clinical detection of low-level 
synovitis is poor, and of ongoing joint damage despite a relative lack of disease 
activity on clinical assessment, we use US to assess RA patients thought to be 
clinical remission. Synovitis detected by US is compared with clinical indices such 
as metrology and CRP, and both ACR and DAS28 criteria of remission. 
2.9.6 Chapter 7 
In chapter 7 we demonstrate the clinical utility of US in a cohort of patients 
with symptoms to suggest an underlying inflammatory arthritis but without much 
clinical evidence to confirm this. Baseline assessment with US to document 
synovitis is followed by treatment with intramuscular methylprednisolone (IM MP) 
following a specific treatment algorithm. Using the response to IM MP as 
suggesting an underlying inflammatory process, response to IM MP is recorded and 
baseline features including US are assessed to determine predictors of response. 
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2.9.7 Chapter 8 
In this chapter, the clinical utility of US in patients who were referred for US 
by their attending consultant is determined. All patients had a clinical assessment 
with the clinician documenting the likely pathologic diagnosis of the area in 
question, as well as the overall clinical diagnosis before US was performed. This 
study documents the referral pattern in a rheumatology academic unit, and also 
compares changes in the local site-specific diagnosis, overall diagnosis and 
management following blinded US assessment. 
2.9.8 Chapter 9 
This chapter will summarise the findings of this thesis and, taking into 
account the published literature, will discuss investigations required in the future to 
justify the continuing use of US in rheumatology practice. 
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Chapter 3 
3.1 Knee synovitis: Construct Validity 
3.2 Clinical relevance 
Synovitis has been shown to be important for the symptoms and progression 
of knee arthritis. Clinical assessment is not reliable, and the gold standard 
assessment, findings with histology requires invasive techniques like arthroscopy. 
This large study using macroscopic findings at arthroscopy as gold standard 
determines the validity and reliability of US-detected synovitis. 
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Accurate detection of synovitis is important in both the diagnosis and 
outcome assessment of arthritis. By comparing US with arthroscopy and clinical 
assessment, this study assessed the validity and reproducibility of US as a means of 
detecting synovitis in the knee. 
3.3.2 Methods 
Sixty consecutive patients with knee pain due to different arthritides had a 
clinical assessment and US of their knee performed immediately prior to 
arthroscopy. All 3 assessments were performed by different clinicians blinded to the 
other modality results. Ultrasonography and clinical assessment were compared with 
arthroscopically detected synovitis as the gold standard. A subset of patients was 
used for calculating the inter- and intra-reader reproducibility of US, using a 
standard dichotomous (absence/presence of synovitis) as well as testing a graded 
(absence/grade of synovitis) scoring system. 
3.3.2 Results 
Using arthroscopy as the gold standard US had a higher sensitivity (98 vs 
85%), specificity (75 vs 25%), accuracy (97 vs 77%), positive predictive value (98 
vs 88%) and negative predictive value (88 vs 20%) compared with clinical 
assessment. The Cohen-kappa values for inter- and intra-reader reproducibility of 
US for distinguishing between presence/absence of synovitis were 0.71 and 0.85 
respectively (p<0.005 for both). The weighted kappa values for distinguishing grade 
of synovitis were 0.65 for inter- and 0.74 for intra-reader reproducibility. The kappa 
value for intra-reader reproducibility of arthroscopy was 0.88. 
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3.3.4 Conclusions 
Ultrasonography is a valid and reproducible technique for detecting synovitis 
in the knee, and is more accurate than clinical assessment. It may be valuable as a 
tool in studies investigating pain, diagnosis and treatment response in knee arthritis. 
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3.4 Introduction 
Synovitis is the usual presenting sign of inflammatory arthritis and has a 
central role in the progression of joint damage in RA (Ostergaard, Hansen et al. 
1999). Synovitis is also frequently present in OA especially with advanced structural 
damage (Pelletier, Martel-Pelletier et al. 2001) has recently been associated with the 
degree of knee pain (Hill, Gale et al. 2001) and predicting progression of cartilage 
loss in the knee (Ayral, Pickering et al. 2001). Clinical assessment of the knee for 
synovitis has poor sensitivity and reproducibility (Jones, Hopkinson et al. 1992; 
Hauzeur, Mathy et al. 1999). A more reliable method of detecting and quantifying 
synovitis is therefore desirable. 
Arthroscopy allows direct visualisation of the synovial membrane and 
structures within the joint compartment. It is frequently used as a method of 
quantifying synovitis of the knee, and has been validated against histological 
findings in both OA and inflammatory arthritis (Lindblad and Hedfors 1985; 
Lindblad and Hedfors 1987). In addition recent evidence suggests synovitis visible 
on arthroscopy is a predictor of progression of OA (Ayral, Pickering et al. 2001). 
Magnetic resonance imaging has been shown to be a sensitive tool for detecting 
synovitis when compared with arthroscopy (Ostergaard, Stoltenberg et al. 1997), but 
issues relating to cost may affect patient access. 
The use of US is increasing because it is relatively inexpensive, non-
invasive, does not involve exposure to ionising radiation and as a result can be used 
repeatedly on the same patient in multiple anatomical areas. It therefore has the 
potential to assess the extent of synovitis and changes in the synovial volume over 
time. However, there are few validation studies of US and its ability to detect 
synovitis in large joints. Relatively small number studies have compared synovitis 
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detected by grey-scale US with MRI (Ostergaard, Court-Payen et al. 1995) and with 
arthroscopy (Worth, Hermann et al. 1986; Rub alte lli , Fiocco et al. 1994; Batalov, 
Kuzmanova et al. 1999), although the latter studies assessed only inflammatory 
arthritis patients with persistent knee synovitis referred for synovectomy, who may 
be expected to have greater volumes of synovitis. A recent publication has assessed 
the relatively new technique of Power Doppler US in the knee comparing it with 
histopathologic findings of synovial membrane vascularity in 23 patients with 
rheumatoid arthritis and osteoarthritis undergoing arthroplasty suggesting good 
correlation (Walther, Harms et al. 2001). 
Whereas US has demonstrated good reproducibility for detecting erosions in 
the MCP joint (Wake field, Gibbon et al. 2000) and assessing cartilage thickness in 
the knee (Disler, Raymond et al. 2000), there is no published data for reproducibility 
of knee synovitis. In this study, US and clinical assessment were compared with 
arthroscopy for the detection of synovitis in a large group of patients with knee pain. 
We also assessed the inter- and intra-reader reproducibility of US, as well as intra-
reader reproducibility of arthroscopy, on a subset of patients. 
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3.5 Methods 
3.5.1 Patients 
Consecutive patients with knee pain referred for artbroscopy of the knee 
were included in the study. All patients had a clinical assessment and US performed 
by different physicians blinded to each other's findings prior to arthroscopy. The 
indications for referral to arthroscopy were either diagnostic or therapeutic and 
arthroscopy was performed on the signal knee only in all patients. Sixty knees from 
60 patients were included in the study (30 female, 30 right knees). The mean age of 
patients was 52 (18-79) and clinical diagnoses included osteoarthritis (n=19), RA 
(n=16), SpA (n=14), oligoarthritis (n=4), gout (n=4) and anterior knee pain (n=3). 
The local research ethics committee gave approval for the study and informed 
consent was obtained from all patients before the procedures. 
3.5.2 Clinical Assessment 
All patients had a standard clinical assessment of the signal knee by the 
assessing physician who documented the presence or absence of synovitis, defined 
as the presence of an effusion (positive patella tap or bulge sign) or palpable 
synovial thickening. 
3.5.3 Ultrasonography 
An ATL (Advanced Technology Laboratories, Bothel, Washington, USA) 
HDI 3000 US machine with a linear array 10-5 MHz 'hockey stick' transducer was 
used to examine the knee on the same day as (but prior to) artbroscopy. Three areas 
of the knee; the medial compartment (MC), lateral compartment (LC) and 
suprapatella pouch (SPP) were assessed. The MC was defined as the area medial to 
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the patella running inferiorly past the medial joint line to the infero-medial aspect of 
the joint capsule; the Le the area lateral to the patella running inferiorly past the 
lateral joint line to the infero-Iateral aspect of the joint capsule, and the SPP as the 
area above the patella. The retro-patella space was not included in the comparison 
because US is unable to fully visualise this space. 
One physician (ZK) performed US on all patients, whereas for the last 10 
patients US was also performed by an additional physician (RJW). Both were 
experienced in performing US and were blinded to the indication for the arthroscopy 
and clinical assessment findings, as well as the findings of the other 
ultrasonographer. 
Ultrasonographic synovitis was defined as the presence of a thickened 
synovial membrane identified as the hypoechoic structure adjacent to the anechoic 
joint effusion and the more hyperechoic fatty tissue (Figure 3.1). 
The patient was examined initially with the knee fully extended, then 
partially flexed to 30 degrees and each compartment was scanned in transverse and 
longitudinal planes. Moving the knee from the extended to partially flexed position 
allowed for better visualisation of all 3 compartments, but also caused movement of 
any synovial fluid if present, which helped create a better acoustic interface. 
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Figure 3.1 Ultrasonography. Knee synovitis. 
This is a longitudinal view of the lateral compartment with the knee extended. The 
hypoechoic synovial membrane (+X*) with vi lli-like protrusions adjacent to the 
anechoic joint effusion and the more hyperechoic fatty tissue seen in a patient with 
RA. LC= Lateral Condyle, SF= Synovial Fluid. 
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Small amounts of fluid were detected by contraction of the quadriceps 
muscle and confirmed by transducer ballottement (Figure 3.2). Images of each 
compartment were recorded and stored on acetates with only the patients study 
number and compartment identified. 
Figure 3.2 Ultrasonography. Ballottement of effusion 
This is a longitudinal view of the suprapatella pouch with the knee flexed . The filled 
arrows demonstrate apposition of the synovial membrane (*) under pressure from 
the transducer. MC= Medial Condyle, SF= Synovial Fluid. 
Synovitis was documented usmg a standard dichotomous scale as either 
present or absent for each of the compartments, with a semi-quantitative assessment 
for degree of synovitis also recorded (Normal = No synovitis; Mild = Flat thickened 
synovium; Moderate = Thickened synovium with few villi-like protrusions; Severe 
= Marked thickening with multiple vi lli-like protrusions) . The presence or absence 
of synovial fluid was also documented. 
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Inter-reader reproducibility was calculated by comparing the findings of the 
2 ultrasonographers for the 10 patients (30 compartments) who were examined 
independently and sequentially on the same day. Intra-observer reproducibility was 
calculated using stored images of 30 randomly chosen compartments reviewed a 
month after the end of the study period. 
3.5.4 Medical Arthroscopy 
A standard procedure was used to assess all knees. Arthroscopy was 
performed under local anaesthetic, using a Storz 2.7mm rigid arthroscope and a 5 
mm drainage cannula. The physician performing arthroscopy was blinded to the 
findings at clinical assessment and us. Prior to insertion of the arthroscope the knee 
was distended with between 40 and 60ml of normal saline. The arthroscope was 
inserted through the infero-Iateral portal with the drainage cannula in the supra-
lateral portal, and the knee was lavaged with normal saline throughout the 
procedure. The knee was assessed in a structured manner with the SPP visualised 
first followed by the MC and LC. 
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Arthroscopic synovitis was defined as the presence of synovial membrane 
hypertrophy, documented as either increased granularity or villous hypertrophy 
(Figure 3.3 , Figure 3.4, Figure 3.5) in each compartment. Increased granularity is 
seen as a milder form of synovitis with uniform low-grade thickening of the 
membrane as opposed to villous hypertrophy where there is increased thickness of 
the membrane with villi-like protrusions into the joint cavity. A 100 mm visual VAS 
to allow for comparison with an overall assessment of the knee, including the retro-
patella space, was also completed by the arthroscopist. Images were captured 
digitally (Dyonics Vision Digital Management System 635) and intra-reader 
reproducibility was calculated using 30 randomly chosen images reviewed a month 
after the end of the study period. 
Figure 3.3 Arthroscopy. Normal synovium. 
Normal Arthroscopy 
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Figure 3.4 Arthroscopy. Increased granularity 
Increased granularity, with the classic "cobblestone" appearance of the synovium, in 
a patient with RA. 
Figure 3.5 Arthroscopy. Villous Hypertrophy 
Corresponding arthroscopy of patient in Figure 3.1 demonstrating villous 
hypertrophy. 
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3.5.5 Statistical Analysis 
Sensitivity, specificity, positive and negative predictive values of US and 
clinical assessment were calculated using arthroscopy, and then arthroscopic VAS, 
as the gold standard. These values were then also calculated comparing clinical 
assessment with US as the gold standard. Intra-reader reproducibility for 
arthroscopy (0 = no synovitis, 1 = granularity, 2 = villous hypertrophy) as well as 
inter- and intra- reader reproducibility for the standard dichotomous (0 = no 
synovitis, 1 = synovitis) US scoring method was calculated using the Cohen-kappa 
test. The reproducibility of the semi-quantitative US scoring method 0-3 (0 =no 
synovitis, 1= mild synovitis, 2 = moderate synovitis, 3 = severe synovitis) for 
distinguishing grade of synovitis was calculated using a standard weighted kappa. 
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3.6 Results 
Arthroscopy was able to assess 175/180 (97%) compartments in 60 patients. 
Access was difficult in 5 compartments due to plicae or adhesions. Arthroscopy 
detected synovitis in 52/60 (87%) patients and 119/175 (68%) compartments 
(differentiated as increased granularity in 43 and villous hypertrophy in 76 
compartments ). 
3.6.1 Ultrasonography compared with Arthroscopy 
Ultrasonography detected synovitis in 52/60 patients (87%) and synovial 
fluid was detected in all of these plus 3 other patients. Synovitis was detected in 
1211175 (69%) compartments assessed by arthroscopy and in 4/5 of the 
compartments not accessible to arthroscopy. 
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Patients 
In the 52 patients with arthroscopic detected synovitis (positive arthroscopy), 
US was positive in 51152 (98%) and negative in 7 of the 8 (88%) negative on 
arthroscopy (i.e. there was one false-positive and one false-negative result with US). 
Using arthroscopy as the gold standard the sensitivity and positive predictive value 
for US was 98% for both and the specificity and negative predictive value in both 
88%, resulting in an overall accuracy of 97% (Table 3.1). Synovial fluid was 
detected by US in 55/60 patients (92%), including all 52 patients with a positive 
arthroscopy plus three others (including the one US false-positive for synovitis) with 
a negative arthroscopy. 
USvsAR CA vsAR CA vs US US vs VAS CA vs VAS 
n=60 n=60 n=60 n=60 n=60 
Patients Patients Patients Patients Patients 
Sensitivity 98 85 87 96 85 
Specificity 88 25 38 86 29 
PPV 98 88 90 98 90 
NPV 88 20 30 75 20 
Accuracy 97 77 80 95 78 
Table 3.1 Knee synovitis, validation by patient 
Validation: Sensitivity, specificity, PP V, NPV, accuracy. Comparisons between 
modalities by patients. Clinical Assessment (CA), Arthroscopy (AR) . Numbers 
described as percentages. 
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Compartments 
Ultrasonography detected synovitis in 107/119 (90%) compartments with a 
positive arthroscopy, and was negative in 42/56 (75%) in whom no synovitis was 
documented at arthroscopy. This resulted in a positive predictive value of 88%, a 
negative predictive value of 78% and an accuracy of 85% (Table 3.1). There was 
insignificant variation in sensitivity between the three compartments (Table 3.2). 
Ultrasonography was more sensitive at detecting villous hypertrophy (70176 (92%)) 
compared with increased granularity (37143 (86%)) as documented by arthroscopy. 
Overall (%) SPP (%) MC(%) LC(%) 
n=175 n=175 n=175 n=175 
Sensitivity 90 91 88 92 
Specificity 75 75 78 73 
PPV 88 90 90 85 
NPV 78 74 74 84 
Accuracy 85 84 84 84 
Table 3.2 Knee synovitis, validation by compartment 
Validation: Sensitivity, specificity, PPV, NPV, accuracy. Comparisons between 
modalities by compartments. Clinical Assessment (CA), Arthroscopy (AR) . 
Numbers described as percentages. 
3.6.2 Clinical assessment compared with Arthroscopy 
Clinical assessment documented synovitis in 50/60 (83%) patients. Clinical 
assessment correctly identified synovitis in 44/52 (85%); 8 patients had arthroscopic 
synovitis undetected by clinical assessment, including the one patient with a false-
negative US result. Clinical assessment was negative in 2/8 (25%) patients 
compared with arthroscopy (i.e. there were six false positive results); synovial fluid 
was detected by US in two of theses six patients (including the only US false-
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positive). The positive and negative predictive values of clinical assessment were 
88% and 20% respectively resulting in an accuracy of77% (Table 3.1). 
3.6.3 Clinical assessment compared with Ultrasonography 
Clinical assessment was positive in 45152 (87%) and negative in 3/8 (38%) 
patients compared with us. This resulted in a positive predictive value of 90%, a 
negative predictive value of 30% and an accuracy of 80% when compared with US 
(Table 3.1). All of the 7 patients with US-detected synovitis not found on clinical 
assessment had arthroscopic synovitis. 
3.6.4 Arthroscopic Visual Analogue Scale 
The VAS scores for overall arthroscopic synovitis (including the retro-
patella space) ranged from 5-99 mm with a mean of 34 mm. The VAS was positive 
in 53/60 (88%) patients; 52/53 (98%) of these had arthroscopic synovitis in the 
compartments under comparison, and one patient had isolated retro-patella granular 
hypertrophy and a VAS of 13mm. 
Ultrasonography detected synovitis in 51153 (96%) patients with a positive 
VAS with false negative results in the above-mentioned patient with retro-patellar 
disease (VAS 13 mm), and another with a VAS of 7 mm (mean lOmm). Both 
patients with false-negative US results had synovial fluid detected on US. 
Ultrasonography was negative in 617 (86%) patients with a VAS of zero. The 
positive and negative predictive values of US compared with arthroscopic VAS for 
overall synovitis were 98% and 75% respectively resulting in an accuracy of 95% 
(Table 3.1). 
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Clinical assessment was positive in 45/53 (85 %) patients with a positive 
VAS, including the one patient with isolated retro-patella disease and a VAS of 
13mm. The 8 patients with a positive VAS and a (false) negative clinical assessment 
had VAS scores between 5 and 47 mm (mean 21). Clinical assessment was negative 
in 217 (29%) patients with a VAS of zero. The positive and negative predictive 
values of clinical assessment compared with arthroscopic VAS for overall synovitis 
were 90% and 20% respectively resulting in an accuracy of78% (Table 3.1). 
3.6.5 Reproducibility 
The kappa value for agreement of intra-observer reproducibility for 
arthroscopy was 0.88. The kappa values using the dichotomous scale for the 
detection of synovitis with US were 0.71 and 0.85 for inter- and intra-observer 
reproducibility respectively (p<0.05 for both). The weighted kappa values for 
agreement of the semi-quantitative US grading system were 0.65 and 0.74 for inter-
and intra-observer reproducibility respectively. 
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3.7 Discussion 
This is the largest study undertaken to validate US-detected knee synovitis in 
patients with a spectrum of disease and synovitis severity. It used arthroscopy as the 
gold standard, whilst also assessing its reproducibility and comparing US with 
clinical assessment. The results suggest that US can detect and accurately localise 
synovitis in the knee, and is more sensitive than clinical assessment. It is the first 
study to report the reproducibility of US-detected synovitis in the knee suggesting 
that US is a technique with high inter- and intra-observer reproducibility. 
Compared with arthroscopy, US of the knee has the advantage of being non-
invasive and able to visualise extra-capsular features such as the collateral 
ligaments, Baker's cysts, quadriceps and patellar tendons. We have demonstrated a 
high positive predictive value for US detection of synovitis suggesting that an US 
assessment of the knee may well negate the requirement for further, often more 
expensive and invasive, investigations. However, arthroscopy still has an important 
role particularly in differentiating between the inflammatory arthritides, performing 
tissue sampling under direct visualisation, and assessing the retropatellar space or 
the cruciate ligaments. The fact that only one knee had isolated retro-patellar 
granular hypertrophy (with a VAS for overall synovitis of 13 mm) suggests in this 
group of patients there is little additional information regarding synovitis in the 
retropatellar space. That US cannot fully visualise this space may be less important 
for the detection of synovitis. 
Ultrasonography was able to detect synovitis in 7 of the 8 (88%) patients in 
whom clinical assessment failed to detect arthroscopic synovitis. The one patient 
with a false negative US had a very low arthroscopic synovitis score (VAS of 7 
mm), compared with an average VAS score of 21 mm for the false negatives on 
86 
MD Thesis- Dr Zunaid Karim 
clinical assessment. This is consistent with previous reports suggesting clinical 
assessment is unable to detect low-grade synovitis (Martino, Angelelli et at. 1992; 
Hauzeur, Mathy et at. 1999). The clinical relevance of this lower grade synovitis 
may be particularly important in osteoarthritis where the degree of synovitis may be 
less, but still an important cause of symptoms (Hill, Gale et at. 200 I) and predictor 
of damage (Ayral, Pickering et at. 2001). This study also suggests US is more 
sensitive at detecting villous hypertrophy than simple granularity of the synovial 
membrane, which is to be expected with granularity representing an early, more 
subtle process with less synovial thickening compared with villous hypertrophy. 
A small amount of synovial fluid may be seen in the normal knee joint with 
US and was present in all patients with arthroscopic synovitis including the one 
patient with a false-negative US result and the other patient with isolated retro-
patella synovitis, suggesting increased vigilance for synovitis is warranted if 
synovial fluid is detected. Synovial fluid was also detected by US in 3 patients 
without synovitis on arthroscopy, but only one of these three had synovitis 
incorrectly diagnosed with US and clinical assessment, suggesting it has no major 
impact on the false-positive diagnosis of synovitis using these techniques. 
This study demonstrates very good kappa values for inter- and intra-
observer reproducibility of US in detecting the presence or absence of synovitis in 
the knee, and for intra-observer reproducibility for grading synovitis. This suggests 
US can be used with confidence in longitudinal studies by either individual or 
mUltiple operators for determining the presence or absence of synovitis, and by an 
individual operator for determining grade of synovitis. The level of inter-observer 
agreement using the semi-quantitative grading scale, although good, suggests when 
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using multiple operators other methods such as measurement of synovial thickness 
may need to be considered. 
There are some limitations to this study. The use of macroscopic findings on 
arthroscopy as the gold standard could be questioned due to the dearth of published 
studies comparing this evaluation with histological changes (Parker and Keefer 
1935; Yates and Scott 1975; Lindblad and Hedfors 1985; Lindblad and Hedfors 
1987). The earlier studies (Parker and Keefer 1935; Yates and Scott 1975) had 
contrasting outcomes with one demonstrating poor (Parker and Keefer 1935) and the 
other demonstrating good correlation (Yates and Scott 1975), although neither took 
into account the variation of histological findings that can be seen within a single 
joint (Cruickshank 1952; Jayson and Dixon 1968; Yates and Scott 1975; Lindblad 
and Hedfors 1985; Hutton, Hinton et al. 1987). Studies addressing this variation, 
using an assessment technique similar to that of the present study, demonstrated 
good correlation between site-specific macroscopic findings and histological 
analysis (Lindblad and Hedfors 1985; Lindblad and Hedfors 1987). Our group have 
also demonstrated good correlation between global arthroscopic V AS for synovitis 
and immunohistology (CD4) (Veale, Reece et al. 1999). Furthermore the current 
study also demonstrates excellent intra-observer reproducibility of arthroscopy. 
The clinical applicability of any gold standard is related to its pathogenic 
relevance, without which its prognostic capacity is diminished (Valenstein 1990). 
Currently there is no firm evidence that correlates histological findings with clinical 
outcomes, in particular joint damage. Also there appears to be only poor correlation 
of histological findings and CRP (Baeten, Demetter et al. 2000), an often-used 
surrogate of disease activity that cumulatively correlates well with disease 
progression (van Leeuwen, van Rijswijk et al. 1997; Plant, Williams et al. 2000). In 
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contrast there is a growing body of evidence which correlates synovial volume with 
subsequent joint erosions (Boers, Kostense et al. 2001; Conaghan, Q'Connor et al. 
2003). Arthroscopy directly visualises the synovium and current scoring methods 
offer a semi-quantitative assessment of severity and therefore disease bulk. There is 
a paucity of studies to correlate arthroscopic synovitis with damage (Ayral, 
Pickering et al. 2001) and while further validation with US is required, this too is an 
area that requires further assessment. 
Due to the difficulty in the anatomical delineation of the three compartments 
there may well be some overlap of compartments between US and arthroscopy. For 
example, if a patient had synovitis extending medially and laterally from the SPP the 
arthroscopist may have identified this as in the SPP only. The ultrasonographer 
however may have felt this extended into both the medial and lateral compartment 
hence scoring two false positives. The better results for patients as a whole 
compared to individual compartments (Table 3.1) may reflect this. 
There is a selection bias in that all patients were referred for arthroscopy 
with knee pain therefore it is more likely that they would have been thought to have 
synovitis on clinical assessment. Furthermore the relatively low number of joints 
without arthroscopic synovitis (n=8) makes it difficult to extrapolate too much the 
specificity of US although it is clear that, even in this group where the majority of 
patients have synovitis, clinical assessment is relatively inaccurate. 
Clinical assessment assessed the knee as a whole and did not differentiate 
between the retropatellar pace and the other compartments, but only one patient had 
isolated retropatellar disease and US remained more sensitive than clinical 
assessment when compared with arthroscopic VAS for overall synovitis, which 
would have included this space. In this study the definition of clinical synovitis 
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deliberately did not include joint tenderness (peri-articular tenderness in the knee is 
common especially in degenerative and entheseal disease). Any increase in 
sensitivity as a result of including tenderness may have also been accompanied by 
an increase in false-positive diagnosis resulting in an even lower specificity and 
negative predictive value. 
This study demonstrates that US is a valid and reproducible tool for the 
detection of synovitis in the knee joint and confirms previous reports that it is 
superior to clinical assessment. 
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3.8 Subsequent literature 
In this chapter we evaluated the role of US in assessing knee joint synovitis, 
using arthroscopic findings to provide validity. Significant additions to the literature 
are described below. 
3.8.1 Knee osteoarthritis 
Clinical assessment 
This cross sectional, multi-centre, European study conducted through the 
EULAR working group assessed six hundred patients with painful knee OA 
(D'Agostino, Conaghan et al. 2005). Ultrasonography was performed to determine 
the presence of synovitis or joint effusion. The authors found that with US; 16 
(2.7%) had synovitis alone, 85 (14.2%) had both synovitis and effusion and 177 
(29.5%) had joint effusion alone. They also found that US-detected 
synovitis/effusion had significant correlation with advanced x-ray changes 
(OR=2.20 and 1.91 for synovitis and joint effusion, respectively). There was also 
significant correlation for US inflammation with clinical signs and symptoms 
suggestive of an inflammatory "flare", such as joint effusion on clinical examination 
(OR=1.97 and 2.70 for synovitis and joint effusion, respectively) or sudden 
aggravation of knee pain (OR=1.77 for joint effusion). The authors concluded that 
US detected evidence of inflammation in over a third of patients and that this 
correlated significantly with advanced x-ray changes, and clinical synovitis/effusion. 
This study again suggests that synovitis is common in OA knee and correlates with 
advanced x-ray changes. 
Using the same cohort of patients described above, this same group 
determined whether clinical findings allow recognition of synovitis in patients with 
painful knee OA (Conaghan, D'Agostino et al. 2005). The authors used a 
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classification and regression tree analysis to find combinations of predictor variables 
that would provide high sensitivity and specificity for clinically detecting synovitis 
and effusion in individual subjects. The outcome of the study was that whilst the 
clinical findings may have been able to demonstrate some predictors in populations 
with OA, clinical findings like effusion, and also x-ray, were poor predictors of 
inflammation in individual patients. The authors concluded that sensitive imaging 
techniques such as US remain the most useful tool for demonstrating inflammation 
in individual cases. 
US findings are associated with pain 
In this study 50 patients with primary OA knee had US, clinical and x-ray 
assessments (Naredo, Cabero et al. 2005). Findings with US were; effusion 47%, 
protrusion of the medial meniscus (MMP) with displacement of the medial collateral 
ligament (MCLD) (61%) and Baker's cyst (22%). This study also demonstrated that 
US effusion, protrusion of the medial meniscus (MMP) and displacement of the 
medial collateral ligament were all associated with a significantly higher VAS 
(P<0.05). Apart from suggesting that certain US features are associated with certain 
pain scores, this study also demonstrates that effusion is common in OA knee. 
3.8.2 Knee rheumatoid arthritis 
Clinical assessment 
This study compared US with clinical assessment in 22 patients (44 knees) 
with RA (Kane, Balint et al. 2003). For each knee the presence of suprapatellar 
bursitis, knee effusion, or Baker's cyst was documented and compared with similar 
findings with clinical assessment. Ultrasonography detected soft tissue abnormality 
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in 42% compared with 28% of sites with clinical assessment. The authors concluded 
that US of the knee is more sensitive than clinical assessment which underestimates 
inflammation in knee RA. The argument has implications for the use of clinical 
assessment as part of disease activity scores. 
Another study compared contrast-enhanced PD US with clinical assessment 
in 42 patients with RA knee (Carotti, Salaffi et at. 2002). Using clinical assessment 
patients were categorised as having inactive, moderately active or active disease. 
The mean value of the area underlying time-intensity curves was 216.2, 186.8 and 
169.6 in patients with active, moderately active and inactive disease. The difference 
between patients with active and inactive disease was significant (P<O.OI). They 
also found that the findings with US correlated weakly with the SJC, but strongly 
with DAS (P=0.006). The authors concluded that PD US is able to distinguish 
between degrees of clinical synovitis. 
This same group also used PD US enhanced with bubble-contrast (Levovist) 
to assess changes following therapy, in this case intra articular corticosteroid 
injection, in RA patients (Salaffi, Carotti et al. 2004). Clinical and US assessments 
were performed prior to, and three weeks after injection. Clinical assessment 
revealed significant reduction in the index of synovitis activity from 7.0 to 3.0 
(p<O.OI), and for US all patients showed a reduction ofPD signal following therapy, 
and a comparison between baseline and follow-up PD US quantitative scores 
revealed a significant reduction (p<O.O I). Changes in the index scores of synovitis 
activity also correlated significantly with changes in the PD US values (r=O.785; 
p<O.Ol). Significant correlation was also observed between baseline PD US values 
and CRP as well. The authors concluded that PD US with contrast agent is sensitive 
to changes in synovial perfusion after intra-articular corticosteroid injection. Whilst 
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this study demonstrates significant changes in PD US findings, this only suggests 
the ability to detect changes rather than true concurrent validity because there is no 
correlation with a gold standard measure, although some may argue that correlation 
with reduction in CRP provides construct validity. 
Validation 
Power Doppler US, with microbubbles (Levovist) has been compared with 
arthroscopy in 17 patients (18 knees) of patients with RA or PsA (Fiocco, F erro et 
al. 2003). In this study, patients had PD US performed on its own, then repeated 
following infusion of contrast microbubbles, then compared with arthroscopy as the 
gold standard. Following administration of microbubble contrast, the PD flow signal 
score was increased in 13/18 knees (72.2%). Microbubble enhanced PD 
demonstrated more reproducible PD signal using arthroscopy as the gold standard 
compared with un-enhanced PD, and was also more sensitive (80% vs. 30%), but 
less specific (62% vs. 87%) at recognising increased vascularity of synovium. The 
authors concluded that microbubble enhanced PD is an effective and reliable tool at 
detecting increases in synovial vascularity. This study confirms the validity of US 
using arthroscopy as the gold standard, but also demonstrates validity for bubble 
contrast. This study also demonstrates however, a pitfall of microbubble enhanced 
PD with a loss of specificity, demonstrating the need for using normal patients as 
controls to try and define what is normal and what is not. 
Response to therapy 
Fiocco and colleagues also assessed 27 knees affected by RA (12 patients) 
and PsA (8 patients) before and after anti-TNF alpha therapy (etanercept) and 
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compared findings with clinical measures (Fiocco, Ferro et al. 2005). Following 
treatment they demonstrated that compared to baseline measurements PD flow 
reduced (p<O.OOI), parallel to reductions of CRP (p<0.05), erythrocyte 
sedimentation rate (ESR) (p<0.001), knee joint articular index (p<0.002), Ritchie 
articular index and global health scores (p<O.OOl). This study, whilst not 
demonstrating any true concurrent validity, suggests PD US is sensitive to change 
following treatment. 
3.8.3 Other joints 
There are also more publications regarding the validation of US-detected synovitis. 
Rheumatoid arthritis 
Small joints 
I have already described earlier work by Backhaus and colleagues 
(Backhaus, Kamradt et al. 1999) comparing US with clinical assessment, MRI and 
bone scintigraphy in 60 patients with RA, OA and arthritis associated with 
connective tissue disease. Forty-nine of the original group had a repeat assessment 2 
years later (Backhaus, Burmester et al. 2002) using similar methodology. They 
documented that inflammation by bone scintigraphy, and synovitis on US and MR! 
had significantly reduced. They did note however that US tenosynovitis of the flexor 
sheath was reduced significantly but increased in the extensor tendon, compared 
with reduction in both with MR!. The same group recently completed a 7 year 
review (Scheel, Hermann et al. 2006) this time using MR!, US and x-ray. Despite a 
loss of group numbers after 7 years US and MR! again documented significant 
reductions in synovitis from baseline (p<O.OOl for both),with significant reductions 
also seen in swollen and tender joint counts. The work by Backhaus & colleagues 
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reflects the degree to which the assessment of US has changed in the last decade, 
demonstrating concurrent validity where US-detected synovitis was compared with 
MRI and bone scintigraphy. 
The same cohort of patients from an earlier study (Szkudlarek, Court-Payen 
et al. 2001) had injection of Levovist with any changes in flow noted (Szkudlarek, 
Court-Payen et al. 2003). Levovist increased the flow signal in 7/9 joints with pre-
contrast flow-signal but did not add signal to the 9 joints previously without. 
Healthy controls remained negative, overall the relative rate of contrast enhanced 
MRI was significantly higher in joints with Levovist enhanced PD US compared to 
those without. There was also no correlation between clinical assessment and 
Levovist enhanced PD US. The authors concluded that intravenous contrast 
injection whilst not increasing the sensitivity in this study may provide additional 
information in the assessment of RA. No healthy controls showed contrast enhanced 
PD US signal. 
This study compared CD US of the wrists, MCPs and PIPs in 29 RA patients 
with MRI and clinical assessment (Terslev, Torp-Pedersen et al. 2003). This study 
confirmed a highly significant association between spectral Doppler resistive index 
and post contrast MRI. There were also significant differences in the groups with 
joint swelling compared to other groups using CD US. The authors concluded that 
CD US was comparable with post contrast MRI and estimation as in this study using 
colour fraction and the resistance index obtained with CD US was a promising 
method for the detection of synovitis in patients with RA. 
This study included 200 MTP joints of 40 patients with RA and 100 MTP 
joints of 20 healthy controls and assessed US, MRI and clinical examination for the 
detection of joint inflammation with MRI being regarded as the gold standard 
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(Szkudlarek, Narvestad et al. 2004) The sensitivity, specificity, and accuracy of US 
for the detection of synovitis were 0.87, 0.74, and 0.79 respectively, while for 
clinical examination; the corresponding values were 0.43, 0.89, and 0.71 
respectively. For patients, US demonstrated synovitis in 36, while MRI and clinical 
examination revealed synovitis in 31 and 20 patients respectively. US and MRI 
synovitis showed intra-class correlation coefficients of 0.56-0.72 (P < 0.0001). The 
sensitivity, specificity and accuracy of US for the detection of bone erosions were 
0.79, 0.97 and 0.96 respectively, while the corresponding values for radiography 
were 0.32, 0.98 and 0.93. With regard to patients, erosions were identified in 26 
patients by US compared with 20 patients by MRI and 11 by x-ray. They also 
demonstrated that the sized-based gradings with US of erosions were closely related 
to MRI and x-ray. The authors concluded that US was more sensitive and accurate 
than clinical examination and had good correlation with MRI for the detection of 
synovitis, and that US is a valid and significantly more sensitive than x-ray at 
detecting erosions. This study again demonstrates the relative lack of sensitivity of 
clinical examination to detect synovitis in the MTP joint, and also demonstrated 
concurrent validity for US. 
Large joints 
This study by Hermann & colleagues (Hermann, Backhaus et al. 2003) used 
US and MRI to detect pathology in the shoulders of 43 consecutive patients with 
RA. US assessment included long head of biceps tendon for tenosynovitis, and 
subacromial or subcoracoid bursitis. This study suggests that MRI is significantly 
more sensitive than US. Synovitis was detected in 12 and 27 patients (P=0.0003), 
tenosynovitis in 15 and 28 patients (p=0.0064), and bursitis in 13 and 18 patients 
97 
MD Thesis- Dr Zunaid Karim 
(not significant), with US and MRI respectively. This study unlike previous studies 
(Alasaarela, Leppilahti et aI. 1998) suggests US is relatively insensitive. 
Comparison with histology in hip 
In this important study PD US findings of synovial tissue vascularity in the 
hip joint have also recently been compared with histology of the same tissue 
(Walther, Harms et aI. 2002). All involved joints were examined with US prior to 
arthroplasty. Samples of synovial tissue that had been assessed with US were 
resected and examined by a blinded pathologist for vascularity. Spearman rank 
correlation tests were used to assess correlation between PD US and findings at 
histology. Correlation between qualitative PD US and qualitative vascularity grades 
from histological analysis was 0.92 (p<O.Ol). The authors concluded that PD US is 
valid for grading vascularity of the hip. This study, like their earlier study of the 
knee (Walther, Harms et aI. 2001), provides true gold-standard concurrent validity 
with PD US compared with histology to detect synovitis. 
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3.9 Summary 
In this chapter we confirm, using arthroscopy as the gold-standard, that US 
has a higher sensitivity, specificity, accuracy, positive- and negative-predictive 
value compared with clinical assessment. Ultrasonography also demonstrated good 
inter- and intra-reader reproducibility for detecting presence or absence of synovitis, 
as well as distinguishing the grade of synovitis, confirming that US is not only a 
valid and reproducible tool for detecting synovitis in the knee but also that it is more 
sensitive than clinical assessment. 
Further work in this area includes the need for more validation with 
histology for gray-scale and PD US, with and without bubble contrast, concentrating 
not only on the ability to measure small differences in synovial thickening or 
vascularity, but also the reliability of these particular measurements. Quantitative 
analysis needs to then be compared with semi-quantitative analysis to evaluate the 
validity of the usually quicker semi-quantitative method for the detection of 
synovitis, and subsequent monitoring of response to therapy. Longitudinal studies 
with reliability comparisons are required to properly assess the sensitivity of US in 
detecting changes over time. Work in assessing US changes and corresponding sites 
of pain in OA, SPA and RA is very interesting and may lead to predictive validity 
studies in the longer term. 
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Chapter 4 
4.1 Clinical Utility: Accuracy of Shoulder Injections 
4.2 Clinical relevance 
There is considerable variation in response to corticosteroid injections and the 
limited evidence is that up to half of these are placed inaccurately. Shoulder pain is 
common and the assessment of patients presenting with signs and symptoms suggesting 
impingement can be particularly challenging. Diagnosis often relies on a combination 
of physical assessment and the use of diagnostic local anaesthetic injections, and 
management the use of corticosteroid injections. Ultrasonography is used to guide 
subacromial injection, but there is limited data confirming the accuracy of placement. 
4.3 Abstract 
4.3.1 Aims 
MD Thesis- Dr Zunaid Karim 
To detennine the accuracy of US-guided subacromial injections in patients 
referred with shoulder pain. 
4.3.2 Methods 
Patients referred for US-guided injection had US perfonned to rule out a full 
thickness tear (exclusion), before having guided injection with a mixture of anaesthetic, 
corticosteroid, and x-ray contrast. Immediate post injection AP and axial radiographs 
were obtained of the injected shoulder joint. The radiographs were then reviewed and 
the injection was classified as being either intrabursal, extrabursal or combined 
intrabursal and extrabursal according to pre-defined criteria. 
4.3.3 Results 
Eleven patients (11 shoulders) were assessed. All 11 had evidence of 
subacromial bursitis, and 9 had evidence of supraspinatus tendinopathy. The 
supraspinatus tendon was intact in all 11. 
Five (45%) of the injections were assessed as being entirely intrabursal with the 
remaining 6 (55%) assessed as combined intra- and extrabursal injections. No 
injections were entirely extrabursal. Extrabursal contrast was limited to the tissue 
planes adjacent to the bursa with no evidence of contrast within the glenohumeral joint. 
No patients suffered any immediate complications as a result of the injections 
perfonned and no patients had to be excluded from the study. 
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4.3.4 Conclusions 
US-guided injections into the subacromial bursa are accurate, but extravasation 
along the needle track is common. 
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4.4 Introduction 
Subacromial impingement is a common and well recognised cause of shoulder 
pain in young and middle aged patients. The diagnosis of shoulder disorders can be 
difficult but US has proved to be of diagnostic value in the identification of tears and 
calcific tendonitis of the rotator cuff (van Moppes, Veldkamp et al. 1995; Alasaarela, 
Takalo et al. 1997; Read and Perko 1998; Swen, Jacobs et al. 1998; Swen, Jacobs et al. 
1999). The clinical assessment of impingement is particularly challenging and relies on 
a combination of physical examination and the use of diagnostic local anaesthetic 
injections. Studies assessing clinical impingement tests against arthroscopic findings 
have shown manoeuvres such as the Neer or Hawkin's tests to be of only limited 
diagnostic value (MacDonald, Clark et al. 2000). 
Diagnostic injections aim to place local anaesthetic in the subacromial bursa and 
then assess patient response. Marked improvement in the patient's symptoms and signs 
strongly suggests a diagnosis of subacromial impingement. These injections are usually 
performed by clinicians in the outpatient clinic using a standard approach as a 'blind' 
procedure. Previous studies have demonstrated that these are often inaccurate. In a 
study of patients who had shoulders injections only 4/14 attempted subacromial 
injections (29%), and 10/24 attempted glenohumeral injections (42%) were accurate 
(Eustace, Brophy et al. 1997). A cadaveric study demonstrated that subacromial bursa 
injection was successful in 20 shoulders (83%), but in 15 (62%) other structures were 
also infiltrated, including seven injections in the rotator cuff (Partington and Broome 
1998). In another study 'blind' injections were accurate in approximately half of all 
cases and 50% large joints (Jones, Regan et al. 1993). These figures raise serious doubt 
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about the validity of blind injections for both diagnostic and therapeutic injections of 
the subacromial bursa. 
Although US has been used to guide joint injections in rheumatology practice, 
and injections into the shoulder sub-acromial bursa are common in our practice (Brown, 
Karim et al. 2001), the only publication to my knowledge at the time of this work is for 
guided injections into the shoulder (glenohumeral) joint (Cicak, Matasovic et al. 1992). 
In this study 24 patients had US-guided shoulder arthrography using a posterior, as 
opposed to the traditional anterior, approach with 100% accuracy and without any 
evidence of injury to adjacent structures or extravasation of injection. 
The importance of placement of injections has been demonstrated by the study 
of Eustace and colleagues described above, where patients with accurate shoulder 
injections had improved VAS and range of movement outcomes in comparison to those 
with inaccurate injections (Eustace, Brophy et al. 1997). In a separate study of 19 
patients with de Quervain's tenosynovitis, accurate injections also led to better 
outcomes (Zingas, Failla et al. 1998). 
The aim of this study was to assess the accuracy of US-guided injection of the 
subacromial bursa. 
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4.5 Methods 
4.5.1 Patients 
11 consecutive patients with painful arc syndrome of the shoulder and US 
findings of bursitis without a full thickness cuff tear were prospectively studied. These 
patients were primary care referrals for shoulder x-ray and US with a clinical request to 
continue to diagnostic or therapeutic injection dependant on the US findings. Patients 
allergic to iodinated contrast or to triamcinolone acetonide were excluded from the 
study, and infonned consent was obtained from all patients prior to injection. 
4.5.2 Injection 
All patients had US and injection perfonned by an experienced musculoskeletal 
radiologist (POe). An ATL (Advanced Technology Laboratories, Bothel, Washington, 
USA) HDI 3000 US machine with a linear array 10-5 Mllz transducer was used to 
examine the shoulder. Once US findings ruled out full thickness tear (Figure 4.1) the 
shoulder to be injected was held in an extended and internally rotated position, and the 
needle path was identified using the US probe and the puncture site marked. 
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Figure 4.1 
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Ultrasonography of subacromial bursa 
The subacromial bursa is demonstrated as the hypoechoic area above the 
more echoic supraspinatus tendon (with black arrow). 
The skin was then cleaned w ith chlorhexidine gluconate surgical kin 
preparation and a small dermal injection of I % lignocaine was performed u ing a 25G 
needle. A 2 1 gauge needle was then directed into the subacromial bursa under US-
guidance, virtuall y para llel to both bursa and the transducer to ensure excellent needle 
visualisation (F igure 4 .2, Figure 4.3). 
Figure 4.2 Needle placement: under direct visualisation 
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Figure 4.3 
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Ultrasonography with needle placement 
The needle is passed into the bursa under direct visualisation . 
To allow injection under direct visuali sation a short connector tube was attached 
to the needle to enab le the operator to scan while injecting. The patients were injected 
with 20mg corticosteroid (triamcinolone acetonide, O.S ml), 3.Sml of local anae thetic 
( 1% lignocaine) and 6mls of iodinated contra t (U ltravist 370, Schering} into the 
subacromial bursa via a 2 1 G needle sited under US monitoring. Jf the injection was 
seen to collect around the needle tip, the needle was repo itioned until free flow, 
without local accumulation, away from the needle tip was obtained. 
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4.5.3 X-ray 
Anterior-posterior and axia l x-rays of the injected shoulder were obtained 
immediately after injection and reviewed by 2 Musculoskeletal Radiologists (JR and 
PR) who gave a consensus opinion as to the placement of each injection. The injection 
was then classified as being either intrabursal, extrabursal or combined intrabursal and 
extrabursal. The position of contrast was determined using the standardised criteria 
derived from cadaveric studies (Strizak, Oanzig et al. 1982; Beals, Harryman et al. 
1998). An intra-bursal injection was defined as a 'cap' like coll ection of contrast with 
clearly defined rounded borders lying in a subdeltoid position extending lateral to the 
greater tuberosity, and extrabursal injections were defined as having unconstrained, 
sharp margins (Figure 4.4, Figure 4.5, Figure 4.6) 
Figure 4.4 X-ray with contrast: Intrabursal injection 
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Figure 4.5 X-ray with contrast: Mainly intrabursal with some extrabursal 
Figure 4.6 X-ray with contrast: Mixed intra- and extra-bursal injection 
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4.6 Results 
A total of eleven patient injections were assessed (4 left, 7 right shoulders). 
There were 8 men, 7 women; age range 31-55, mean age 46. All patients had unilateral 
shoulder symptoms and none had a diagnosis of inflammatory arthritis such as RA or 
PsA. The initial US showed all eleven to have subacromial bursitis and evidence of 
impingement (bunching of the subacromial bursa under the coracoacromialligament as 
the arm is flexed, abducted and externally rotated from an extended and internally 
rotated position). Nine out of the eleven had supraspinatus tendinopathy but in all 
eleven the supraspinatus tendon was intact. 
After review of the plain radiographs five (45%) of the injections were assessed 
as being entirely intrabursal with the remaining 6 (55%) assessed as combined intra-
and extrabursal injections. No injections were entirely extrabursal. Extrabursal 
contrast accumulation was limited to the tissue planes adjacent to the bursa with no 
evidence of contrast within the glenohumeral joint. 
No patients suffered any immediate complications as a result of the injections 
performed and no patients had to be excluded from the study. 
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4.7 Discussion 
Clinical tests for impingement have limited diagnostic value with studies 
showing the Neer and Hawkins tests to have high sensitivity but low specificity when 
compared to an arthroscopic gold standard (MacDonald, Clark et al. 2000) while the 
'drop-ann' and Yergason tests have low sensitivity and high specificity (Calis, Akgun 
et al. 2000). Furthennore many studies and clinical practices are based upon the 
assumption that blind injections are accurate (Petri, Dobrow et al. 1987; Vecchio, 
Hazleman et al. 1993; Winters, Sobel et al. 1997). 
The requirement for accurate placement of diagnostic injections is manifest. 
Therapeutic injections may require exact placement, since accurate injections are shown 
to have greater therapeutic effect (Eustace, 8rophy et al. 1997; Zingas, Failla et al. 
1998). It has not yet been shown whether accurate placement of subacromial injections 
is essential although as the Neer classification clearly describes a pathological process 
centred on the subacromial bursa it would seem logical for injection treatment of 
impingement to be sited within the bursa (Neer 1983). 
In our study nearly half of all injections perfonned US-guidance were entirely 
intrabursal, with 100% being at least in part intrabursal. The definition applied by the 
observers in detennining the presence of intrabursal contrast required good distension 
to demonstrate the rounded clearly defined outline of the subacromial-subdeltoid bursa, 
suggesting the remaining injections all had a substantial intrabursal component. Since 
it is anatomically impossible for a purely extrabursal injection to enter the bursa in 
nonnal patients, it is therefore likely that the retrograde extravasation down the needle 
track in between the injection and the perfonnance of the x-ray is the likely cause for 
the combined intra and extrabursal injections. 
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In the study of posterior approach US-guided glenohumeral injections however, 
there were no extravasations noted (Cicak, Matasovic et al. 1992), although the 
shoulder joint will accept more fluid without a noticeable increase in pressure and in 
our study 10mls of fluid was injected. In the cadaveric study 7/20 injections involved 
infiltration into the rotator cuff, which while alarming is not truly representative of 
clinical practice where one would expect resistance to injection, and patients to describe 
discomfort if the needle entered the cuff (Partington and Broome 1998). The study 
involving de Quervain's tenosynovitis where the APL and EPB tendons are in close 
proximity, with the smaller EPB often deeper than the APL tendon suggests that in 
complex areas US-guided injection may be advantageous. 
The main limitation of this study is that it is relatively small, and the large 
volume of injection with contrast does not reflect usual practice when using US to guide 
injections. 
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4.8 Subsequent literature 
In this chapter we evaluated the accuracy of US-guided injections of 
corticosteroid (with contrast) in the shoulder subacromial bursa, confirming placement 
with x-ray immediately after injection. There have been a large amount of publications 
related to this subject since this original work was carried out. Significant additions to 
the literature are described below. 
4.8.1 New Techniques 
'Blind' knee injection 
In this study using an injection mixture of air and x-ray contrast, patients were 
either ascribed to receive an intraarticular (20 knees ) or extraarticular injection (10 
knees) (Glattes, Spindler et al. 2004). Using the hypothesis that a small amount of air 
injected into the knee produces an audible "squishing" sound with range of motion 
patients were assessed for this sign immediately after injection. Clearly audible 
squishing sounds were present in 17120 (85%) intraarticular and none of the 
extraarticular injections. The authors concluded that this simple technique can confirm 
accurate placement of injection and should be routinely documented. 
US-guided carpal tunnel injection 
In this pictorial essay guided injection in carpal tunnel syndrome associated with 
tenosynovitis of the finger flexor tendons is demonstrated (Grassi, Farina et al. 2002). 
Using a thin metal clip placed on the skin the best injection site is determined, before 
the needle is guided under direct visualisation. They conclude this is a safe and simple 
method to accurately guide therapy in carpal tunnel syndrome. 
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US injection with 'air' contrast 
This descriptive study demonstrates the technique of adding air to the injection 
to provide echo contrast that is easily detected with US (Qvistgaard, Kristoffersen et a1. 
2001). US was used to guide the needle into the joint (knee or hip) and 0.5-1 ml of 
atmospheric air and 1 ml lignocaine 1 % was injected with direct visualisation. In the 
hip joint the injected air was readily demonstrated with a sharp echoic contrast on the 
US recording. In the knee best results were seen with injection into either the 
suprapatellar bursa or lateral joint space. The authors suggest this simple technique 
should be used with US to avoid using contrast and x-ray to confirm placement. 
A similar study using small volumes of air in the injection mixture has 
demonstrated good echo contrast under direct US visualisation in the wrist, shoulder, 
knee, ankle and foot joint (Koski, Saarakkala et a1. 2005). 
US-guided surgery 
This study describes findings in 75 patients who had US-guided percutaneous 
tenotomy of the Achilles tendon under local-anaesthetic in the outpatient setting after 
failure of conservative therapy (Testa, Capasso et al. 2002). Sixty-three patients had 
prolonged follow-up; 35 were rated excellent, 12 good, 9 fair, and 7 poor. The US 
findings of thickening persisted in the operated tendons even 8 years after the operation, 
without interfering with physical training. The authors argue that this technique should 
be used in patients with localised tendinopathy and avoided in diffuse tendon disease. 
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4.8.2 US compared with clinical aspiration 
A study compared the accuracy of palpation-guided with US-guided needle 
placement in small joints for fluid aspiration (Raza, Lee et al. 2003). Palpation-guided 
injections were intra-articular in 59% (6/12 PIP and 4/5 MCP joints) cases. In 
comparison US-guided injections were intra-articular in 96% of cases (24/26 PIP and 
27/27 MCP joints). 
A similar study by Balint and colleagues performed a study of joint aspiration 
comparing conventional 'blind' needle placing techniques with US-guided placement 
(Batint, Kane et al. 2002). A total of 61 consecutive patients were included in this 
study. In the group that had conventional 'blind' aspiration, 32 joints in 30 consecutive 
patients were referred for joint aspirated, compared with 31 consecutive patients having 
US-guided aspirations. Ten joints (32%) had fluid aspirated using the 'blind' technique 
compared with 30 (97%) using US, however there was no difference in the volumes of 
fluid aspirated when successful aspiration occurred to confirm the presence and 
location of fluid. The authors concluded that US was a useful tool in guiding aspiration 
and also joint injection. 
4.8.3 Accuracy 
Subacromial bursa 
This study which is similar in methodology to the study by Eustace and 
colleagues (Eustace, Brophy et al. 1997) compared outcomes in 48 patients with 
'blind' subacromial injections. All injections included x-ray contrast with the 
corticosteroid and local anaesthetic (Esenyel, Esenyel et al. 2003). Using an 
anterolateral approach 42/48 (87%) injections were accurate. This study also assessed 
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outcome, and while both accurate and inaccurate injections demonstrated improvement 
2 hours after injection (local anaesthetic effect) patients with inaccurate injections had 
relapsed as opposed to the accurate injection group where improvement continued. The 
authors concluded that accurate injections had a longer effect. 
In a cadaveric study, the anterolateral approach was compared with the posterior 
approach (Mathews and Glousman 2005). Using x-ray contrast the anterolateral 
approach was deemed to be accurate in 18/20 (90%) compared with 16/20 (80%) of 
posterior injections. The authors concluded that using fluoroscopy to confirm injection, 
accuracy was good and that there was no significant difference between either 
approach. 
In another study (Yamakado 2002) using the anterolateral approach, 
subacromial injections using x-ray contrast, were seen to be accurate in 39/56 (70%) of 
cases. Twelve (21%) were seen in and around the deltoid muscle; 2 (4%) were in the 
glenohumeral joint; and 3 (5%) were subcutaneous. The authors concluded that whilst 
the majority of injections were in the subacromial bursa a significant number entered 
the deltoid. 
Glenohumeral joint 
This cadaveric study compared the anterior versus the posterior approach (20 
shoulders each) to inject the glenohumeral joint (Sethi and El Attrache 2006). They 
found that the anterior approach had an 80% accuracy rate, compared with 50% 
accuracy for the posterior approach. The authors concluded that the anterior approach to 
glenohumeral joint injection was more appropriate. 
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US-guided hip injections 
This study used US-guided intra-articular sodium hyaluronate in 10 patients 
with hip OA (Pourbagher, Ozalay et al. 2005). Each patient received three injections, 1 
per week for three consecutive weeks using contrast medium injected and confirmed 
with CT prior to injection with hyaluronate. CT confirmed accurate placement in all 30 
injections. This study provides a good level of concurrent validity for guided injections 
in the hip, confirmed with CT. 
4.8.4 Outcome 
US-guided injection; Calcific tendonitis 
This study of US-guided injections In calcific tendonitis demonstrates 
considerable benefits in 34/39 patients without complications in any of the 39 cases 
(Galletti, Magnani et at. 2004). The authors suggest that this is a simple relatively low 
cost method of treating calcific tendonitis. 
Calcific tendonitis; comparison with 'blind'injections 
Ch en and colleagues performed a randomised controlled short-term injection 
trial of 40 patients with US confirmed subacromial bursitis (Chen, Lew et al. 2006). 
Patients were randomly allocated to have a 'blind' or US-guided injection. This study 
demonstrated significant increases in the range of abduction of patients with US-guided 
injections from 69 to 139 degrees. The improvement in the 'blind' injection group (71 
to 100 degrees) did not reach statistical significance. The authors concluded that US-
guided injections can result in significant improvement in shoulder abduction. 
117 
MD Thesis- Dr Zunaid Karim 
Painful shoulder; comparison with 'blind' injection 
This prospective randomised study, compared US-guided (n=21) injection with 
'blind' (n=20) injection in patients with painful shoulders (Naredo, Cabero et aI. 2004). 
Following corticosteroid injection significantly greater improvements in both shoulder 
function and pain were observed in patients who had received US-guided injection. 
This was also accompanied by greater accuracy of needle placement. 
Plantar fasciitis; comparison with 'blind' injection 
This study randomly divided patients with plantar fasciitis into US-guided 
(n=12) or the standard palpation-guided (n=13) injection (Tsai, Hsu et aI. 2006). 
Following injection of corticosteroid and local anaesthetic patients were assessed at 2 
weeks, 2 months, and 1 year later. Following injection there was significant 
improvements in both groups for pain, tenderness, as well as reduction in plantar fascia 
thickness and number of patients with hypoechogenicity. The recurrence rate however 
was significantly higher in the palpation-guided group (6/13) compared with the US-
guided group (1112) (p< 0.05). The authors suggested that US-guided treatment reduced 
recurrent rate in plantar fasciitis. In contrast another study with similar methodology 
and patient numbers, but without time-structured follow-up did not show any difference 
between palpation and US guided injection (Kane, Greaney et aI. 2001). Like the study 
mentioned above, they too demonstrated a reduction in plantar fascia thickness. 
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4.9 Summary 
In this chapter we confirm the accuracy of US-guided subacromial injections in 
patients with shoulder pain. In our study all our injections were intrabursal with 6/11 
having a small extrabursal element as well. We argue that this is likely the result of 
extravasation in part due to the volume injected. 
More work needs to be done to determine the accuracy of injection techniques 
using dissection and imaging modalities like eT including randomisation to guided or 
'blind' injections to provide comparison. Thereafter, the impact of these more accurate 
injection techniques need to be assessed in randomised longitudinal studies with 
validated outcome studies. 
A larger study incorporating controlled randomisation to a 'blind' injection arm 
using the same volume of injection would have ruled out any potential bias from this. 
Despite this the results of this study have important implications for the use of US in 
guiding diagnostic and therapeutic injections of the subacromial bursa, and provide vital 
baseline data for future studies to assess the therapeutic impact of guided versus blind 
injections. 
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Chapter 5 
5.1 Efficacy and Predictive Validity of Guided Hip Injections 
5.2 Clinical relevance 
Intra-articular corticosteroid injections are commonly used in rheumatology 
practice to provide symptoms relief. Until recently they have not been commonly used 
in hip OA, one of the reasons being the technical difficulty in delivering such injections. 
As a consequence corticosteroid injection is omitted from current treatment guidelines 
although the same procedure is advised in knee OA. 
Ultrasonography, a safe non-invasive procedure may represent a credible 
alternative to fluoroscopy especially owing to the lack of radiation exposure. It can 
localise collections of fluid within the joint allowing guided aspiration if infection is a 
concern, as well as being able to check accuracy of the injection without the use of 
contrast and ionising radiation, as is the case with fluoroscopy. In addition US is able to 
detect features of OA such as joint space narrowing and osteophyte formation that may 
help predict response to therapy. 
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In this prospective pilot study the efficacy of US-guided intraarticular 
corticosteroid hip injections were evaluated. Baseline features were documented to 
assess predictive validity of response. 
5.3.2 Methods 
Patients over 18 wait listed for THR were invited to take part in the study, with 
exclusions. Baseline assessment included X-ray and US of the hip and clinical 
parameters including VAS scores. Corticosteroid was injected under US-guidance, and 
clinical assessments were repeated at 2, 6 and 12 weeks. 
5.3.3 Results 
Eleven patients were recruited with a mean age 63 (53-72), and a mean VAS for 
pain at baseline 78 mm. Six patients had severe OA changes on x-ray and the remaining 
5 had moderate OA. Eight had an effusion on US; 4 each with moderate and severe x-
ray OA changes. Five patients had anterior osteophytes on US; 3 with severe and 2 with 
moderate OA on x-ray. Six (55%) patients described a response at 2 weeks, compared 
with 4/11 (33%) and 3/8 (38%) at 6 and 12 weeks respectively. 
Of the 6 responders at 2 weeks; 2 had severe OA on x-ray but both had US 
effusion, compared with 4 who had moderate OA (3 with US effusion). At week 6; 3/4 
responders had moderate OA on x-ray, all with US effusions, and these 3 continued to 
benefit up to week 12. All five patients with an effusion but without osteophytes on US, 
responded at week 2 with 4/5 (80%) and 3/4 (75%) continuing to respond at 6 and 12 
weeks respectively. Only 115 (20%) patients with osteophytes on US responded at 2 
weeks. 
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5.3.4 Conclusions 
In this study severe OA on x-ray and US osteophytes were both (not 
surprisingly) associated with poor response (20%), whereas those with an effusion but 
no osteophytes on US had the greatest chance of sustained response (75%), suggesting 
that this may be a predictor of favourable response. 
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5.4 Introduction 
Osteoarthritis is the commonest cause of total hip joint replacement. The 
indication for this procedure is pain and loss of function as a result of joint disease that 
has not responded adequately to conservative therapy. Maintaining good muscle 
strength and optimising weight is important to good outcome post-surgery. This is 
difficult when symptoms reduce patients' mobility. 
Intra-articular corticosteroid injections are commonly used, for short-term relief 
of joint symptoms (van Holsbeeck, van Holsbeeck et aI. 1988; Blyth, Hunter et aI. 
1994; Hochberg, Altman et al. 1995; Hochberg, Altman et al. 1995; Newman, Laing et 
aI. 1996; Creamer 1997; Jacob and Sallay 1997; Fredberg, Bolvig et aI. 2004), in 
rheumatology practice to provide relief of symptoms, and are suggest as part of the 
medical management of knee OA (Hochberg, Altman et aI. 1995) but until recently they 
have not been commonly used in hip OA. A commonly used explanation is the 
technical difficulty in delivering such injections and concern over accuracy (Hochberg, 
Altman et al. 1995; ACR subcommittee 2000) because the hip is a deep and difficult to 
palpate joint, as a result these injections are traditionally given under fluoroscopic 
control. 
As a consequence corticosteroid injection is omitted from current treatment 
guidelines (Hochberg, Altman et aI. 1995). Many patients awaiting total hip 
replacement (THR) have not had a trial of corticosteroid and the efficacy of these drugs 
in patients with more severe arthritis requiring hip replacement has not been tested. 
Ultrasonography, a safe non-invasive procedure may represent a credible 
alternative to fluoroscopy especially owing to the lack of radiation exposure. It can 
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localise collections of fluid within the joint allowing guided aspiration if infection is a 
concern, as well as being able to check accuracy of the injection without the use of 
contrast and ionising radiation, as is the case with fluoroscopy. In addition US is able to 
detect features of OA such as joint space narrowing and osteophyte formation that may 
help predict response to therapy. 
Ultrasonography of the hip is able to accurately detect effusions and synovitis in 
RA patients (Koski, Anttila et at. 1990), even early in disease (Eberhardt, Fex et at. 
1995). It is able to detect and aspirate effusions in patients without symptoms (Koski 
and Isomaki 1990). In comparison clinical assessment when compared with US has 
poor sensitivitiy (Koski 1989; Eberhardt, Fex et al. 1995). Set criteria for the detection 
of hip effusion have been determined (Koski 1989). 
The main aim of this pilot study is to determine whether corticosteroid 
injections improve pain and function in patients with severe osteoarthritis of the hip, 
and also to identify any baseline features that predict response. 
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5.5 Methods 
5.5.1 Patients 
All infonnation gathered was returned to a database manager, and stored on a 
stand-alone computer with multiple levels of security and an audit trail. 
All patients fulfilling ACR criteria for hip OA (Altman, Alarcon et al. 1991), 
with ongoing pain and disability despite NSAID and analgesic use awaiting total hip 
replacement were invited to take part. All received patient infonnation leaflets as well 
as adequate time and opportunity to discuss the study before giving consent. The local 
ethics committee approved the study. Patients unwilling or unable to give consent, and 
those with contraindication to corticosteroid, evidence of generalised inflammatory 
arthritis, co-existent serious medical illness or malignancy were excluded. Patients who 
had received corticosteroid in the last 3 months or those with pending TlIR (within 3 
months) were excluded. 
5.5.2 Baseline assessment 
The baseline assessment included documenting analgesic requirements, hip 
range of movement (ROM), 100 mm visual analogue scale (VAS) for pain during rest, 
walking and at night. Patients had x-ray of the affected hip (unless perfonned within 
the last year) for conventional assessment of joint damage; scored by a Rheumatologist 
blinded to US findings as mild, moderate or severe. 
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5.5.3 Ultrasonography 
Ultrasonography was perfomled uSing an A TL HDI 3000 (Advanced 
Technology Laboratori es, Bothel Washington, USA) machine, by a rheumatologist 
(ZK) experienced in US having performed more than 15 hip injections. The patient was 
pos itioned supine with the hip extended (leg straight) and slightly externally rotated. A 
curvi-linear array 5-3 MHz transducer, was placed in an oblique saggital plane 
anteriorly (see Figure 5. 1, Figure 5.2, Figure 5.3) on the patient, and the neck of femur 
was identified in the longitudinal ax is. The degree of osteophytosis and capsule 
di stension was measured measured; 2: 7mm capsular distension was defined as definite 
effu sion following published validation of US findings with surgery (Koski, Anttila et 
al. 1990) . 
Ant sup. 
Iliac spine 
Greater 
Intertrochanteric 
line 
Lesser lrochan l .. r --''''~~~ 
Figure 5.1 US of Hip: Hip anatomy 
- - - - = Line of transducer 
126 
MD Thesis- Dr Zunaid Karim 
Figure 5.2 US of Hip: Scanning technique 
Figure 5.3 US of Hip: US image 
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A transverse scan was also performed to ensure major vessels were avoided. The 
injection site was then marked over the neck of femur before the skin was thoroughly 
cleaned with antiseptic. The needle was inserted perpendicularly through the skin and 
capsule onto the neck of femur, hence avoiding the risk of needle injury to the cartilage. 
Forty mg triamcinolone acetonide (lm!) with 20 mg lignocaine hydrochloride (2 ml) 
was injected into the hip, and follow-up US was performed to check for correct 
placement of the injection in the joint. Patients were advised to rest the joint for the next 
24 hours. A full aseptic technique was used during the injection to reduce the risk of 
introducing infection. 
5.5.4 Repeat assessments 
Follow-up visits were performed at 2, 6 and 12 weeks when response to 
corticosteroid injection was noted and baseline assessments except x-ray and US were 
repeated. 
5.5.5 Outcome measures 
Response to the injection, defined as a reduction in VAS pain scores> 15mm 
(arbitrary cut-off) for walking, was the main outcome. Other outcome measures were 
number of patients with reduction in VAS pain scores > 15mm at rest and at night, 
change in WOMAC, increase in hip ROM > 15° and analgesic requirements. Baseline 
findings on X-ray and US were analysed for any features that might predict response. 
There was no previous data available on which to base any meaningful sample size 
calculation, and the small numbers in this study precluded any meaningful statistical 
analysis. 
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5.6 Results 
5.6.1 Baseline assessment 
Eleven patients were recruited (7 female), with a mean age 63 (53-72), The 
mean VAS for pain at baseline was; at rest 69 mm, walking 78 mm, and at night 72 mm. 
Six patients had severe OA changes on x-ray and the remaining 5 had moderate OA. 
With US assessment 8 had an effusion; 4 each with moderate and severe OA changes. 
Five patients had anterior osteophytes on US; 3 with severe OA 2 of whom had an 
effusion, and 2 with moderate OA one with an effusion. Post-injection all injections 
were confirmed to be accurately placed by US. Three patients did not complete the 
week 12 assessment. 
5.6.2 Response 
Six patients (55%) described a >15 mm reduction in VAS for walking at 2 
weeks, compared with 4/11 (33%) and 3/8 (38%) at 6 and 12 weeks respectively. There 
were also> 15mm reductions in VAS for pain at rest (4/11,3/11, and 2/8 at 2,6, and 12 
weeks respectively), and at night (5/11, 3/11, and 3/8 at 2, 6, and 12 weeks respectively) 
(Figure 5.4). 
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Figure 5.4 Patients with improvement in V AS scores at 2, 6 and 12 
weeks 
Two (I8%) others reported a benefit from the injection at the 2nd week 
assessment, which did not persist, but did not meet the pre-defined criteria of response 
(partial response). Four patients described a reduction in analgesic use at two weeks, 
and 2 of these maintained this through week 6 and 12 assessments. No patient had an 
improvement in hip range of movement. There were no complications such as joint 
infection. 
5.6.3 Predictors of response 
Of the 6 responders (> 15 mm reduction in VAS for walking) at 2 weeks; 2 had 
severe OA on x-ray but both had US effusion, compared with 4 who had moderate OA 
(3 with US effusion) . At week 6; 3/4 responders had moderate OA on x-ray, all with US 
effusions, and these 3 continued to benefit up to week 12. All five patients with an 
effusion but without osteophytes on US, responded at week 2 with 4/5 (80%) and 3/4 
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(75%) continuing to respond at 6 and 12 weeks respectively. Only 115 (20%) patients 
with osteophytes on US responded at 2 weeks. 
Of the 5 patients with anterior osteophytes on US; only 1 with moderate OA and 
no effusion, had a response at 2 weeks which did not persist to 6 weeks. Two patients 
described a partial response; one with severe OA and no effusion the other with 
moderate OA and an effusion. All five patients with an effusion but no US 
osteophytosis responded at week 2 compared with 4/5 (80%) and 3/4 (75%) at 6 and 12 
weeks respectively. 
When response was compared with x-ray changes, of the 6 patients with severe 
OA on x-ray; two (33%) and one (17%) patient had a positive response at 2 and 6 
weeks respectively (both with an effusion), but not persisting to week 12. No patient 
with severe OA and US osteophytosis had responded at week 2, although one described 
a partial response. Four (80%) of patients with moderate OA on x-ray had a positive 
response at 2 weeks; 3/5 (60%), all with effusions and no US osteophytosis, sustained 
this through weeks 6 and 12. 
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5.7 Discussion 
In this study of patients with OA hip awaiting THR, response to injection was 
moderate and short-lived for most. In this study severe OA on x-ray and US osteophytes 
were both (not surprisingly) associated with poor response (20%), whereas those with 
an effusion but no osteophytes on US had the greatest chance of sustained response 
(75%), suggesting that this may be a predictor of favourable response. 
Ultrasonography is a safe, non-invasive imaging modality able to assess 
effusions as well as other features of OA such as joint space narrowing and osteophyte 
formation; although in the hip access to the joint is limited (mainly anterior). In this 
study patients were not enrolled and injected at the same time because of ethical 
considerations, but in standard practice this can be performed during the same 
outpatient visit reducing the need for a return visit. US has the advantage of being able 
to check accuracy of the injection during the procedure without the use of contrast or 
any ionising radiation. It can also localise collections of fluid within the joint allowing 
guided aspiration if infection is a concern. 
This study suggests certain patients waiting THR may benefit from 
corticosteroid injection. Although the numbers involved in this study were small, it also 
suggests x-ray and US findings can be used to predict response even in patients with 
severe disease. A prospective study with larger numbers is required to investigate this 
further. 
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5.8 Subsequent literature 
In this chapter we covered work regarding the role of US in guiding hip injections and 
also to predict prognostic groups. Significant additions to the literature are described 
below. 
5.8.1 Validity of hip synovitis; comparison with histology 
In this important study PD US findings of synovial tissue vascularity in the hip 
joint have also recently been compared with histology of the same tissue (Walther, 
Hanns et al. 2002). All involved joints were examined with US prior to THR, and 
samples of synovial tissue that had been assessed with US were resected and examined 
by a blinded pathologist for vascularity. Speannan rank correlation tests were used to 
assess correlation between PD US and findings at histology. Correlation between 
qualitative PD US and qualitative vascularity grades from histological analysis was 0.92 
(p<O.OI). The authors concluded that PD US is valid for grading vascularity of the hip. 
This study, like in their earlier study of the knee (Walther, Hanns et al. 2001), provides 
true gold-standard concurrent validity with PD US compared with histology to detect 
synovitis. 
5.8.2 US injection with air 'contrast' 
Two studies described in the previous chapter have recently described the 
technique of adding air to the injection to provide echo contrast which is easily detected 
with US (Qvistgaard, Kristoffersen et al. 2001; Koski, Saarakkala et al. 2005), 
including one which specifically assessed the hip (Qvistgaard, Kristoffersen et at. 
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2001). The authors suggest this simple technique should be used with US to avoid using 
contrast and x-ray to confinn placement. 
S.S.3 Efficacy in hip OA 
In a study of 510 patients Margules and colleagues perfonned fluoroscopic 
guided injections of corticosteroid into the hip and assessed response 8 weeks later 
(Margules 2001). Twenty-one out of 234 (9%) of patients with severe hip OA had 
benefit of pain at 8 weeks compared with 1311226 «58%) with moderate OA. There 
was improvement (>10°) in range of movement (internal rotation) in 108/226 (48%) 
hips with moderate OA, but no patient with severe OA described improvement. They 
concluded that corticosteroid injection in OA had potential benefit and required further 
investigation. 
A later study in 28 patients with rapidly destructive hip OA assessed whether 
fluoroscopic guided corticosteroid followed by non-weight bearing (4-6 weeks) reduced 
the need for THR (ViIIoutreix, Pham et aI. 2006). Twenty-seven out of twenty-eight 
patients required THR (including 20 within one year of injection), and the authors 
concluded that this was not an effective management for rapidly destructive hip OA. 
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5.9 Summary 
In this chapter we confirm that patients with at least moderate hip OA can 
benefit in the medium-term from US-guided injection (indirect guidance) of 
corticosteroid. This study suggests that findings at US, particularly effusion and lack of 
osteophytes, may predict those likely to respond. In an important study synovitis as 
defined by PO US (we used gray-scale only) correlates well with histology (Walther, 
Harms et al. 2002). In our study we guided and confirmed placement of injection with 
US, and there is also evidence that us-guided hip injections are accurate from a study 
using contrast with eT to confirm 100% placement (Pourbagher, Ozalay et at. 2005). 
The study by Margules and colleagues have found better outcomes in a larger 
group of patients (Margules 2001), but their group while including patients with 
moderate and severe arthritis probably had less severe disease than our group who were 
all waiting hip replacement. It seems however, that there is no role for corticosteroid 
injections at the other end of the severity spectrum, with no benefit in rapidly 
destructive hip OA (Villoutreix, Pham et at. 2006). 
Future work should include a placebo-controlled randomised study of guided 
injection to remove 'placebo' response, and also include features that might predict 
response. The data from our pilot study provide valuable baseline data for power 
calculations for future studies. 
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LEEDS HIP US-GUIDED INJECTION STUDY 
WEEK 0- DEMOGRAPHIC DATA 
Patient id code: 
----
Please affix patient label here 
Weight kg Height cm 
ESR PV CRP 
RF titre ANA Urate __ 
Ultrasound findings 
Study hip Right Left (please circle) 
Joint space narrowing Do 01 02 03 
Osteophytes Do 01 02 03 
Capsular distention Do 01 02 03 mm 
Radiographic damage (please circle) 
Mild Moderate Severe 
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LEEDS HIP US-GUIDED INJECTION STUDY 
WEEK 0 
Patient id code: Date: / / 
---- -- -- --
Pain relieving medication 
1. _________ _ 2 .. ___________ _ 
Study hip Right Left (please circle) 
1. With respect to your painful hip, how much pain do you have during the day, at rest? 
No pain ____ mm Pain as severe 
as it could be 
2. With respect to your painful hip, how much pain do you have during the day, when 
walking? 
No pain ____ mm Pain as severe 
as it could be 
3. With respect to your painful hip, how much pain do you have during the night? 
No pain ____ mm Pain as severe 
as it could be 
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LEEDS HIP US-GUIDED INJECTION STUDY 
WEEK 2 
Patient id code: Date: I / 
----
Pain relieving medication 
1. 
---------------------
2 .. ___________________ _ 
Do you think the injection has helped DYesDNo 
Study hip Right Left (please circle) 
I. With respect to your painful hip, how much pain do you have during the day, at rest? 
No pain ____ mm Pain as severe 
as it could be 
2. With respect to your painful hip, how much pain do you have during the day, when 
walking? 
No pain ___ --'mm Pain as severe 
as it could be 
3. With respect to your painful hip, how much pain do you have during the night? 
No pain ____ mm Pain as severe 
as it could be 
4. How do you think the injection has helped overall? (please circle) 
-1 o 1 2 3 
Worse No different Mild Moderate Marked 
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LEEDS HIP US-GUIDED INJECTION STUDY 
WEEK612 
Patient id code: Date: I I 
----
Pain relieving medication 
1. 
------------------
2. ____________ _ 
Do you think the injection is still helping DYes ONo 
Study hip Right Left (please circle) 
1. With respect to your painful hip, how much pain do you have during the day, at rest? 
No pain ____ mm Pain as severe 
as it could be 
2. With respect to your painful hip, how much pain do you have during the day, when 
walking? 
No pain _____ .mm Pain as severe 
as it could be 
3. With respect to your painful hip, how much pain do you have during the night? 
No pain ____ mm Pain as severe 
as it could be 
4. How do you think the injection has helped overall? (please circle) 
-1 o 1 2 3 
Worse No different Mild Moderate Marked 
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Chapter 6 
6.1 Clinical Utility: Synovitis in clinical remission 
6.2 Clinical relevance 
Early, aggressive therapy and more effective DMARDs have contributed to 
increasing rates of clinical remission in RA. Despite this, progression of disease with 
structural damage may still occur, suggesting ongoing disease activity and questioning 
the validity of current methods of remission assessment. Ultrasonography is more 
sensitive than clinical assessment at detecting synovitis, and in this study we tested the 
hypothesis that US-detected synovitis is present in clinical states of remission. 
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More timely and effective RA therapy has contributed to increasing rates of 
clinical remission. However, progression of structural damage may still occur despite 
patients satisfying clinical assessment based remission criteria, suggesting ongoing 
disease activity and questioning the validity of current methods of remission 
assessment. We tested the hypothesis that US-detected synovitis is present in clinical 
states of remission. 
6.3.2 Methods 
107 RA patients on DMARD therapy, judged to be in remission by their 
consultant rheumatologist were studied. Patients underwent clinical, laboratory, 
functional and quality of life assessments. DAS28 and ACR remission criteria together 
with strict clinical definitions of remission were applied. Ultrasonography of the hand 
and wrist was performed using standardised acquisition and scoring techniques. In a 
cohort of patients inter- and intra-observer reliability of US was assessed. 
6.3.3 Results 
Irrespective of which clinical criteria were applied to determine remission, the 
majority of patients continued to have evidence of active inflammation using an 
imaging assessment. Even in asymptomatic patients with clinically normal joints, 73% 
had grey-scale synovial hypertrophy and 43% increased power Doppler signal on US. 
Inter- and intra-observer reliability to detect synovitis was 0.60 for both, and intra-
observer reliability for PD was 0.62. 
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6.3.4 Conclusions 
Ultrasonography detected synovitis in most RA patients satisfying remission 
criteria with normal clinical and laboratory findings. This sub-clinical synovitis may 
explain the observed discrepancy between disease activity and outcome. 
Ultrasonography is reliable for detecting synovitis in low disease activity states, and 
may be necessary for accurate evaluation of disease state and confirmation of 'Ime 
remission '. 
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6.4 Introduction 
The treatment of rheumatoid arthritis (RA) is directed at suppressing 
inflammation with the aim of eliminating synovitis and establishing a state of remission 
(Emery and Salmon 1995). Remission is regarded as the ideal therapeutic target for 
patients with RA, as further joint damage and disability should be prevented and 
function and quality of life maintained. Rates of remission are increasing with modern 
therapeutic strategies and more effective drug treatments (Boers, Verhoeven et al. 1997; 
Mottonen, Hannonen et al. 2002; Klareskog, van der Heijde et al. 2004; Korpela, 
Laasonen et al. 2004). It is therefore important to ensure that our methods of disease 
activity assessment are accurate in order that correct management decisions can be 
made for the most favourable patient outcome. 
Current methods used to evaluate remission in RA largely rely on composite 
scores based on clinical and laboratory assessment and include the ACR Remission 
Criteria (Pinals, Baum et al. 1982) and Disease Activity Score (DAS) (van der Heijde, 
van 't Hof et al. 1990; Prevoo, van 't Hof et at. 1995; Prevoo, van Gestel et al. 1996). 
Such measures have the disadvantage of not directly measuring inflammation at the 
primary site of pathology (Lee, Lee et al. 1997) and may be subject to confounding 
influences (Balsa, Carmona et al. 2004; Paulus 2004). In addition, reports suggest a 
disparity between clinical state and outcome with evidence of progression of joint 
damage despite apparent remission (Mulherin, Fitzgerald et al. 1996; Molenaar, 
Voskuyl et a1. 2004). This has been interpreted as evidence of a dissociation between 
synovitis and subsequent erosive joint damage (Kirwan 2004) but could reflect the 
inadequate sensitivity of the traditional clinical approaches to detection of synovitis. 
143 
MD Thesis- Dr Zunaid Karim 
Ultrasonography is capable of directly visualising and objectively quantifying 
synovial inflammation. There are increasing data to support US validity as a disease 
assessment tool as well as it's superior sensitivity compared to clinical assessment at 
detecting inflammation (Backhaus, Kamradt et al. 1999; Szkudlarek, Court-Payen et al. 
2001; Walther, Harms et al. 2001; Backhaus, Burmester et al. 2002; Grassi 2003; 
Karim, Wakefield et al. 2004; Wakefield, Brown et al. 2004). 
There have also been two studies with controls assessing any increase in 
sensitivity using US enhanced with micro-bubble contrast agent (Levovist in both). In 
the first study with 46 RA patients (Klauser, Frauscher et al. 2002), CD US was positive 
in 7 (8%) of 83 inactive joints, in 31 (52%) of 60 moderately active joints, and in 32 
(58%) of 55 active joints. Following infusion of Levovist CD was positive in 41 (49%) 
of 83 joints with inactive RA, in 59 (98%) of 60 joints with moderately active RA, and 
in all 55 joints with active RA, confirming significant improvement in detection of 
vascularisation following Levovist. A smaller study of 15 patients and 3 controls (1 
MCP each) however, whilst noting increased signal in 7/9 joints with pre-contrast flow-
signal did not detect signal to the 9 joints previously without signal following contrast 
(Szkudlarek, Court-Payen et al. 2003). In this study, unlike the first there was also no 
correlation between clinical assessment and Levovist enhanced PD US. In both studies 
healthy joints did not demonstrate vascularisation before or after contrast. 
In a recent study of 200 MTP joints in 40 patients with RA with 100 healthy 
controls, US was compared with MRl and clinical examination for the detection of joint 
inflammation with MRl being regarded as the gold standard (Szkudlarek, Narvestad et 
al. 2004). The sensitivity, specificity, and accuracy of US for the detection of synovitis 
were 0.87, 0.74, and 0.79 respectively, while for clinical examination; the 
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corresponding values were 0.43, 0.89, and 0.71 respectively. Another study confinned a 
highly significant association between spectral Doppler resistive index and post contrast 
MRI in 29 RA patients (Terslev, Torp-Pedersen et a1. 2003). In this study there were 
also significant differences in the groups with joint swelling compared to other groups 
using CD US. The authors concluded that CD US was comparable with post contrast 
MRI and estimation as in this study using colour fraction and the resistance index 
obtained with CD US was a promising method for the detection of synovitis in patients 
with RA. 
Levels of MRI (Ostergaard, Hansen et a1. 1999; Huang, Stew art et a1. 2000; 
Conaghan, O'Connor et a1. 2003; McQueen, Benton et a1. 2003) and US-detected 
synovitis (Taylor, Steuer et a1. 2004) have also been shown to correlate with subsequent 
bone damage and functional outcomes. This suggests imaging modalities offer the 
potential to provide a more accurate measure of disease activity than the established 
clinical methods, and may be particularly useful in states where levels of inflammation 
may be low and assessment may be more challenging. The aim of this study was to 
assess the degree of US-detected synovitis in patients in clinical remission. 
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6.5 Methods 
6.5.1 Patients 
In this prospective controlled cohort study, 107 patients attending rheumatology 
outpatient clinics at Leeds General Infirmary were studied. Ethical approval for the 
project was obtained from the Leeds Teaching Hospitals NHS Trust Ethics Committee. 
Written informed consent was obtained from all subjects prior to inclusion. 
6.5.2 Inclusion criteria 
Using their clinical judgment, consultant rheumatologists identified patients 
from their outpatient clinics who they believed to be in remission ('physician 
remission,) using whatever assessments they thought necessary. In addition, all patients 
satisfied the following criteria: (1) RA classified according to ARA criteria (Arnett, 
Edworthy et al. 1988); (2) Over 18 years of age; (3) At least 12 months disease 
duration; (4) No disease flare within preceding 6 months; (5) Stable treatment for 6 
months; (6) No clinical indication to change treatment. 
6.5.3 Definitions of remission 
Three definitions of remission have been applied in this study and used in the 
analysis: 
1) 'Physician remission ': RA deemed to be in remission in the clinical judgment of the 
consultant rheumatologist, using whatever assessments they consider necessary. This 
reflects stable, controlled disease, requiring no change in therapy (see inclusion 
criteria); 
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2) 'Established remission criteria ': subjects satisfying the ACR (Pinals, Baum et a1. 
1982) or DAS28 remission criteria (van der Heijde, van 't Hof et a1. 1990; Prevoo, van 't 
Hof et a1. 1995; Prevoo, van Gestel et a1. 1996); 
3) 'Complete clinical remission': asymptomatic patients with no objective examination 
findings of disease activity, indicated by the absence of painful, tender or swollen joints 
on formal metrology. 
6.5.4 Study assessments 
Patients had their ACR Remission status (Pinals, Baum et a1. 1982) determined 
at -2 and 0 months (baseline). Inclusion criteria were applied at both these time points 
by their consultant rheumatologist. At baseline, they underwent full clinical, laboratory, 
functional, quality of life and imaging assessments. 
6.5.5 Demographic and clinical characteristics 
The following demographic and clinical characteristics were recorded at 
baseline: age, sex, ethnicity, marital status, presenting history of RA, presence of RF, 
extra-articular RA features, current and previous DMARD's and other therapies, 
duration of current remission, other medical and occupational history. Clinical data 
included duration of morning stiffness; Likert and V AS for fatigue, joint pain, observer 
assessment of disease activity and VAS for the patient's global impression of health and 
disease activity; number of painful, tender and swollen joints as assessed by an 
independent, trained metrologist. Health Assessment Questionnaire (Fries, Spitz et a1. 
1980) and quality of life (RAQoL) (de Jong, van der Heijde et a1. 1997; Whalley, 
McKenna et a1. 1997) questionnaires were completed and corresponding scores 
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calculated. Remission and disease activity scores were calculated using the ACR 
Remission Criteria (Pinals, Baum et al. 1982) and DAS28 (Prevoo, van 't Hof et al. 
1995). 
6.5.6 Laboratory assessment 
Full blood count, ESR, PV, CRP and RF were measured at baseline. Human 
leucocyte antigen typing was performed to assess presence of RA susceptibility alleles 
(shared epitope). 
6.5.7 Radiographic assessment 
Standard posterior-anterior x-rays of the hands, wrists and feet were obtained. 
Radiographic damage was scored using the Genant scoring method (Genant, Jiang et al. 
1998; Jiang, Genant et al. 2000) by a single experienced reader, who was blinded to all 
other imaging and clinical findings. 
6.5.8 Ultrasonography 
Each patient received an US assessment of the dominant hand and wrist joints 
using gray-scale and PD. Eight joint regions were imaged with US: the 2nd_5th MCP 
and RC, UC, IC, and ORU joints of the wrist. Ultrasonography was performed by a 
single experienced operator (ZK), blinded to all other study findings, using an A TL 
HOI 3000 machine with a 10-5 MHz linear array 'hockey-stick' transducer, according 
to EULAR guidelines (Backhaus, Burmester et al. 2001). The presence and location of 
any synovial hypertrophy and tenosynovitis was recorded with reference to the 
OMERACT/EULAR pathology definitions (Wake field, Batint et al. 2005). 
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Synovial hypertrophy was graded in g ray-scale using a 0-3 semi -quantitative 
scoring method (the Leeds Score) (Karim, Brown et at. 2004; Wakefie ld, Green et at. 
2004) (O:no synovial hypertrophy; I :mild ; 2: moderate; 3 :severe) (Figures 6.1-6.7; 
examples of grading system) and the max imal area of enhancement on PO was recorded 
using a previously described semi-quantitative technique (Newman, Laing et al. 1996) 
(O:normal/minimal vascularity; 1 :mild hyperaemia; 2: moderate; 3: marked) (Figures 6.8, 
6.9; examples of grading system)). Tenosynovitis was recorded as either present or 
absent. 
Figure 6.1 US of Mep: No synovitis 
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Figure 6.2 US of Mep: Mild synovitis 
Figurc 6.3 US of Mep: Mild synoviti 
Figurc 6.4 US of Mep: Moderate synovitis 
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Figure 6.5 US of MCP: Moderate synovitis 
Figure 6.6 US of MCP: Severe synovitis 
Figure 6.7 US of Mep: Severe synovitis 
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Figure 6.8 US of Mep: Gray scale with corresponding Power Doppler 
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Figure 6.9 US of wrist: Gray scale with corresponding Power Doppler 
Each patient assessment took approximately 30 minutes and representative 
Images were archived. Inter-observer reliability was determined by a second 
experienced rheumatologist ultrasonographer (RJW) performing US assessments of 120 
joint regions in a random subset of 15 patients, and comparing the fmdings of the two 
rheumatologists. Each examiner performed their US assessment independently and 
sequentially, blinded to all other study data. Intra-observer reliability was assessed by 
blinded re-scoring of the archived US images in the same subset, approximately 12 
months after the original US assessment. 
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6.5.9 Analysis 
Data evaluation and statistical analysis was carried out using SPSS Version 
11.5. Normally distributed continuous data were analysed using parametric tests 
(independent t-test, ANOV A) and were summarised with means and standard 
deviations. Non-normally distributed and ordinal data were analysed using non-
parametric tests (Mann-Whitney U, Kruskal-Wallis) and were summarised with 
medians and ranges. Categorical data were analysed using Chi-squared tests. The Holm 
correction (Holm 1979) was used to correct for multiple comparisons on a family-wise 
basis. Critical P for testing at the 5% level of significance was set at P=0.003 for Chi-
squared, Mann-Whitney U and Kruskal-Wallis tests, and at 0.005 for independent t-
tests and ANOV As. Inter and intra-observer agreement was calculated by overall 
agreement (percentage of observed exact agreement), intraclass correlation coefficients 
(lCC) and kappa statistics (un-weighted for dichotomous scoring e.g. presence/absence 
of synovitis; weighted for semi-quantitative scoring). 
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6.6 Results 
6.6.1 Patient demographics 
One-hundred and seven patients satisfied the physician remission inclusion 
criteria. All provided written consent prior to taking part in the study. The study 
population was predominantly female (66%) with a mean age of 56 years. The control 
group comprised 71% females with a mean age of 38 years. Sixty four percent of 
patients were RF positive and 61 % were shared epitope positive. The mean disease 
duration was 7 years and median period of remission was almost 2 years. Eighty-one 
percent had evidence of radiographic erosions in the hands or feet. Ninety-nine percent 
of the study subjects had received OMARD therapy during the course of their disease 
and the majority had received more than one drug. Ninety-two percent of the cohort 
were currently taking DMARD therapy, with oral methotrexate and sulphasalazine 
being the most commonly used medications; 24% were taking combination therapies; 5 
patients were currently receiving biologic drugs either as mono or combination therapy 
and 4 patients had previously received biologic therapy. Forty percent were currently 
receiving an NSAIO prescription and 2% were taking oral prednisolone (~5mg). (Table 
6.1) 
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Age (m ean. range) 56 years (23-8 1) 
Sex 66% female, 34% male 
Duration of RA (median. range) 7 years (2-38) 
Rheumatoid factor +ve (>40iu) (m ean titre) 64% (249) 
Shared epitope positive 6 1% 
hOl1lo'!J'gote 15% 
hetero'!J'gote 46% 
Duratioll 0fremission [median (range)) 22 months (6- 144) 
Radiographic erosions in hands amI/or feet 81% 
% patients with 69% 
eros ions 
Hands/wrists Erosion score 4 (0 - 5 1) 
Radiographic scoring JSN score 2 (0 - 39) Total score 6.5 (0 - 90) 
[median (range)] 
% patient wi th 65% 
(total n=94) erosions 
Erosion score 2 (0 - 24) 
Feet JSN score I (0 - 32) 
Tota l score 2.25 (0 - 48) 
0 8% 
I 68% 38% PO MTX; 21 % SSZ; 
Current DMA RD therapy I % biologies 
(median I; range 0-3) 2 18% 9% SSZlMTX; 4% 
biologicslMTX 
3 6% 5% SSZIMTXlHCQ 
0 46% Most MTX or SSZ I 32% Previous DMA RD therapy 2 13% monotherapyl combination (median I; range 0-4) 
3 8% 
therapy; 
4 2% 
3% previous biologies 
Current NSA ID 40% 
Current oral steroid 2% (all <5m~) 
Table 6.1 Demographics of RA cohort 
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6.6.2 Clinical, laboratory, function and quality of life assessments 
Clinica l and laboratory measures of disease activity were all low, as measured 
by Likert scale and V AS, duration of early morning stiffness, formal joint counts and 
acute phase markers (Tab le 6.2). The group had generally low levels of functional 
impairment and disability as assessed by HAQ and only mild quality of life impairment 
as measured by RAQoL. 
Likert scale [ %] VAS (0-100) [median (range)] 
Nil Mild Moderate Severe 
Fatiglle 89 3 7 1 20 (0-8 1) 
Joint pain 79 15 6 0 14 (0-8 1) 
Patient global assessment n/a n/a nJa n/a 14 (0-7 1) 
Physician's global 38 62 0 0 10 (0-30) 
assessment 
Early morning stiffness [median (range)] o minutes (0- 120) 
Painflll joint count (/80) [median (range)) 0(0-22) 
Tender joint count (/28) [median (range)] 0_(0- 15} 
Swollen joint count (/28) [median (range)] 110-13) 
PV [mean. standard deviation] 1.6410.091 
ESR (mm/hI) [median (range)] 10 1-571 
CRP (m~/L) [median (range)] 5 iO-30) 
Function HAQ Disabi lity score 0-3) [median (range)] 0.38(0-2.5) 
Quality of life RAQoL (0-30) [median (range)] 3 _LO-23) 
ACR Yes 59 (55%) 
Remission No 48 (45%) 
Remiss ion (score <2.6) 61 (57O/~ 
DAS28 Low disease activUY (score >2.6 & <3.2) 21 (20o/~ 
Moderate disease activUY (score> 3.2 & <5. I) 24i22%) 
High disease activi!Y(score >5. /) 1 il O/~ 
Table 6.2 Clinical laboratory, function and quality of life assessments 
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6.6.3 Established remission criteria assessment 
Of the 107 patients in physician remission, 55% fulfilled the ACR remission 
criteria and 57% satisfied DAS28 remission (DAS28 score <2.6) (Table 6.2). The mean 
DAS28 score was 2.5 (SD 0.96; range 0.64-5.42). 
6.6.4 Ultrasonography 
Ninety patients (85%) had evidence of synovial hypertrophy with gray-scale and 
60% had increased PD signal, confirming active synovitis. In all patients, 843 joint 
regions in the hand and wrist were examined with US. Eighty-six percent (725) of these 
joints had no clinical synovitis (SJC=O) on clinical assessment. Of these, 36% (263) had 
synovial hypertrophy detected with US, despite normal clinical findings. Of the 354 
joints with US synovial hypertrophy, 82% (291) were graded as mild, 16% (57) 
moderate and 2% (6) severe using the Leeds score. Increased PD signal was 
demonstrated in one third of these joints. Tenosynovitis was uncommon but was more 
likely to be detected at the wrist (Table 6.3). 
The reliability of US imaging was calculated. For inter-observer reliability exact 
agreement was found in 91 % for presence/absence of synovial hypertrophy and 92% for 
PD signal, with a kappa 0.60 for presence/absence of synovial hypertrophy. Using the 
semi-quantitative grading system, exact agreement was found in 38% for synovial 
hypertrophy and 92% for PD, with a weighted kappa of 0.53 and ICC of 0.57 for 
synovial hypertrophy. For intra-observer reliability exact agreement was found in 82% 
for presence/absence of synovial hypertrophy and 90% for PD signal, with a kappa 0.60 
for presence/absence of synovial hypertrophy and 0.62 for PD. Using the semi-
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quantitative grading system, exact agreement was 66% and 60%, with a weighted kappa 
of 0.55 and 0.59, ICC 0.54 and 0.38 for synovial hypertrophy and PO respectively. 
Number of patients with US pathology 
Gray-scale synovitis [number (%)] 90 (84.9%) 
Increased PD signal [number (%)] 64 (60.4%) 
Tenosynovitis [number (%)] 40 (37.7%) 
Frequency (%) of US pathology (per patient, per joint) 
MCP2 MCP3 MCP4 MCP5 
Synovitis 67.9 64.2 44.3 33.0 
Power Doppler 13.2 14.2 3.8 1.9 
US RCJ UCJ DRU Inter-Carpal 
Synovitis 38.1 39.0 18.3 30.5 
Power Doppler 34.3 18.1 5.8 18.1 
Table 6.3 US findings in 'remission' 
6.6.5 Established remission criteria vs. imaging measures of disease activity 
Eighty-one percent and 55% of patients in ACR remission had US synovitis and 
PD signal respectively, compared with 84% and 51 % of patients in OAS28 remission. 
Patients not satisfying ACR or DAS28 remission criteria were more likely to have a 
significantly greater number of joints with US-detected synovial hypertrophy; 90% 
patients not in ACR remission compared with 81 % in remission, and 100% patients in 
OAS 28 remission compared with 84% in remission. 
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6.6.6 Complete clinical remission vs. US synovitis 
Despite a total absence of joint symptoms and signs, 73% of patients in 
complete chnical remission had US synovitis with associated PO flow in 43% (Table 
6.4) . 
Variable Zero prrls >Zero P-vallle joints prrls joints 
N (% of total patients) 3 1 (29 .0) 76 (71 .0) nla 
Early morning stiffness (min utes) [median 0(0 - 60) 0(0 - 120) MWUO.032 (ral1~e)7 
Joint pain : nil 26 (83 .9) 70 (92. 1) 
[n, %J mild 2 (6.5) 1 (1.3) Chi 0.059 
moderate 2 (6.5) 5 (6 .6) 
severe I (3.2) 0(0) 
VAS (mm) [median (range)] 
Fatigue 
22.0 (0 - 66) 20.0(0 - 81) MWU O. 706 loint pain 
Patient global di sease activity 11.0 (0 - 28) 18.0(0 - 81) MWUO.OI 2 
12.0(0 - 47) 16.5 (0 - 71) MWUO.052 Physician global disease activity 8.0 (0 - 22) 11 (0 - 30) MWUO.OIO 
Physician 's global assessment: 
18(58.1) 23 (30.3) Asymptomatic hi 0.007* 
Mild 13 (4 1.9) 53 (69 .7) 
Joint counts - median (range) : 
0(0 - 0) 0(0 - 22) MWU<O.OOI Painful 
Swoll en 0(0 - 0) 2 (0 - 13) MWU<O.OOI 
Tender 0(0 - 0) 1 (0 - \ 5) MWU <O.OOI 
HAQ di sability score [median (range)] 0.25 (0 - 2.5) 0.44(0- 2.25) MWUO.062 
RAQoL {median (ranJ!e)J 3 (0 - \ 7) 3(0 - 23) MWUO.288 
CRp· (mg/L) [median (range)] 0(0 - 15) 5(0 - 23) MWUO.515 
ES Rb (mm/hr) [median (range)J 9 (2 - 34) 9.5 (2 - 52) MWUO.5/4 
PVc {mean (s tandard deviation)l \ .60 (0.07) 1.63(0. 10) TO.06..! 
AC R remission criteria met 29 (93.5) 30 (39.5) Chi <0.001 
DAS28 di sease activity category 
Remission 29 (93 .5) 30 (39.5) 
Low disease activi ty 2 (6.5) \ 9 (25 .0) Chi <0.001 
Moderate disease ac tivity 0(0) 24 (31.6) 
High di sease activity 0(0) 0(0) 
Total number of patients with synovi ti sd 22 (73.3) 68 (89 .5) Chi 0.037 
Total number of joints with synov itis 
MCPs [median (range)] \ (0 - 4) 3 (0 - 4) MWU<O.OOI Wrist 0(0 - 3) I (0 - 4) 
Total 2 (0 - 6) 4 (0 - 8) 
Total number of patients wi th increased PD 
13 (43 .3) 50 (65 .8) Chi 0.210 signald 
Total number of patients with tenosynovitisd 7 (23.3) 33 (43.4) Chi 0.055 
.. Bold slglllfies a statl sllcally slglllficant difference. • Trends towards a difference, which followmg correctIOn for 
multipl e comparisons were not sign ifi cant. • N = 31 174,b N = 30176,< N = 25/66,d N = 3 
Table 6.4 Complete clinical remission (i.e. zero painful/tender/swollen joints) 
vs. clinical, laboratory and imaging measures of disease activity of RA cohort 
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6.7 Discussion 
One hundred and seven RA patients were identified as being in a state of 
remission based on clinical assessment by their consultant rheumatologist (physician 
remission). Such an assessment accurately reflects the pragmatic clinical judgments that 
are made every day in routine rheumatology practice. Objectively, all of these patients 
had clinical and laboratory measures which confirmed low levels of inflammation. 
Applying the established remission criteria, the cohort was divided into two roughly 
equal sets of ACR and DAS28 remission and non-remission. In addition, employing our 
definition of complete clinical remission, one third of the patients had a total absence of 
painful, swollen or tender joints. However, when disease activity was assessed using 
US, the majority of patients had ongoing active synovitis, irrespective of which criteria 
were used to define remission. Furthermore, there were no significant differences in the 
number of patients with US synovitis and their remission status determined by either 
ACR or DAS28 classification or joint count metrology. These observations provide 
evidence that current methods of remission assessment including DAS and ACR 
remission criteria do not necessarily correlate with an absence of disease so may be 
inaccurate measures of true RA remission. 
The findings from this study may have a number of important 
pathophysiological implications. These data provide a possible pathological explanation 
for the paradoxical observation that patients in apparent remission may experience 
progression of joint damage (Mulherin, Fitzgerald et a1. 1996; Molenaar, Voskuyl et a1. 
2004). The primacy of synovitis in RA and a direct link between inflammation and 
structural damage has been established using MRI (McGonagle, Conaghan et a1. 1999; 
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Conaghan, O'Connor et a1. 2003), and it is recognized that even relatively small 
amounts of MRI synovitis or bone oedema may cause new erosions (Ostergaard, 
Hansen et a1. 1999; Huang, Stewart et a1. 2000; McQueen, Benton et a1. 2003) and that 
bone damage is unlikely to occur in the absence of inflammation (Conaghan, O'Connor 
et a1. 2003). A recent study has also demonstrated that US synovitis correlates to x-ray 
damage 1 year on (Taylor, Steuer et a1. 2004) in patients with RA. Given this evidence, 
one may predict that the synovitis identified in this cohort may result in subsequent 
structural damage. Therefore, the persistence of active synovitis may be the explanation 
for adverse outcome despite patients achieving ACR and OAS28 remission. 
Ultrasonography was used to assess the degree of sub-clinical disease in this 
large cohort of RA patients in clinical remission and identified ongoing synovitis. The 
advantage of US over clinical assessment has again been demonstrated, with 
approximately a third of clinically normal joints having synovial hypertrophy on US. 
Ninety-two percent of patients in this cohort were receiving OMARD therapy, almost 
exclusively traditional non-biologic drugs. It may be that such therapies are not 
sufficiently potent to completely suppress inflammation, and that US imaging is 
required to assess these patients to decide whether increase in OMARD therapy is 
required. The reliability of US has again been demonstrated, consistent with published 
data (Backhaus, Kamradt et al. 1999; Qvistgaard, Rogind et a1. 2001; Ribbens, Andre et 
a1. 2003; Szkudlarek, Court-Payen et al. 2003) in patients with higher levels of 
synovitis. 
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This study confirms the hypothesis that the majority of patients achieving ACR 
and DAS28 remission status as well as asymptomatic patients with no objective signs 
on joint assessment have sub-clinical synovitis when assessed with US. Therefore, it 
appears that such clinical remission criteria may not select patients with an absence of 
inflammation and as such may be inaccurate measures of true remission. This 
observation may explain the apparent discrepancy between clinical improvement and 
progression of joint damage in some patients with RA and could be important in 
determining therapeutic decisions such as how far to pursue disease suppression. 
Ultrasonography is a sensitive measure of joint inflammation and may provide a 
more accurate assessment of remission. Modification of the current RA remission 
criteria may be required in light of these findings in order to optimize disease activity 
assessment and facilitate the most favourable outcome for our patients. These data 
support the use of US for accurate assessment of disease state even when clinical 
measures of response have normalised, and suggests that true remission should be 
defined with an imaging (in this case US) based assessment. 
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6.8 Subsequent literature 
The work from this chapter has only just been completed and there are no 
relevant additional publications to my knowledge. 
6.9 Summary 
In this chapter we continue the theme of this thesis assessing the role of US in 
patients with clinical remission. This study again reveals the insensitivity of clinical 
assessment and also the degree of sub-clinical disease present even in this group with 
apparently low disease activity, demonstrating widespread synovitis regardless of the 
type of remission criteria imposed. This suggests that US because of its validity, and 
easy use should be included in any future definition of remission. The reliability of US 
in low grade synovitis is also established for the first time. 
Future work is ongoing with his cohort to assess the long tenn outcome of sub-
clinical disease. Healthy age-matched controls are required to differentiate between 
normal and abnormal perfusion, and any US findings in this sub-group should be 
correlated with other standards such as MRI or ideally histology. 
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Chapter 7 
7.1 Clinical Utility: Predictive validity of US-detected 
synovitis 
7.2 Clinical relevance 
Hand pain with significant stiffness is a common clinical presentation to 
rheumatologists. These patients often lack clinical evidence of inflammation which 
makes diagnosis challenging, and the knowledge that some of these patients may 
develop a persistent arthritis is of concern. Our group has demonstrated sub-clinical 
synovitis in many patients groups and we hypothesised that detecting synovitis would 
predict how patients respond to therapy. 
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7.3 Abstract 
7.3.1 Aims 
Hand pain with stiffness without obvious clinical synovitis is a common clinical 
presentation to rheumatologists, with the outcome varying from spontaneous resolution 
of symptoms to the development of rheumatoid arthritis. This study assessed the 
response and predictors of response to intramuscular methyl prednisolone (lM MP) and 
hydroxychloroquine (HCQ) using a standardised treatment protocol. 
7.3.2 Methods 
Patients were defined as having inflammatory hand pain (HIP) if they had 
predominant hand pain and morning stiffness of at least 30 minutes duration, with 
specific exclusions. All received a standardised clinical US assessment prior to 
receiving IM MP. Response (primary outcome) at 4 weeks was a patient perceived 50% 
improvement in symptoms; responders who relapsed received repeat IM MP and HCQ. 
7.3.3 Results 
102 patients were recruited. 21 % RF positive, 23% had clinical synovitis, 25% 
raised CRP and 55% US synovitis. 73% satisfied our definition as responders, reflected 
by significant reductions in morning stiffness, HAQ, painful and tender joint counts, 
and patient VAS's (p::::0.006 for all). US synovitis (p<O.OOI) and RF (p=O.04), but not 
clinical synovitis (p=0.74), were significantly associated with response to IM MP. 86% 
who remained on HCQ long-term reported a benefit. 
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7.3.4 Conclusions 
Treatment with IM MP produces significant improvement of symptoms and 
function in most patients with IHP. Presence of US synovitis and RF were the best 
predictors of response; responders whose symptoms recurred benefited from repeat IM 
MP and HCQ. This study suggests a practical management algorithm for patients with 
IHP. The potential role of imaging-detected synovitis in predicting response requires 
further investigation. 
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7.4 Introduction 
The presence of concomitant hand pain and stiffness is common, accounting for 
between 5-50% (Wolfe, Ross et a1. 1993; van der Horst-Bruinsma, Speyer et a1. 1998; 
Quinn, Green et a1. 2003) of presenting complaints to rheumatologists. These patients 
often lack clinical evidence of inflammation which makes diagnosis challenging and 
less reliable (Gormley, Steele et a1. 2001). Their outcome however is not necessarily 
benign as such patients can develop persistent, joint-damaging disease such as RA. 
Using classification criteria for RA in patients with recent onset arthritis has inherent 
difficulties as classic features may be absent early on (Harrison, Symmons et a1. 1998; 
Green, Marzo-Ortega et a1. 1999), but also because only a small number of patients that 
fulfil criteria at presentation continue to do so after a few years (Mikkelsen and Dodge 
1969; O'Sullivan and Cathcart 1972; Dugowson, Nelson et a1. 1990). 
Studies that have assessed patients with so-called early undifferentiated disease 
have usually defined their cohort by a failure to satisfy other accepted diagnostic 
criteria, whilst also including features suggesting the potential to evolve into a 
persistent inflammatory arthritis (Wolfe, Ross et a1. 1993; van der Borst-Bruinsma, 
Speyer et a1. 1998; Quinn, Green et a1. 2003). The lack of a specific diagnostic 
category, with patients being variably labelled as 'undifferentiated arthritis' (UA) 
(Schumacher 2002) or 'hand undifferentiated arthritis' (BUA) (Quinn, Green et a1. 
2003), makes comparisons between studies difficult. Hand involvement has also been 
suggested as a specific marker of poor prognosis having the greatest likelihood of 
persistence of symptoms and DMARD use (Jansen, van Schaardenburg et a1. 2002). 
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Synovitis on clinical examination (Boers, Kostense et al. 2001) and MRI 
(Conaghan, O'Connor et al. 2003; Mc Queen, Benton et al. 2003; Ostergaard, Hansen et 
al. 2003) predicts bone damage in RA and large cohort studies suggest early DMARD 
therapy in RA improves outcome (Boers, Verhoeven et al. 1997; American College of 
Rheumatology Subcommittee on Rheumatoid Arthritis 2002; Landewe, Boers et al. 
2002; O'Dell, Leff et al. 2002). Imaging modalities such as US (Backbaus, Kamradt et 
al. 1999; Karim, Wakefield et al. 2001) and MRI (Klarlund, Ostergaard et al. 1999; 
Goupille, Roulot et al. 2001; Conaghan, O'Connor et al. 2003; McQueen, Benton et at. 
2003; Ostergaard, Hansen et at. 2003) are able to detect synovitis in joints without 
clinically detectable synovitis, so called 'sub-clinical' synovitis. 
Ultrasonography has also demonstrated good levels of reliability at detecting 
synovitis in the small joints of the hands (Backhaus, Kamradt et at. 1999; Ribbens, 
Andre et al. 2003). It could be envisaged that imaging-detected synovitis may be used 
to enhance existing classification criteria, thereby allowing for earlier diagnosis and 
therapeutic intervention, with consequent improved outcome. Ultrasonography is safe, 
relatively inexpensive and can be used for multiple real-time, dynamic assessments in 
the outpatient setting offering a valuable addition to the evaluation of patients with 
early inflammatory arthritis. Such attractive attributes have contributed to the increasing 
use of ultrasonography by rheumatologists throughout Europe and more recently in 
North America. 
Corticosteroids are used to treat a flare of inflammatory symptoms and to 
maintain disease control in oligoarthritis (Green, Marzo-Ortega et at. 2001), RA (Boers, 
Verhoeven et at. 1997), and osteoarthritis (Hochberg, Altman et al. 1995; Creamer 
1997). The actions of corticosteroid include inhibition of cell receptor transcription, and 
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down regulation of adhesion molecule and cytokine (e.g. IL-l, IL-6, TNFa) expression 
(Barnes 1998). Intramuscular methyl prednisolone is used as an alternative to oral 
prednisolone in an attempt to reduce long-term side effects although there is little data 
assessing its efficacy. Hydroxychloroquine, a DMARD with a low toxicity index, has 
been used with benefit in RA (Clark, Casas et a1. 1993; Tsakonas, Fitzgerald et a1. 
2000), connective tissue disease (Williams, Egger et a1. 1994) and inflammatory 
osteoarthritis (Robertson, Rice et a1. 1993; Bryant, des Rosier et a1. 1995). Recently it 
has been suggested HCQ works in part by blocking the innate immune response to 
bacteria by interfering with Toll-like receptor signalling and as such may prevent the 
progression to arthritis (Klinman 2003). 
In this proof of concept study we tested the hypothesis that patients presenting 
with predominant hand pain and stiffness have an inflammatory aetiology to their 
symptoms and should respond to corticosteroids, with those that had evidence of 
synovitis most likely to respond. We wished to establish a practical, clinically useful 
management algorithm and HCQ, chosen because of its mild toxicity, was given to 
responders who subsequently relapsed. Following the logic that inflammation is 
suppressed by steroids and DMARDs, we tested the hypothesis that patients presenting 
with hand pain and stiffness most likely to respond to IM MP would be those with 
synovitis; either clinically or detected by US. In addition, those patients with a good 
response to IM MP have a predominant inflammatory aetiology to their symptoms and 
are therefore most likely to respond to a DMARD. 
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Therefore the primary aim of the study was to assess this group's response to IM 
MP. Secondary aims included predictors of this response US synovitis in particular, and 
the response and predictors of response to HCQ. 
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7.5 Methods 
7.5.1 Patients 
Patients presenting to the Leeds Early Arthritis clinic with symptoms of 
inflammatory hand pain (IHP) of more than 3 months duration failing to respond to, or 
intolerant of NSAIDs were invited to take part. Inflammatory hand pain was defined as 
predominant hand pain, with diurnal variation of symptoms and early morning stiffness 
of the hands (EMS) ::: 30 minutes. Patients with predominant hand pain were assessed 
due to the increased probability of persistence and disease evolution (Jansen, van 
Schaardenburg et al. 2002), and to minimise overlap of patients with classic 
oligoarthritis (mainly affecting lower limbs). Patients with skin psoriasis were included. 
Patients with clinical synovitis in ::: 5 joints, or satisfying ACR classification 
criteria for RA (Arnett, Edworthy et al. 1988) or the European Spondyloarthropathy 
Study Group criteria for spondyloarthropathy (Dougados, van der Linden et al. 1991) 
were excluded. Patients with other inflammatory arthritis including gout, or connective 
tissue illness were also excluded, as were those with a history of sensitivity to 
corticosteroid or hydroxychloroquine. Written informed consent was obtained prior to 
entry into the study and approval for the study was obtained from the Local Research 
Ethics Committee. 
7.5.2 Clinical asessment 
Baseline assessment was undertaken in the early arthritis clinic on a single visit 
and included a full history and physical examination including metrology by an 
independent joint assessor. Clinical synovitis was documented by the assessing 
physician, as defined by two out of three of i) joint swelling, ii) joint tenderness and iii) 
reduced range of movement (Green, Marzo-Ortega et al. 2001; Quinn, Green et al. 
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2003). Other data collected included EMS, pain relieving medication, and 1 Ocm VAS 
for hand pain and stiffness completed by the patient, and for disease activity completed 
by the patient and physician. Functional disability was assessed using the HAQ. 
Laboratory tests included C-reactive protein, rheumatoid factor (RF), anti-nuclear 
antibodies and uric acid, with a RF titre of >40 IU, and an ANA of >1180 titre defined 
as positive. 
7.5.3 Ultrasonography 
Ultrasonography was also undertaken by a single rheumatologist (ZK) 
experienced in US to document synovitis. Synovitis was defined as the presence of 
abnormally hypoechoic intra-articular tissue, which, unlike synovial fluid, is non-
displaceable and only poorly compressible. The 2nd to 5th MCP and PIP joints of the 
hand with the most symptoms, or the dominant hand if similar symptoms, were 
examined using an ATL HOI 3000 (Phi lips) with a 10-5 MHz hockey stick transducer 
with a small footprint size (24xl0mm) to improve access to the finger joints. The 
palmar and volar aspects of all MCP's were assessed plus the radial and ulnar aspects of 
the 2nd and 5th MCPs respectively. The PIP joints were assessed from all 4 aspects as 
above, and each area was imaged in longitudinal and transverse planes. 
7.5.4 Treatment 
Patients received an IM injection of 120mg MP (patients :s 55kg were given 
80mg) at baseline assessment. Patients were then reviewed after 4 weeks to assess 
response and have all baseline assessments except US and blood tests repeated. 
Thereafter patients were reviewed every 12 weeks for a further 48 weeks. The study 
protocol allowed NSAIO or analgesic use for symptom relief during the study period, 
but corticosteroid use other than within the protocol was not allowed. Responders to IM 
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MP who subsequently relapsed (recurrence of original symptoms) were treated with a 
further IM MP and started on HCQ 200mg daily and observed to assess response after 
24 weeks of HCQ treatment.· Non responders continued with NSAID and analgesic 
therapy as required. Any patients who subsequently fulfilled criteria for a specific 
rheumatic condition (e.g RA) had this documented and treated accordingly (Table 7.1). 
Week 0 
Baseline Assessment 
IMMP 
1 
Week 4 Assessment ~ Yes I 50% Benefit? J No I I ~l 
! 
Review every 
12 weeks 
Relapse? 
" I Yes I No J 
~ ~ IM MP, HCQ 
Review every Review every Review every 
12 weeks, assess 12 weeks 12 weeks 
response after 24 weeks 
treatment with HCQ 
Table 7.1 Study design 
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7.5.5 Outcome assessment 
The primary outcome was response to IM MP at 4 weeks, defined as a 50% 
improvement in patient symptoms (hand pain and stiffness) in response to a direct 
question from the assessor. Secondary outcome measures included change in baseline 
assessments at 4 weeks, change in pain relieving medication use, and predictors of 
response to IM MP. For the later observational ann of the study, response and 
predictors of response to HCQ, also defined as a 50% improvement in patient 
symptoms, were measured. The number of patients evolving into a specific rheumatic 
condition and side effects of therapy including new-onset diabetes or osteoporotic 
fracture were also documented. 
7.5.6 Statistical analysis 
The change in EMS, HAQ, joint counts, and visual analogue scores after IM MP 
were calculated by subtracting individual baseline data from the 4 week follow-up data. 
These changes were then compared between responders and non-responders using non-
parametric Mann-Whitney U tests. Following Bonferroni correction for multiple 
comparisons, critical P for testing at the 5% significance level was set at 0.006 for these 
tests. 
Maximum likelihood logistic regression was performed to identify any variables 
that might affect the odds of responding to treatment. Initially, separate models were 
run for each predictor in order to obtain age- and sex-corrected odds ratios for each. 
Prior to entry into the models, age was converted to a 4-level categorical variable based 
on the quartiles of its distribution. EMS was assigned to three categories: 30-59 
minutes, 60-119 minutes, 2:120 minutes. Having run models for each predictor 
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separately to obtain univariate odds ratios, we then created a multivariate model, which 
consisted of three blocks: demographics (age, sex); markers of inflammation (EMS, 
CRP and RF); synovitis (clinical and US). The demo graphics block was forced into the 
multivariate model, but the variables in the remaining two blocks were added 
sequentially on a stepwise, likelihood ratio basis (inclusion/exclusion criteria 
P=O.05/0.1 ). 
Logistic regression analysis for predictors of response to HCQ could not be 
performed due to the small numbers of non-responders to HCQ. Sensitivity, specificity 
and predictive values were assessed using the standard measures. 
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7.6 Results 
7.6.1 Patient demographics 
One-hundred and sixteen patients were screened, fourteen of whom were 
excluded at screening because they had less than 30 minutes early morning stiffness. 
One-hundred and two patients were recruited and received IM MP but eleven, whose 
baseline characteristics were similar to the rest, did not attend the 4 week assessment 
and were excluded from the study. The majority of the remaining ninety-one patients 
were female (81 %), the mean age was 51 years (18-86), with duration of symptoms 
between 3-18 months (mean 7 months). Four patients were::: 55 kg and received 80 mg 
IMMP 
7.6.2 Baseline assessment 
The RF titre was positive in 21 % (19/89), CRP was raised in 25% (23/91) and 
ANA positive in 5% (4/87). Clinical synovitis was detected in 23% patients (21/91); the 
remaining 70 patients that did not have any clinically-detectable synovitis were labelled 
the 'arthralgia' group. Synovitis was detected by US in 55% patients (50/91) (Table 
7.2). Seventy-two patients were on pain relieving medication at baseline; 44 on 
NSAIDs, 23 on analgesics and 5 on both. 
The median duration of EMS for the group was 60 with a HAQ of 1, PJC of 10, 
TJC of 14, and SJC of 2. The patients VAS for hand pain and stiffness, and disease 
activity were both 55 mm, while the physician VAS for disease activity was 18 mm 
(Table 7.3). 
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Variable All Responders Non- Age/sex-adjusted P= 
patients N= 66 (73%) responders OR 
N=91J%) N = 25 (27%) (95% C.I.) 
Age<41 24 (26) 15 (23) 9 (36) (reference category) 
-
41-49 21 (23) 16 (24) 5 (20) 2.12 (0.59 -7.64) 0.25 
50-61 23 (25) 18 (27) 5 (20) 2.45 (0.64 - 9.36) 0.19 
~62 23 (25) 17 (26) 6 (24) 1.88 (0.52 - 6.86) 0.34 
Female 74 (81) 53 (80) 21 (84) 0.75 0.75 
(0.21 - 2.60) 
Elevated 23 (25) 18 (27) 5 (20) 1.51 0.48 
CRP (0.48 - 4.78) 
RF positive 19*(21) 18***(28) 1 ** (4) 9.30 0.04 
(1.15 -75.39) 
Clinical 21 (23) 16 (24) 5 (20) 1.23 0.74 
synovitis (0.37 - 4.11) 
Arthralgia 70 (77) 50(76) 20 (80) 0.81 0.74 
(0.24-2.72) 
US synovitis 50 (55) 45 (68) 5 (20) 9.28 <0.001 
(2.84 - 30.35) 
EMS 
30-59 32 (35) 23 (35) 9 (36) (reference category) 
-
60-119 35 (38) 24 (36) 11 (44) 0.72 (0.24 - 2.19) 0.56 
>120 24 (26) 19 (29) 5 (20) 1.48 (0.41 - 5.39) 0.55 
Table 7.2 Baseline characteristics with OR of response to IMMP 
Baseline characteristics for all patients, responders and non-responders, with odds ratios 
for response to IM MP adjusted for age and sex. RF data not available for 2 patients; 
*total N = 89, **total N = 24, ***total N = 65 
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Table 7.3 Baseline characteristics and change after IMMP 
Baseline characteristics and change after four weeks following IM MP for all patients, non-responders, and responders to steroid. Figures 
presented are medians (range). P values are for improvement in baseline assessments between responders and non-responders using non-
parametric Mann-Whitney U tests. *total N = 90 **total N = 80 
Variable Baseline Change over 4 weeks Mann-
WhitneyU 
test 
All patients Non- Responders Overall Non- Responders P= 
responders responders 
EMS (minutes) <0.001 
60 (30 to 320l 60 (30 to 320) 60 (30 to 320) -30 (-320 to 120) 0(-120 to 120) -35 (-320 to 30) 
HAQ <0.001 
1 (0 to 2.751 1 (0 to 2.13) 1.0610 to 2.75) -0.13 (-1.50 to 0.75) 0(-0.38 to 0.38) -0.38 (-1.50 to 0.75) 
PJC* 10 (0 to 72) 9 (0 to 44) 10 (1 to 72) -3 (-48 to 22) 0(-36 to 22) -6 (-48 to 16) <0.001 
TJC 14 (0 to 72) 18 (0 to 72) 10 (0 to 58) -2 (-43 to 30) 0(-24 to 30) -3 (-43 to 18) 0.006 
SJC 2 (0 to 24) 2(Oto 16) 2 (0 to 24) -1 (-17 to 6) 0(-11 to 3) -1 (-17 to 6) 0.500 
Pain/Stiffness <0.001 
VAS (mm) 55 (3 to 98) 53 (3 to 96) 59.5 (9 to 98) -16 (-71 to 44) -1 (-63 to 44) -26.5 (-71 to 42) 
Disease activity <0.001 
VAS (mm) 55 (2 to 100) 50 (2 to 100) 56 (2 to 98) -16 (-82 to 49) 0(-47 to 49) -20.5 (-82 to 43) 
Physician 0.007 
VAS**(mm) 18 (0 to 91) 18 (4 to 64) 21(0 to 91) -3.5 (-57 to 23) 2 (-52 to 12) -6.5 (-57 to 23) 
MD Thesis- Dr Zunaid Karim 
7.6.3 Response to IM MP 
A positive response to IM MP was noted in 73% (66/91) of patients; 28% 
(18/65) were positive for RP and 27% (18/66) of responders had a raised CRP, and 
all 4 patients with a positive ANA responded to IM MP. Sixteen responders (24%) 
had clinical synovitis and 50/66 (76%) had arthralgia, and synovitis was detected by 
US in 68% (45/66) (Table 7.2). Nineteen patients in total discontinued pain 
relieving medication (14 on NSAIDs and 5 on analgesics). 
Age and sex- adjusted logistic regression analyses on individual baseline 
characteristics demonstrated a significant association between response to IM MP 
and US synovitis (OR 9.28, p<O.OOl) and RP (OR 9.30, p=0.04), but not for clinical 
synovitis (OR 1.23, p=0.74) or an elevated CRP (OR 1.51, p=0.48) (Table 7.2). 
There were only small, non-significant differences in baseline assessments between 
responders and non-responders to IM MP (Table 7.3). 
Change in baseline assessments 
Overall responders had a reduction in EMS of 35 minutes and a reduction in 
HAQ of 0.38 compared with no change in both for non-responders (p<O.OOI for 
both). Changes in metrology for responders saw a reduction in PJC of 6 compared 
with no change (p<O.OOl), a reduction in TJC of 3 compared with no change 
(p=0.006), and a reduction in SJC of 1 compared with an increase in 1 (p=0.500) in 
non-responders. The patients VAS for hand pain and stiffness in responders reduced 
by 26.5 mm compared with Imm and VAS for disease activity reduced by 20.5 mm 
compared to no change in non-responders (p<O.OO 1 for both). The physician VAS 
for disease activity reduced by 6.5 mm in responders compared with an increase of 2 
mm (p=0.007) in non-responders (Table 7.3). 
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Predictors of response to IM MP 
Multivariate regression analyses were performed for age, sex, EMS, CRP, 
RF, CS, and US synovitis. Age and sex were forced into the model; all other 
variables were entered on a forwards, stepwise basis. The stepwise selection process 
excluded EMS, clinical synovitis and CRP from the model, leaving age, sex, RF, 
and US synovitis in the model. Of these variables, only US synovitis made a 
significant contribution, with RF being retained in the model but not having a 
sufficiently great individual impact to emerge as a significant predictor. The 
presence of US synovitis at baseline significantly increased the odds of response to 
IM MP (adjusted OR = 8.77, 95% C.1. 2.46 - 31.19, P<O.OOI). The adjusted odds 
ratio for RP was 5.73 (95% C.1. = 0.65 - 50.16, P = 0.115). This model correctly 
predicted 83.1 percent of responders and 50% of non-responders (Nagelkerke R-
squared value 0.341, Hosmer & Lemeshow goodness-of-fit test p=0.56). 
Age and sex did not make significant individual contributions to the model, 
so an additional logistic regression model containing only US synovitis and RF 
(forced entry) was created. This performed somewhat better than the first model, 
correctly predicting 72.3 percent of responders and 79.2% of non-responders to IM 
MP (Nagelkerke R-squared value 0.327, Hosmer & Lemeshow goodness-of-fit test 
p=0.75). In this second model US synovitis at baseline was associated with a 
significant increase in the odds of response (adjusted OR = 7.41, 95% C.1. = 2.51 -
21.82, P<O.OOI), although RF again did not make a significant contribution to the 
model (adjusted OR = 5.48, 95% C.l. = 0.63 - 47.71, P = 0.123) (Table 7.2). 
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7.6.4 Response to HCQ 
Following IM MP 36% (24/66) of responders remained well to the end of the 
study period (52 weeks) and did not receive any further IM MP or HCQ. Sixty-four 
percent (42/66) of responders relapsed (all within 24 weeks) and were treated with 
repeat IM MP and HCQ. Thirty-three percent (14/42) of patients stopped taking 
HCQ within the first 3 months; 11 were unable tolerate HCQ, and 3 were non-
compliant. Of those that remained on HCQ (with minimum follow up of 28 weeks) 
86% (24/28) reported a benefit. Thirty-three percent (8/24) of responders had a 
raised CRP and 22% (5/23) were positive for RF. Twenty-five percent (6/24) had 
clinically-detectable synovitis and 75% (18/24) had arthralgia. Sixty-three percent 
(15/24) of responders had US synovitis at baseline. Seventy-nine percent (11114) of 
the patients who stopped taking HCQ within the first 3 months relapsed. 
Predictors of Response to HCQ 
In patients who remained on HCQ long-term, US synovitis at baseline had a 
positive predictive value of 94% (15/16); compared with 82% (18/22) for arthralgia, 
83% (5/6) for a positive RF, and 89% (8/9) for a raised CRP. All 6 patients with 
clinical synovitis and all 3 with a positive ANA responded to HCQ. 
7.6.5 Other outcomes 
Eight out of91 patients (9%) developed RA during the course of the study; 6 
had responded to IM MP, and 3 of these 6 also responded to lICQ given later. Two 
patients developed psoriatic arthritis, with 1 each labelled as having reactive arthritis 
and gout. No patients developed diabetes and there were no reports of osteoporotic 
fracture. 
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We also compared the finding of clinical synovitis in patients with US 
synovitis. At baseline 50 patients had US synovitis; 16 of whom had clinical 
synovitis (5 patients with clinical synovitis did not have US Synovitis). Forty-five 
responders to IM MP had US synovitis; 14 of whom had clinical synovitis (2 
patients with clinical synovitis did not have US Synovitis) (Table 7.4). 
Clinical Synovitis Arthralgia Total 
US-ve US+ve US+ve US-ve 
All patients 5 16 34 36 91 
Responders 2 14 31 19 66 
Non-responders 3 2 3 17 25 
Table 7.4 US synovitis in polyarthralgia and clinical synovitis 
Relationship between US synovitis, clinical synovitis and response to IM MP. US 
+ve = US synovitis, US -ve = no US synovitis. Nearly half the arthralgia group had 
US synovitis and proportionately more non-responders had clinical synovitis 
without US synovitis than responders. 
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7.7 Discussion 
This is the first study to examine the clinical features of HIP and relate their 
response to IM MP; in particular to study the predictive value of baseline features in 
such patients. This study demonstrated that most patients respond well to IM MP 
and, consistent with our hypothesis, US synovitis at baseline was significantly 
associated with this response. This potentially provides an insight into the 
pathological basis of these patients' symptoms, and may also indicate that our 
traditional methods of assessment are not sensitive enough to detect this level of 
synovitis suggesting a possible role for US. We also observed that many who 
respond to IM MP relapse; and IICQ may be an appropriate choice of DMARD 
therapy in this sub-group. 
We defined response as a patient-perceived 50% improvement in symptoms in 
the absence of any known appropriate outcome measures, and using this definition, 
responders had a significant reduction in most baseline assessments compared to 
non-responders. In addition the reduction in IIAQ of 0.38 following IM MP (Table 
7.3) is greater than what is considered to be the minimal clinically significant 
difference in HAQ for RA (0.22) (Wells, Tugwell et al. 1993), and for a 
combination of arthritides (0.20) (Redelmeier and Lorig 1993), suggesting our 
definition of response is likely to be clinically significant. 
The logistic regression analyses identified 2 models, which only reasonably 
predicted response to IM MP suggesting other factors, not recorded in this study, 
may affect response to steroid. That US synovitis remained a significant predictor of 
response throughout all of the logistic regression models suggests there is an 
association between the presence of US synovitis at baseline and the odds of 
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responding to corticosteroid. Further research with a greater number of patients is 
required to assess the true extent of this. 
Contrary to our expectations clinical synovitis was not a factor at predicting 
response. One explanation may be that clinical examination has poor accuracy in 
detecting "clinically important synovitis" that may be amenable to therapy. In our 
study US detected synovitis in almost half of those without clinically detectable 
synovitis, thus demonstrating the insensitivity of clinical assessment at detecting 
low-grade inflammation. Another explanation might be that patients with clinical 
synovitis have a greater amount of inflammation and our response criteria of greater 
than 50% patient-perceived improvement may have been too stringent excluding 
some patients with a partial response. The fact that 2 patients who developed RA, 
were defined as non-responders according to this criteria might support this. 
This study highlights the varying outcome of this cohort of patients with HIP. 
One third of patients remained well, either due to the impact of corticosteroid or 
spontaneous resolution, although other results suggest this is not an entirely benign 
group. The baseline HAQ scores in our study were similar to those with early RA 
(Wolfe and Cathey 1991; Harrison, Symmons et at. 1996) and inflammatory 
polyarthritis (Guillemin, Suurmeijer et at. 1994), and with over 1 in 10 developing a 
specific chronic inflammatory arthritis these patients should be monitored carefully. 
Most patients in our study did not have clinical synovitis and we also excluded those 
with polyarthritis, but despite our cohort appearing more benign, with less 
documented clinical synovitis, than previous studies (Green, Marzo-Ortega et al. 
2001; Jansen, van Schaardenburg et al. 2002; Schumacher 2002; Quinn, Green et al. 
2003) similar numbers developed a specific rheumatic disease. 
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A possible limitation of the study was that it was a pragmatic study evaluating a 
clinical algorithm, and not a placebo controlled trial. We included patients with a 
diagnosis of OA because this is a common condition that on its own does not 
exclude the presence, or the development, of arthritis such as RA. Another possible 
limitation is that we did not have long-tenn assessments for those patients on HCQ, 
but this reflects standard patient care where patients are asked whether they felt they 
have responded to medication. It could be argued that part of the response to HCQ 
could be a result of the repeat IM MP, but response to HCQ was assessed after 24 
weeks and most patients that stopped HCQ relapsed, suggesting response to HCQ 
rather than IM MP. This highlights the need for a randomised control trial. 
In summary this study provides preliminary evidence, insights into pathology 
and an approach to the management of patients with inflammatory hand pain. We 
suggest that in patients who present with predominant hand pain, stiffness, and signs 
of synovitis one can justify the use of IM MP. Furthennore, those patients with 
synovitis demonstrable on US only should also receive an IM MP injection. Where 
US assessment is not available it is still reasonable to proceed with an IM MP if 
inflammatory symptoms but not signs are present. 
One could predict from our results that the majority of patients would get 
significant short to medium tenn benefit. If they respond to IM MP and have a 
recurrence of symptoms it is reasonable to undertake a trial of IlCQ expecting that 
some will have side effects. 
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7.8 Subsequent literature 
7.S.1 Efficacy of IM MP 
Since this work has been done there has been a randomised placebo 
controlled trial of monthly injections of IM MP in active RA demonstrating that IM 
MP has short term benefit over placebo (Choy, Kingsley et al. 2005). Disease 
activity improved more rapidly than in the placebo group, but this did not continue 
at 6 months. There was however a significant reduction in erosion counts in the 
treatment arm. The treatment group did however, suffer significantly more adverse 
reactions (55 vs 42) including vertebral fracture and diabetes, as well as a 
significantly greater drop in hip bone density compared with placebo. The results of 
this study warn that IM MP given as a series of 24 monthly injections can cause 
considerable side-effects and suggest that if a patient has increased disease activity; 
the best option is to increase DMARD therapy if possible and consider any potential 
benefit of IM MP against the potential risks as described. 
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7.9 Summary 
In this chapter we suggest a possible underlying inflammatory aetiology of many 
patients that present with symptoms, but no signs, to suggest inflammatory arthritis. 
In this study most had sub-clinical synovitis and US synovitis was the best predictor 
of response to IM MP which we assumed was a pointer to an inflammatory 
aetiology. The treatment algorithm we used is a practical way of managing this 
group of patients. 
Further work should include a repeat US assessment to evaluate the outcome of 
sub-clinical synovitis after IM MP and determine whether any change in synovitis 
reflects response. Patients need to be randomised to receive placebo or IM MP to 
remove any placebo effect bias, and also to observe the natural progression of this 
group. 
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Chapter 8 
8.1 Clinical Utility: Impact of Ultrasonography 
8.2 Clinical relevance 
The use of US is increasing because US is safe (uses no ionising radiation), 
non-invasive and can be used repeatedly in an outpatient setting providing 
immediate access for patients. Availability of US varies widely between hospitals 
with most referrals for specific conditions such as rotator cuff tears, often requiring 
a visit to the radiology department and then a return visit to the referring physician. 
There is however a paucity of data assessing its actual impact on patient 
management. This is the first study to assess the impact of US in a rheumatology 
clinic using it as an adjunct to routine clinical assessment. 
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The aim of this study was to investigate the diagnostic and therapeutic 
impact of US in a routine rheumatology setting. 
8.3.2 Methods 
One hundred consecutive referrals for US from rheumatology outpatient 
clinics were assessed. The referring clinicians documented the site-specific clinical 
diagnosis (SSD), overall diagnosis (OD) and management plan before US. 
Ultrasonography was then perfonned in the clinic and the patient immediately 
reviewed by the referring clinician with the US report. Any change in diagnosis or 
management as a result of US was recorded. 
8.3.3 Results 
One hundred and twenty-one sites were examined by US. Ultrasonography 
altered SSD in 53/100 (53%) and the OD in 5/100 (5%) patients. Management plan 
was altered in 53/100 (53%) patients and predominantly involved changes to guided 
corticosteroid therapy (36 patients) although use of disease modifying anti-
rheumatic drugs was also altered (13 patients). The most frequent reason for referral 
to US was to assess synovitis in 86/121 (71%) sites, and the Mep joints were the 
most scanned sites in 451121 (37%). 
8.3.4 Conclusions 
This study demonstrated that US has a positive impact on diagnosis and 
therapy offering important benefits when used as an adjunct to clinical examination 
in the rheumatology setting. If this transfers into improved outcome, it is likely to 
have major implications for the future practice of rheumatology. 
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8.4 Introduction 
There is increasing interest in the use of US in rheumatology (Grassi and 
Cervini 1998; Wake field, Gibbon et al. 1999; Tan, Wakefield et al. 2003; Kane, 
Bruyn et al. 2006). Ultrasonography is non-invasive, safe (uses no ionising 
radiation) and can be used repeatedly in an outpatient setting providing immediate 
access for patients. Unlike conventional x-ray and other imaging modalities, US can 
be repeated as often as necessary since it does not involve ionising radiation or high 
unit costs. Availability of US varies widely between hospitals with most referrals for 
specific conditions such as rotator cuff tears. This usually requires a separate visit to 
the radiology department and then a return visit to the referring physician. 
Advances in technology has made US more amenable to assess smaller joints 
and there is accumulating evidence that US is more accurate than clinical 
examination in the detection of synovitis and tenosynovitis in small joints (Grassi, 
Tittarelli et al. 1993; Grassi, Tittarelli et al. 1995; Lund, lIeikal et al. 1995; 
Backhaus, Kamradt et al. 1999; Swen, Jacobs et al. 2000). The benefits of US have 
also been determined in the assessment of the painful shoulder (Alasaarela, Takalo 
et al. 1997; Swen, Jacobs et al. 1998), hip (Koski 1989; Koski, Anttila et al. 1990), 
knee (Hauzeur, Mathy et al. 1999; Ward, Jacobson et al. 2001), ankle (Koski 1990; 
Jacobson, Andresen et al. 1998), and in conditions such as RA (Gratz, Gobel et al. 
1999), OA (Iagnocco and Coari 2000), and SpA (Lehtinen, Taavitsainen et al. 
1994). In addition, US also enables accurate placement of corticosteroid injections 
(Cicak, Matasovic et al. 1992). 
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Rankine and colleagues in a controlled prospective observational study, have 
assessed the influence of lumbar spine MRI on the management of patients with low 
back and leg pain, with a clinical diagnosis of neural compression (Rankine, Gill et 
al. 1998). Of the 72 patients examined, 65 (90.3%) had leg pain as a predominant 
feature and 31 (43%) had abnormalities in neurological examination. Following 
MRI 23/48 (47.9%) of patients had management changed from surgery to 
conservative management. The diagnosis altered in 50 % of cases with the largest 
change in diagnosis occurring in 13 patients where MRI did not confirm the clinical 
impression of nerve root compression. Interestingly 17 with no abnormality on 
neurological examination were subsequently treated by surgery which included all 
12 patients treated by spinal fusion. The authors concluded that the major impact of 
MRI was to avoid surgery with its potential morbidities. There is a paucity of 
similar data on the effect of US on these processes (Grassi and Cervini 1998; 
Wakefield, Gibbon et al. 1999). 
This study evaluated the diagnostic and therapeutic impact of 
musculoskeletal US in rheumatology outpatient clinics. 
192 
MD Thesis- Dr Zunaid Karim 
8.5 Methods 
8.5.1 Patients 
Of 520 rheumatology outpatients seen in the Department of Rheumatology at 
Leeds General Infirmary, 100 consecutive patients referred for US were included in 
this observational study. These were referred from an early arthritis clinic (EAC) 
and general clinics. The EAC is a 'fast-track' referral service for patients with a 
history suggestive of inflammatory arthritis of less than 12 months duration. The 
local ethics committee approved the study and informed consent was obtained from 
all patients. All patients referred for US as part of a research protocol were 
excluded. 
8.5.2 Study Procedure 
All patients underwent a routine assessment, which included a detailed 
interview and clinical examination by an experienced physician. Information with 
the referral included the indication for US, the site of interest and site-specific 
diagnosis (SSD), e.g. synovitis, tenosynovitis. The overall diagnosis (OD), (e.g. 
rheumatoid arthritis, gout) and management plan were recorded separately i.e. data 
not available to the person performing US. Patients then had US performed during 
the same clinic visit using an on-site ATL IIDI 3000 (Advanced Technology 
Laboratories, Bothel Washington, USA) machine, which operated throughout clinic 
time. A linear array 10-5 MHz 'hockey stick' transducer was used to examine most 
joints, being particularly useful for the small joints. A curvi-linear array 5-3 Mllz 
transducer was used to examine the hip. An experienced rheumatology research 
fellow (RJW) trained by musculoskeletal radiologists performed the US. The 
physician subsequently reviewed the patient in the same clinic with the US report. 
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Any change in the diagnosis or management plan as a result of US was documented. 
The completed referral forms were then returned to an independent database 
manager who was not involved in the clinical or US assessment. 
8.5.3 Statistical analysis 
The number of changes in management and diagnosis are presented descriptively. 
The primary outcome measure was change in SSD after US. Change in OD and 
management were secondary outcomes. 
8.6 Results 
Of the 100 patients referred for US, 73 were female and the mean age was 50 
years (range 17-87). Fifty-eight patients were referred from general clinics and 42 
from EAC; there were 30 new patients in total. Sixty-four patients were referred to 
confirm a diagnosis alone, with 36 referred to confirm a diagnosis with the aim of 
subsequent local corticosteroid injection. Twenty of these 36 (56%) had reported a 
poor response to a previous 'blind' corticosteroid injection. 
A total of 121 sites were examined by US, the commonest sites being the 
small joints of the hands and feet with the MCP the most frequently requested in 
45/121 (37%) sites (Table 8.1). The most common request of US was to confirm the 
presence or absence of synovitis 86/121(71 %), followed by enquiries regarding 
enthesitis 111121 (9%) and tenosynovitis 9/121(7%) (Figure 8.1). 
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Figure 8.1 US requests by pathology 
With regard to OD, of the 100 patients, 45 had a pre-US diagno is of 
inflammatory arthritis, 35 had a local diagnosis only (eg. epicondyliti , rotator cuff 
tendonitis), 12 patients were diagnosed as having degenerative disea e and had 
other diagnoses including crystal arthropathy and polymyalgia rheumatica. 
8.6.1 Changes in site-specific diagnosis 
The SSD was changed in 531100 (53%) patients and 60/ 121 ite (50%). The 
most frequent change in diagnosis was the clinical assessment of ynovitis, which 
changed in 43/60 (72%) sites. In order of frequency the changes in clinical SSD 
were: synovitis in 43/60 (72%) sites, tenosynovitis in 7/60 (12%) sites and enthesitis 
in 5/60 (8%) sites. There were similar changes in SSD in both EAC and general 
clinic patients. 
For synovitis this involved documenting no synovitis on US when synovitis 
had been clinically diagnosed in 18 sites; demonstrating synovitis on US when none 
was detected clinically in 18 (Figure 8.2, Figure 8.3). In the remaining 7 sites the 
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pre-US diagnosis of synovitis was changed to degenerative changes (defined as the 
presence of osteophytes and/or joint space narrowing) without synovitis in 3 sites, 
tenosynovitis in 2, and bursitis and enthesitis in 1 site each. 
Figure 8.2 Photograph of subject without clinical synovitis 
Figure 8.3 Corresponding US demonstrating synovitis/effusion 
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For tenosynovitis the SSD was changed; to synovitis in 4, no pathology in 2 
and periostitis in 1 site. The diagnosis of enthesitis was changed; to synovitis and 
bursitis in 2 sites each, and to normal in 1 site. 
The commonest site where SSD was altered was at the most frequently 
scanned joints; MCPs in 24/60 (40%) and the wrist in 8/60 (13%) sites (Table 8.1). 
Ultrasonography was also able to provide additional information, not provided by 
clinical examination in 55 sites; this included erosions, osteophytes, reduced joint 
space and calcific tendonitis. 
Site of scan Number Frequency of 
(%) SSD change (%) 
Overall 121 (100) 60/121 (50) 
Metacarpophalangeal joints 45 (37) 24/45 (53) 
Wrist 17 (14) 8/17 (47) 
Proximal interphalangeal 15 (12) 5115 (33) 
joints 
Hindfoot 12 (10) 7112 (58) 
Knee 10 (8) 5/10 (50) 
Forefoot 7 (6) 617 (86) 
Elbow 5 (4) 1/5 (20) 
Others 10 (8) 4/10 (40) 
Table 8.1 Sites assessed by US, with change in SSD 
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8.6.2 Changes in overall diagnosis 
The OD was changed in 5/100 (5%) patients. Two patients had a clinical 
diagnosis of rheumatoid arthritis altered to seronegative spondyloarthropathy after 
US documented entheseal pathology. In one patient with a clinically hot swollen 
elbow (suspected joint sepsis) US documented extensive enthesitis without any joint 
effusion; in another patient with PMR and suspected peripheral synovitis, US 
confirmed joint synovitis but also erosive changes with the OD then being changed 
to rheumatoid arthritis (RA). A seropositive patient with monoarthritis of the wrist 
had US, which documented symmetrical synovitis of the wrist and MCPs with 
erosions in the wrist hence the OD being changed to RA. There were a further 8/100 
(8%) patients, 7 of whom were new referrals, in which US helped confirm a 
provisional OD. Seven of these had a diagnosis of inflammatory arthritis confirmed 
after US documented a combination of synovitis, tenosynovitis and erosions, and in 
1 patient US documented degenerative changes confirming the OD of osteoarthritis. 
8.6.3 Changes in management 
The management plan was altered in 53/100 (53%) patients after US, in 39 
due to a change in SSD and in 14 as a result of US confirming a provisional SSD. 
Corticosteroid therapy was affected in 43 patients. The decision to give a 
soft tissue or intra-articular corticosteroid injection was altered in 22 patients: 12 
were withheld and 10 given at a different site. In addition, 14 patients had a 'newly 
planned' injection after US. Only 14 of the original 36 (39%) intended injections 
were given at the planned site (Figure 8.4). Parenteral corticosteroid therapy was 
affected in 7 patients, 6 were newly planned and 1 withheld, as a result of US. Two 
of the patients with a newly planned parenteral corticosteroid were also commenced 
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on disease modifying anti-rheumatic drug (DMARD) therapy because of a new OD 
after US. 
Disease modifying drug therapy was affected in 13 patients; increased in 10 
patients due to the detection of extensive subclinical synovitis and reduced in 3 due 
to an absence of synovitis demonstrated by US. Other changes included 4 new 
podiatry referrals, 2 planned diagnostic medical arthroscopies withheld and 1 new x-
ray referral after US. Seven patients had more than 1 management change. 
Figure 8.4 Impact on Intra-articular corticosteroid use 
Same site: Injections were given at the planned site (n= 14) 
Diff. Site: Injections were still, given, but at a different site (n= 1 0) 
Withheld: No injection given (n= 12) 
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8.7 Discussion 
This study suggests that US has a diagnostic and therapeutic impact in the 
majority of referred patients attending rheumatology clinics. When these findings 
are applied in the context of all patients attending clinics during the study period, 
US has an impact on diagnosis and management in at least 10% (53/520) of all 
cases. This study also documents the referral pattern when rheumatologists have 
direct access to US, with most patients referred for assessment of small joint 
synovitis and guided injections. 
Accurate detection of synovitis is important not only for appropriate local 
treatments but also, with the advent of expensive systemic therapies, to assess 
disease activity and subsequent bone damage. Early treatment of inflammatory 
arthritis improves patient outcome (Stenger, Van Leeuwen et at. 1998; Green, 
Marzo-Ortega et at. 1999) and potentially reduces the cost to society in the long-
term. Consistent with previous reports, this study demonstrates a poor correlation 
between US and clinical examination in the detection of synovitis; the changes to 
DMARD therapy were mainly a result of US detecting subclinical synovitis. 
A study of 40 patients with RA observed over 6 years demonstrated ongoing 
progression of x-ray damage despite improvement in clinical indices like ESR and 
grip strength (Mulherin, Fitzgerald et al. 1996). Another study using MRI concluded 
that progression of disease occurs early in disease and also found disagreement 
between clinical improvement and progression of MRI erosions (Mc Queen, Stewart 
et at. 1999). Our findings, in addition to the evidence that US is able to differentiate 
between active and inactive disease in RA (Hau, Schultz et at. 1999), concur with 
their conclusion that patients with clinically stable disease are often under-treated 
emphasising the role for better assessment modalities like US. 
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Response to corticosteroid injections is known to vary considerably, and 
there is evidence that accurately placed injections lead to better outcomes (Jones, 
Regan et al. 1993; Eustace, Bropl}.y et al. 1997). Interestingly the majority of 
patients referred with a planned corticosteroid injection reported a poor response to 
a previous blind corticosteroid injection and, in this study as a consequence of US, 
less than half received the injection at the pre-US planned site. The impact of US on 
corticosteroid injections therefore reflects the inability of clinical assessment to 
accurately localise pathology; and may explain part of the variation in response to 
conventionally placed injections. 
The US examinations took place in the outpatient department where direct 
access has the advantage of immediate alteration in management, if necessary, 
without additional hospital visits and waiting time. This helps reduce both the direct 
and indirect costs to the hospital service and the patient. After initial capital 
expenditure, the only running costs for US are the service contract and operators' 
time, in this case taking 10-15 minutes per patient assessment. 
There are limitations to this study. There was an initial selection bias since 
the patients assessed were all referred for US in the first instance, suggesting a 
degree of uncertainty in the diagnosis or management at the outset. Although a 
change in the clinical diagnosis or management plan is an important first step to 
demonstrate, it does not necessarily follow that outcome will be improved. Any 
benefit will have to be offset with the additional cost of US equipment and training, 
but should also take into account the direct and indirect cost benefit of a 'one-stop' 
patient service. 
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s.s Subsequent literature 
In this chapter we evaluated the impact of US in the diagnosis and management of 
rheumatology patients. Significant additions to the literature are described below. 
8.8.1 Diagnosis 
Inflammatory OA 
To evaluate the ability of high resolution US in the diagnosis of erosive OA, 
110 patients had plain x-ray with US of the DIP and PIP joints (lagnocco, Filippucci 
et al. 2005). The presence of articular bone surface irregularities defined as either 
marginal osteophytes or central erosions was recorded. Central erosions were 
detected by US in 16/22 (72.7%) patients with x-ray features of erosive OA and in 
none of 88 patients with classical hand OA without erosions on x-ray. Sensitivity 
and specificity for the detection of central erosions by US were 73% and 100%, 
respectively. The positive and negative likelihood ratios were 100% and 94%. This 
is the first study to evaluate the presence of erosions in patients with erosive OA by 
US. The authors conclude that US is a useful technique for differentiating erosive 
and classical hand OA. 
Carpal Tunnel Syndrome 
This study assessed US diagnosis with nerve conduction study diagnosis of 
carpal tunnel syndrome (Swen, Jacobs et al. 2001). Sixty-three patients with a 
clinical diagnosis of carpal tunnel syndrome, waiting carpal tunnel release, had US 
and nerve conduction studies performed. The criterion for diagnosis of carpal tunnel 
syndrome, and the gold-standard, was 90% or greater improvement of initial 
complaints 3 months after surgery. Following surgery, 47 patients (75%) 
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experienced 90% or greater relief of complaints. Using this criterion, mean cross 
sectional area of the median nerve for patients with CTS was 11.3 mm2 compared to 
6.1 mm2 in the control group. The sensitivity to detect carpal tunnel syndrome was 
0.70 and 0.98, and specificity was 0.63 and 0.19 positive predictive value was 0.85 
and 0.78, negative predictive value was 0.42 and 0.75, and accuracy was 0.68 and 
0.78, all for US and nerve conduction study respectively. The authors concluded that 
while US was slightly less sensitive it was significantly more specific than nerve 
conduction study. 
Scaphoid fracture 
This study used US to assess patients with clinically suspected scaphoid 
fractures (Senall, Failla et at. 2004). Eighteen patients attending accident and 
emergency with a history of wrist trauma, snuffbox tenderness, swelling, and a 
negative wrist x-ray were assessed. Ultrasonography correctly identified 7/9 cases of 
scaphoid fracture that were eventually positive on x-ray. Eight out of 9 cases were 
correctly identified as negative. Ultrasonography had a sensitivity of 78% and 
specificity of 89%, with a positive predictive value of 88% and negative predictive 
value of 80%. The authors concluded that US should be used in suspected cases of 
fracture where x-ray is negative. This study again demonstrates a clinical utility of 
US. Whilst US clearly has face and content validity to detect scaphoid fracture this 
study potentially adds concurrent validity because in the clinical setting repeat x-ray 
of the wrist to confinn scaphoid fracture would be seen as an acceptable gold 
standard. This study was limited however by the fact that US incorrectly identified 
one case as negative, which x-ray subsequently found as having scaphoid fracture. 
Whilst scaphoid fracture is probably more appropriately discussed in an orthopaedic 
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setting, we see many patients with hand and wrist pain, a significant number of 
whom describe a history of trauma. It is important that Rheumatologists are aware 
of this but also aware of the validity of US in assessing this feature. 
Lateral epicondylitis 
This study evaluated US features in patients with a clinical diagnosis of 
lateral epicondylitis including healthy patients as controls (Levin, Nazarian et at. 
2005). Ultrasonography of the common extensor tendon was performed in 10 
asymptomatic volunteers (20 elbows), and 22 patients (37 elbows) with symptoms 
of lateral epicondylitis. Abnormal images were assessed to see how many pre-set US 
findings were demonstrated. Using a clinical diagnosis of epicondylitis as the gold 
standard US demonstrated sensitivities ranging from 72% to 88% and specificities 
from 36% to 48% amongst the three readers. Odds ratios for the following findings 
were statistically significant (P < .05): calcification of common extensor tendon, 
tendon thickening, adjacent bone irregularity, focal hypoechoic regions, and diffuse 
heterogeneity, however odds ratios for lateral epicondyle enthesophytes were 
statistically significant (P < 0.05) for the first (of 2) reading sessions only. Odds 
ratios for linear intrasubstance tears and peritendinous fluid were not statistically 
significant. The authors concluded that there was a statistically significant 
relationship between symptoms and intra-tendon calcification, tendon thickening, 
adjacent bone irregularity, focal hypoechoic regions, and diffuse heterogeneity. This 
study describes common US features in lateral epicondylitis. 
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Plantar fasciitis 
This study used PD US to demonstrate findings in plantar fasciitis by 
assessing both heels of 20 patients with unilateral plantar fasciitis, with 20 healthy 
volunteers as controls (Walther, Radke et at. 2004). Duration of disease was noted 
and pain was assessed using a VAS score. Moderate or marked hyperaemia was 
found with PD US in the plantar fascia and the surrounding soft tissue along the first 
cm distally from the insertion in 8 (40%) of the 20 symptomatic heels and in 1 
patient (5%) on the asymptomatic side. There were no significant abnormalities in 
any of the control group and the difference between both groups was significant 
(p<0.05). This study suggests that PD US is valuable in diagnosing, and also gives 
some insight into the potential pathogenesis of plantar fasciitis. 
8.8.2 Comparison with clinical assessment 
Rheumatoid arthritis 
This study assessed the relationship between clinical examination and 
effusion detected by US in the MTP and ankle joints in 30 patients with RA 
(Luukkainen, Saltyshev et al. 2003). Altogether 288 MTP joints were assessed with 
agreement between clinical examination and US in 194. Of the 60 ankle joints 
assessed there was agreement in only 34. The Kappa coefficient between 
investigations was 0.165 in MTP and 0.043 in ankle joints. The authors concluded 
that there was a poor agreement between clinical assessment and US in the foot. 
This study included 200 MTP joints of 40 patients with RA and 100 MTP 
joints of 20 healthy controls and assessed US, MRI and clinical examination for the 
detection of joint inflammation with MRI being regarded as the gold standard 
(Szkudlarek, Narvestad et al. 2004) The sensitivity, specificity, and accuracy of US 
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for the detection of synovitis were 0.87, 0.74, and 0.79 respectively, while for 
clinical examination; the corresponding values were 0.43, 0.89, and 0.71 
respectively. For patients, US demonstrated synovitis in 36, while MRI and clinical 
examination revealed synovitis in 31 and 20 patients respectively. US and MRI 
synovitis showed intra-class correlation coefficients of 0.56-0.72 (P < 0.000 I). The 
authors concluded that US was more sensitive and accurate than clinical 
examination and had good correlation with MRI. This study again demonstrates the 
relative lack of sensitivity of clinical examination to detect synovitis in the MTP 
joint, and also demonstrated concurrent validity for US. 
This study compared the relationship between clinical detection of swelling 
and effusion with US findings in the elbows of 50 RA patients and 20 healthy 
controls (Luukkainen, Sanila et al. 2005). They found there was only fair agreement 
in assessments of 77 RA joints, resulting in a kappa coefficient of 003 71. There was 
one hundred percent concordance in the control group elbow assessments (40 
elbows). The authors concluded that clinical assessment was not accurate at 
detecting elbow effusions. 
This pioneering study compared clinical assessment of overall inflammatory 
activity in 94 patients with RA using gray-scale and PO US, comparing findings 
with inflammatory markers and joint counts (Naredo, 80nilla et a1. 2005). Each 
patient had 60 joints examined by US and two rheumatologists reached a consensus 
for the presence of tender joints, swollen joints and subjective swelling score from 1 
to 3. Similarly US joint effusion, synovitis, and PO signal were graded from I to 30 
in all 60 joints. A 28 joint count for clinical and US variables was also calculated. 
Using the 60 joint count, US showed significantly more joints with effusion (mean 
15.2) and synovitis (mean 14.6) than clinical examination (mean 11.5, p<0.05). A 
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significant correlation was found between joint count and joint index for swelling, 
US effusion, synovitis, and PD signal. The reduced 28 joint count for effusion, 
synovitis, and PD signal all correlated highly with the corresponding 60 joint 
counts. US findings also correlated better with CRP and ESR than clinical measures. 
They concluded that US is more sensitive at detecting synovitis in RA and that the 
reduced 28 joint count is comparable to the 60 joint count. The same authors have 
subsequently completed a further analysis and concluded that a 12 joint count is 
comparable to the 60 joint count (Naredo, Gamero et al. 2005). 
Spondyloarthropathy 
In this study, US was compared with clinical assessment in detecting 
entheseal abnormalities in patients with SpA (Balint, Kane et al. 2002). Thirty five 
patients had US examination of both lower limbs at five entheseal sites to detect 
bursitis, structural thickness, bony erosion, and enthesophyte. All patients also had a 
separate independent clinical assessment. The study findings were, on clinical 
examination, 75/348 (22%) entheseal sites were abnormal compared with 195/348 
(56%) using US. In 19 entheseal sites with bursitis on US, only five were detected 
by clinical examination. Compared with US, clinical examination had a low 
sensitivity (22.6%) and moderate specificity (79.7%). There was no significant 
correlation between the US score of enthesitis and acute phase parameters such as 
erythrocyte sedimentation rate (ESR) or C reactive protein (CRP). The authors 
concluded that US was better than clinical assessment for the assessment of 
entheseal abnormalities in patients with SpA and went on to propose an US 
entheseal score. 
In another study of patients with SpA, D' Agostino and colleagues 
(D'Agostino, Said-Nahal et al. 2003) assessed the prevalence and severity of 
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peripheral enthesitis in SpA with US and PO US. One hundred and sixty-four 
consecutive patients with SpA and 64 control patients (34 with RA, 34 with 
mechanical low back pain) had US examination of major entheses. Evidence of 
vascularisation was documented, concentrating on the following sites; cortical bone 
insertion of entheses, junction between tendon and entheses, body of tendon, and 
bursa. US findings consistent with enthesitis were observed in 1611164 SpA patients 
(98%), affecting 1,13112,952 entheses examined (38%). In contrast, only 132 of 
1,152 entheses (11 %) were found to be abnonnal in 33 of 64 control patients (52%). 
Abnormal findings were most commonly distributed in the distal portion of the 
lower limbs. Regarding PO US, none of the abnonnal entheses in control patients 
showed vascularisation, compared with 916 of 1,131 abnonnal entheses in SpA 
patients (81 %). Vascularisation was nearly always detected at the cortical bone 
insertion and sometimes also in the bursa. The authors concluded that US combined 
with PO allowed for the detection of peripheral enthesitis in the majority of SpA 
patients, but without falsely including other patient groups. This study, whilst not 
being compared with any gold standard, gives a better understanding of entheseal 
pathology and its prevalence in patients with SpA. 
Oligoarthritis 
This study set out to detennine the prevalence of sub-clinical synovitis using 
US assessment of painful and asymptomatic joints in early, untreated oligoarthritis 
«=5 joints) (Wake field, Green et at. 2004). Eighty patients underwent a detailed 
clinical assessment by two physicians and all painful joints were identified and 
assessed by US. In the last 40 patients all painful joints were assessed, but also a 
preordained set of joints were included even if asymptomatic. In 80 patients, 644 
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painful joints (with and without clinical synovitis) were identified and each 
underwent a US assessment. Of these joints, 185 had clinical synovitis, of which, 
US detected synovitis in only 79% (147/185). In the other 38 joints US 
demonstrated tenosynovitis instead of synovitis in 12 joints and possible, but not 
definite, synovitis in 11 joints. Fifteen joints were, however, normal on US. In 459 
joints that were not clinically synovitic, US detected synovitis in 33% (150/459). In 
64% (51180) of patients, US detected synovitis in more joints than clinical 
examination and in 36% (29/80) of patients, US detected a polyarthritis (>6 joints). 
Of the 826 asymptomatic (non-painful) joints scanned, 13% (107/826) had US 
detected synovitis. The authors concluded that US detected more synovitis than 
clinical examination in patients with oligoarthritis. In almost two thirds of patients 
there was evidence of sub-clinical disease while one third could be reclassified as 
polyarticular. They also concluded that the definition of oligoarthritis based on 
clinical findings may be inappropriate in many patients where US confirms 
polyarthritis. 
8.8.3 Disease progression despite improvement 
There is now more evidence that disease progressIon continues despite 
clinical assessment appearing to indicate disease improvement, or actual remission. 
Rheumatoid arthritis 
This study of 187 RA patientrs in clinical remission (modified ACR criteria) 
followed patients for two years (Molenaar, Voskuyl et al. 2004). Remission 
persisted in 52% of patients after two years; however the median Sharp/van der 
Heijde score for x-ray progression between baseline and 2 years was 0.5. Clinically 
relevant progression of damage occurred in 7% of patients with persistent remission, 
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leading the authors to conclude that even with a patient appearing to be in clinical 
remission, clinical vigilance and repeat x-ray measurement is required. This study 
adds to the work described earlier by Mulherin and colleagues (Mulherin, 
Fitzgerald et al. 1996). 
Psoriatic arthritis 
This study assessed 129 patients with PSA over a two year period (Kane, Stafford et 
al. 2003). They found that despite improvements in clinical parameters such as, 
HAQ and ESR, x-ray damage progressed. 
8.8.4 Change in diagnosis 
In a study of patients with a clinical diagnosis of chronic Achilles (24) or 
patellar (24) tendonitis, used US to guide either corticosteroid or placebo injection 
(Fredberg, Bolvig et aI. 2004). At the baseline assessment US confirmed the clinical 
diagnosis in only one third of patients. This study whilst not setting out to assess the 
diagnostic input of US, again demonstrates the inaccuracy of clinical assessment. 
8.8.5 Impact on planned foot injections 
This study is similar to the work of this thesis in that patients referred for 
injection had US assessment blinded to clinical findings (d'Agostino, Ayral et al. 
2005). This study used a better methodology by having two groups; in one group the 
physician was made aware of US findings and any change in management was 
documented, whereas in the second group the physician remained blinded to US 
findings until after injections were performed. In the group where the physician was 
informed of US findings this led to a change in the decision regarding local injection 
in 56 (82%) of 68 patients studied. Injection was cancelled in 37 (15%) of 242 
210 
MD Thesis- Dr Zunaid Karim 
proposed sites, whereas it was decided in 74 (8%) additional sites. Regarding 
outcome there was significant improvement in the unblinded group compared to the 
blinded group of patients which persisted to the end of the study at three months. 
This is an important study further investigating the impact of US on management, 
but also on outcome. 
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8.9 Summary 
In this chapter we have demonstrated the clinical utility of US in patients 
who were referred by their attending consultant. Patients had a clinical assessment 
with the clinician documenting the likely pathologic diagnosis of the area in 
question, as well as the overall clinical diagnosis before US was performed. This 
study demonstrates that most referrals in our rheumatology practice were related to 
the assessment of small joints and the reason for referral is usually related to the 
detection of synovitis and tenosynovitis. In this study US altered the local SSO and 
overall management in half the patients assessed, and also led to a change in the 
overall diagnosis in approximately lout of 10 patients. 
There have been many publications demonstrating the ability of US to detect 
changes in patients with specific conditions like RA and also for problems like 
plantar fasciitis and epicondylitis. This study also reflects the increasing trend of 
rheumatologists performing US, in the present case trained by musculoskeletal 
radiologists. Future investigations should include demonstrating outcomes between 
groups with access to US, and those without. This can be done for regional problems 
like those with injections in the ankle described by (d'Agostino, Ayral et aI. 2005), 
in specific diagnostic groups like RA or involving all attendees to out-patient 
departments. 
212 
MD Thesis- Dr Zunaid Karim 
Chapter 9 
9.1 Summary and Future Directions 
In the last decade there has been a trend towards earlier more aggressive 
therapy for inflammatory arthritis using the adage that inflammation over time 
causes damage. This requires the assessing physician to be confident that they have 
made a reliable initial diagnosis prior to starting long-term potentially harmful 
treatment. This has inevitably led to physicians becoming interested in any modality 
that can be used to reliably detect a condition and then monitor response to therapy. 
As the use of US has increased, there has been greater critical assessment of 
this technique particularly in academic units resulting in more evidence confirming 
its role in rheumatology practice. With increasing awareness of the technical 
requirements, and with portability of machines allowing direct visualisation of the 
area of interest to rheumatologists, more rheumatologists have taken on the role of 
performing US themselves. A good US assessment requires knowledge of the 
anatomy and potential pathology at the site of interest to avoid misinterpretation of 
normal anatomy, as well as an understanding of the clinical scenario leaving 
rheumatologists well placed to continue this work. 
213 
MD Thesis- Dr Zunaid Karim 
9.2 Summary of thesis 
This thesis set out to determine the performance merits of US in 
rheumatology, by examining issues concerning validity, reliability and clinical 
utility. 
9.2.1 Knee synovitis 
In chapter 3 we confirm, using arthroscopy as the gold-standard, that US has 
a higher sensitivity, specificity, accuracy, positive- and negative-predictive value 
compared with clinical assessment. Ultrasonography also demonstrated good inter-
and intra-reader reproducibility for detecting presence or absence of synovitis, as 
well as distinguishing the grade of synovitis, confirming that US is not only a valid 
and reproducible tool for detecting synovitis in the knee but also that it is more 
sensitive than clinical assessment. Another study by part of our group using the 
same arthroscopy technique as in this chapter on 60 patients with knee arthritis (32 
with RA, 18 with PsA, and 10 with OA) demonstrated good correlation between 
global arthroscopic VAS for synovitis and synovial fluid matrix metalloproteinase 1 
(Fraser, Fearon et al. 2003). 
There is evidence that synovitis is common In knee OA (D'Agostino, 
Conaghan et al. 2005), US findings can relate to symptoms (Naredo, Cabero et at. 
2005), and synovitis has a role in the symptoms and progression of knee arthritis 
(Ostergaard, Hansen et at. 1999; Ayral, Pickering et al. 2001; Ayral, Pickering et at. 
2005). 
Recent publications confirm the insensitivity of clinical assessment (Kane, 
Stafford et at. 2003; Conaghan, D'Agostino et al. 2005; D'Agostino, Conaghan et at. 
2005), whilst demonstrating validity of US at detecting synovitis in the knee with 
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PO and bubble contrast (Fiocco, Ferro et al. 2003), and in large (lIermann, 
Backhaus et al. 2003) and small joints (Backhaus, Burmester et al. 2002; Terslev, 
Torp-Pedersen et al. 2003; Szkudlarek, Narvestad et al. 2004; Scheel, Hermann et 
al. 2006) including with contrast (Szkudlarek, Court-Payen et al. 2003) in RA. This 
suggests that US should be increasingly used in order to improve the diagnosis and 
management of patients with knee symptoms. 
Further work in this area includes the need for more validation with 
histology for gray-scale and PO US, with and without bubble contrast, concentrating 
not only on the ability to measure small differences in synovial thickening or 
vascularity, but also the reliability to detect these particular changes. Semi-
quantitative scoring is usually quicker than quantitative analysis and these need to 
be compared, so that semi-quantitative analysis allowing for quicker assessments 
could be used in the clinical setting. Longitudinal studies with reliability 
comparisons are required to properly assess the sensitivity of US to detect changes 
over time and monitor response to therapy. Work in assessing US pathology and 
corresponding sites of pain in OA, SPA and RA is very interesting and may lead to 
predictive validity studies in the longer term measure. 
The clinical applicability of any gold standard is related to its pathogenic 
relevance, without which its prognostic capacity is diminished (Valenstein 1990). 
There is a paucity of studies to correlate arthroscopic synovitis with damage (Ayral, 
Pickering et al. 2001) and at present there is no firm evidence that correlates 
histological findings with clinical outcomes, in particular joint damage. While 
further validation with US is required, this too is an area that requires further 
investigation. 
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9.2.2 Accuracy of US-guided injections 
In chapter 4 we confirm the accuracy of US-guided subacromial injections in 
patients with shoulder pain. In our study all our injections were intrabursal with 6/11 
having a small extrabursal element as well, which we argue is the likely result of 
extravasation possibly related to the volume of injection (lOmls). 
Recent publications have added to the evidence for the accuracy of US 
placement (Esenyel, Esenyel et al. 2003), while novel ways of guiding injection are 
being demonstrated (Koski, Saarakkala et al. 2005), with US even being used to 
guide surgery (Testa, Capasso et al. 2002). 
There is evidence suggesting that US-guided aspiration is better than clinical 
palpation-guided aspiration (8alint, Kane et al. 2002; Raza, Lee et al. 2003), and 
that US-guided injections are better than 'blind' injections in the shoulder (Galletti, 
Magnani et at. 2004; Naredo, Cabero et al. 2004; Chen, Lew et al. 2006) . This is 
not true for all sites with benefit from guided compared with 'blind' injections in 
one study (Tsai, Hsu et al. 2006) compared with no benefit in another (Kane, 
Greaney et al. 2001) for the injections of plantar fasciitis. 
Further work needs to be done to determine the accuracy of injection 
technique using dissection and imaging modalities like CT including randomisation 
to guided or 'blind' injections to provide comparison. The volumes injected using 
'blind' and guided techniques vary and this also requires further investigation to 
assess whether the volume of injection has an impact on the outcome. Thereafter, 
the impact of these more accurate injection techniques need to be assessed in 
randomised longitudinal studies using validated outcome measures. 
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9.2.3 Efficacy of US-guided hip injections 
In chapter 5 we confirm that patients with moderate to severe hip OA can 
benefit in the medium-term from US-guided injection of corticosteroid. In this pilot 
study response was better in those with moderate OA. We also demonstrate that US 
findings, particularly effusion and lack of osteophytes, may predict those likely to 
respond. Subsequent work has confirmed the efficacy of corticosteroid in moderate, 
but not severe OA. 
In an important study synovitis as defined by PD US (we used gray-scale 
only) correlated well with histology (Walther, Harms et a1. 2002). In our study we 
indirectly guided and confirmed placement of injection with US. There is also 
evidence that us-guided hip injections are accurate from a study using contrast with 
eT to confirm 100% placement (Pourbagher, Ozalay et a1. 2005). 
The study by Margules and colleagues has found better outcomes in a larger 
group of patients (Margules 2001», but their group while including patients with 
moderate and severe arthritis probably had less severe disease than our group who 
were all waiting hip replacement. It seems there is no role for corticosteroid 
injections at the other end of the severity spectrum, with no benefit in rapidly 
destructive hip OA (Villoutreix, Ph am et at. 2006). 
Future work should include a placebo-controlled randomised study of guided 
injection to remove 'placebo' response, and also include features that might predict 
response including highly sensitive CRP and also repeating US post injection to 
determine whether objective measures of synovitis change with symptoms. The data 
from our pilot study provide valuable baseline data for power calculations for future 
studies. 
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9.2.4 US synovitis in clinical remission 
In chapter 6, we continue with one of the mam themes of this thesis 
assessing the role of US in detecting synovitis in patients with low disease activity 
states or clinical remission. This study again demonstrates the insensitivity of 
clinical assessment and also the extent of sub-clinical disease present, even in this 
group in clinical remission, with widespread synovitis regardless of the type of 
remission criteria imposed. This in addition to reports that clinical measures of 
disease activity such as DAS do not always reflect clinical changes following 
therapy (Gardiner, Bell et a1. 2005), suggests that US should be included in any 
future definition of remission. 
The findings from this study may have a number of important 
pathophysiological implications. These data provide a possible pathological 
explanation for the paradoxical observation that patients in apparent remission may 
experience progression of joint damage (Mulherin, Fitzgerald et a1. 1996; Molenaar, 
Voskuyl et a1. 2004). In support of this a recent study has also demonstrated that US 
synovitis at baseline correlates with x-ray damage 1 year later in patients with RA 
receiving methotrexate (Taylor, Steuer et a1. 2004). 
Work is ongoing with this cohort to assess the long term outcome of sub-
clinical disease. Healthy age-matched controls are required to differentiate between 
normal and abnormal perfusion, and while MRI has become the most common 
standard that US is compared with, findings should ideally be correlated with 
histology. 
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9.2.5 US synovitis is predictive of response 
In chapter 7 we suggest a possible underlying inflammatory aetiology in 
many patients that present with symptoms, but no signs, to suggest inflammatory 
arthritis. In this study most had US-detected synovitis, the majority of whom had no 
evidence of synovitis on clinical assessment. Using the response to IM MP as a 
means of suggesting an underlying inflammatory process we demonstrated that US-
detected synovitis was the best predictor of this response and also a predictor of 
subsequent response to HCQ. 
This work provides an insight into the potential pathogenesis of this patient 
group suggesting along with other work in this thesis that clinical assessment is 
insensitive to subtle degrees of synovitis. The treatment algorithm we used is a 
practical way of managing this group of patients. A recent publication whilst 
demonstrating the short term efficacy of IM MP warns of the potential for adverse 
events with frequent injections (Choy, Kingsley et al. 2005). 
Further work with this group of patients should include checking anti-ccp 
antibodies, and repeating highly sensitive CRP and US assessment to document any 
changes in these markers of inflammation following IM MP and determine whether 
any changes reflect response. Patients need to be randomised to receive placebo or 
IM MP to remove any placebo effect bias, and also to detect any significant side 
effects as described (Choy, Kingsley et al. 2005), and also to observe the natural 
progression and outcome of this group. 
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9.2.6 Clinical impact of US 
In chapter 8 we demonstrate the clinical utility of US in patients who were 
referred by their attending consultant. Patients had a clinical assessment with the 
clinician documenting the likely pathologic diagnosis of the area in question, as well 
as the overall clinical diagnosis before US was performed. This study demonstrates 
that most referrals in our rheumatology practice were related to the assessment of 
small joints and the reason for referral is usually related to the detection of synovitis 
and tenosynovitis. In this study US altered the local site-specific diagnosis and 
overall management in half the patients assessed, and also led to a change in the 
overall diagnosis in approximately lout of 10 patients. This study also reflects the 
increasing trend of rheumatologists performing US, in the present case trained by 
musculoskeletal radiologists. 
More recently the impact of US has been measured by blinding US reports in 
one group of patients (with the physician having access to reports and changing 
management if appropriate in the other) and comparing outcomes (d'Agostino, Ayral 
et al. 2005). 
Further work is required with methods similar to the study above where 
under randomised control one cohort of patients receives the benefit of US input 
comparing outcome against validated measures. This can be performed for a specific 
area of interest like the ankle or shoulder, or in conditions like RA, and allows 
comparison with a control or 'placebo' group. In our study patients were originally 
referred for US due to a certain degree of clinical uncertainty so any outcome needs 
to take this into account. To avoid this referral bias and demonstrate the real impact 
of US in rheumatology practice requires all patients attending the service to be 
invited to take part in a study and be randomised to having their physician receiving 
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information gained from US or not. Long-term monitoring, particularly in chronic 
disease would be required using validated outcome measures to assess any impact 
on function. 
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There is now increasing evidence in the literature to support the observation 
that US is superior to clinical assessment at detecting synovitis in small and large 
joints (Backhaus, Kamradt et al. 1999; Hau, Schultz et al. 1999; Kane, Balint et al. 
2003; Luukkainen, Saltyshev et al. 2003; Szkudlarek, Court-Payen et al. 2003; 
Wake field, Green et al. 2004; Luukkainen, Sanila et al. 2005; Naredo, Bonilla et al. 
2005). Further studies have attempted to provide validation by comparison with 
other imaging techniques such as MRI, arthroscopy, scintigraphy and thermography 
(Ostergaard, Court-Payen et al. 1995; Backhaus, Kamradt et al. 1999; Backhaus, 
Burmester et al. 2002), including one which suggested that inflammatory arthritis 
US may even be more sensitive than MRI at detecting synovitis in finger joints 
(Backhaus, Kamradt et al. 1999). 
More recently additional US techniques such as Power Doppler or contrast-
enhanced Doppler have become available potentially improving the accuracy of US 
by differentiating between hypervascular (active) and fibrotic (inactive) synovial 
thickening or pannus in patients with established disease. Observational studies 
comparing PD with traditional gray-scale US and clinical disease activity 
assessments seemed to have confirmed this (Hau, Schultz et al. 1999; Weidekamm, 
Koller et al. 2003). 
Validity has been assessed by comparison with histopathology in hip joints 
due for arthroplasty (Walther, Harms et al. 2002), in knee OA and RA (Schmidt, 
Volker et al. 2000; Walther, Harms et al. 2001); and with dynamic MRI in RA of the 
MCP (Szkudlarek, Court-Payen et al. 2001; Terslev, Torp-Pedersen et al. 2003) and 
MTP joints (Szkudlarek, Narvestad et al. 2004). Power Doppler has also been used 
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to assess disease activity in RA (Hau, Schultz et al. 1999; Qvistgaard, Rogind et al. 
2001; Carotti, Salaffi et al. 2002; Weidekamm, Koller et al. 2003) as well as monitor 
response to treatment (Newman, Laing et al. 1996; Hau, Schultz et al. 1999; Stone, 
Bergin et al. 2001; Teh, Stevens et al. 2003; Terslev, Torp-Pedersen et al. 2003; 
Fiocco, Ferro et al. 2005). 
Intravenous microbubble echo contrast agents increase the intensity of weak 
signals to a potentially detectable level, possibly further increasing the sensitivity of 
PD. Most studies that have assessed this have reported an increase in Doppler 
signal (Magarelli, Guglielmi et al. 2001; Qvistgaard, Rogind et al. 2001; Klauser, 
Frauscher et al. 2002; Fiocco, Ferro et al. 2003) with the exception of one notable 
study (Szkudlarek, Court-Payen et al. 2003). Contrast enhanced MRI has also been 
used and in one study (Magarelli, Guglielmi et al. 200 I) confirmed concordance in 
all cases. In the knee echo contrast enhanced PD has been compared with 
arthroscopy demonstrating a higher sensitivity, but a lower specificity (Fiocco, Ferro 
et al. 2003). 
There are to my knowledge only 2 reports of cohorts with any sequential 
assessment of synovitis with US. One group published results after 2 (Backhaus, 
Burmester et al. 2002) and 7 years (Scheel, Hermann et al. 2006). In this study 
reductions in levels of synovitis were documented which were comparable to MRI 
and also reflected in clinical and laboratory assessments. The other study with 6 
months between assessments revealed conflicting data with US having less synovitis 
at base line, and more synovitis after 6 months compared with MRI, but detecting 
more effusions than MRI at both time points (Hoving, Buchbinder et al. 2004). 
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9.3.2 Erosions 
X-ray documented bone erosions are used to help with a diagnosis of RA, 
but these changes are often absent in early disease. Ultrasonography has consistently 
demonstrated greater sensitivity than x-ray at detecting erosions in the hand, wrists, 
feet and shoulder (Alasaarela, Suramo et al. 1998; Backhaus, Kamradt et al. 1999; 
Wakefield, Gibbon et al. 2000; Grassi, Filippucci et al. 2001; Klocke, Glew et al. 
2001; Szkudlarek, Court-Payen et al. 2001; Hermann, Backhaus et al. 2003; 
Weidekamm, Koller et al. 2003; Lopez-Ben, Bemreuter et al. 2004). 
A particular benefit seems to be in early disease where US is able to detect 
6.5 x more erosions in early disease, compared with 3.4 x more erosions in 
established disease compared with x-ray (Wakefield, Gibbon et al. 2000). This is 
possibly explained by the, relative to x-ray, high resolution and the multi planar 
nature of US assessment lending to it able to detect small lesions. 
Other studies have shown that US may be less sensitive than MRI at 
detecting bony erosions in the shoulder (Alasaarela, Suramo et al. 1998; Hermann, 
Backhaus et al. 2003), and the knee (Ostergaard, Court-Payen et al. 1995) although 
this may be less important regarding diagnosis. Another study demonstrated that US 
was less sensitive than x-ray at detecting central erosions in the DIP joints of 
patients with inflammatory osteoarthritis (lagnocco, Filippucci et al. 2005). 
The same cohorts described in synovitis have been assessed for longitudinal 
progression of erosions. Over both the 2 (Backhaus, Burmester et at. 2002) and 7 
year (Scheel, Hermann et al. 2006) period, progression of erosions was seen more 
often on US and MRI than x-ray. By 7 years many erosions previously undetected 
by x-ray, but present on US and MRI were detectable on x-ray. This suggests that 
while x-ray may be less sensitive at detecting erosions early in disease compared 
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with US and MRI, in time perhaps as the size of erosions increase x-ray detects 
these changes. Likewise US detected less erosions than MRI early on and many of 
these erosions were subsequently detected by US, suggesting that when MRI lesions 
erode cortical bone US where it has access will detect these. In the second cohort 
(Hoving, Buchbinder et al. 2004) erosions progressed over a 6 month period, 
however US identified less erosions than either MRI or x-ray. 
That US is relatively less sensitive in established disease suggests either x-
ray 'catches up' with US as erosions become larger, or that especially in a complex 
joint like the wrist as more damage occurs and the joint becomes disrupted it 
becomes more difficult for US to differentiate between additional bone and erosion. 
Our experience suggests US in the wrist becomes considerably difficult to monitor 
erosions in the extensively damaged wrist. 
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9.3.3 Monitoring response to therapy 
Ultrasonography has been used to monitor outcome following the different 
treatment interventions in different cohorts of inflammatory arthritis patients. Many 
studies have shown a reduction in US markers of synovial inflammation including 
gray-scale and PD parameters after different treatments in the hand (Spiegel, King et 
al. 1987; N ewman, Laing et al. 1996; Stone, Bergin et al. 2001; Hau, Kneitz et al. 
2002; Teh, Stevens et a1. 2003; Terslev, Torp-Pedersen et a1. 2003) and knee (van 
Holsbeeck, van Holsbeeck et al. 1988; Rubaltelli, Fiocco et al. 1994; Fiocco, Cozzi 
et al. 1996; N ewman, Laing et al. 1996; Gratz, Gobel et al. 1999; Salaffi, Carotti et 
al. 2004; Fiocco, Ferro et al. 2005). This suggests that US is sensitive enough to 
detect often subtle but clinically important changes in response to treatment, but 
without any studies confirming the reliability of detecting these changes (i.e. no 
evidence of discriminant validity). 
9.3.4 Disease activity assessment 
With the increasing conviction that imaging led disease activity scores are 
more sensitive and reliable, and more sensitive at detecting changes in assessment of 
synovitis and/or damage following therapy, some groups have suggested US 
assessment scores for inflammatory arthritis. 
One such study set out to develop a simplified US assessment scoring system 
for assessment of the MCP and PIP joints in patients with RA (Scheel, Hermann et 
al. 2005). The authors conclude that US assessment of finger joint synovitis could 
be simplified by examining the palmar side of 2nd, 3rd and 4th MCP and PIP joints on 
one hand, applying a semi-quantative grading measurement. Despite assessing just 
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under 50 patients this study demonstrated good concurrent validity with the semi-
quantitative US method revealing high concordance with MR!. 
A 12 joint assessment for overall disease activity in RA has also been 
proposed (Naredo, Gamero et al. 2005). In this study a 60 joint clinical and US 
scoring system in patients with RA were initially compared. Joint effusion, joint 
synovitis and PO signal were graded from 0 to 3 in all joints scored with US. 
Reduced US joints counts were then compared against the overall 60 joint count for 
correlation. The 60 joint US count was then compared against smaller joint count 
versions. They found that a 12 joint assessment for effusion, synovitis and PD signal 
which included wrists, knees, and bilateral second and third Mep, and bilateral 
second and third PIP joints correlated well with the overall 60 joint count. 
In SpA, an entheseal pathology scoring system has been suggested (Balint, 
Kane et al. 2002). This study comparing clinical with US assessment of both lower 
limbs demonstrated that US was more sensitive at detecting entheseal changes than 
clinical assessment. The 5 sites they assessed were the common superior and 
inferior pole of patella, tibial tuberosity, achilles tendon, and plantar aponeurosis. 
At each site US was used to detect bursitis, structural thickness, bony erosion, and 
enthesophyte (bone spur). The intra-observer kappa value for US analysis was 0.9. 
Wake field and colleagues demonstrated a significant proportion of patients 
with a clinical diagnosis of oligoarthritis «= 5 joints) had US-detected polyarthritis 
(Wakefield, Green et al. 2004). They suggest a standard assessment technique 
including examination of all painful, but also certain other joints (e.g. MTP joints) 
even if asymptomatic. This work would suggest that US assessment has a significant 
role to play in the management of patients with clinical oligoarthritis. In this group 
further assessment of this role for US is required; including what impact US would 
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have on the patient's actual management, particularly its impact on injection or 
DMARD therapy, but also more importantly in the longer term, to assess whether 
this change will have any impact on long term out come. 
Regarding disease assessment the main issue In the longer term is to 
determine whether these assessments are accurate and reliable in detecting changes 
over time. A particular difficulty with this is to define the most appropriate standard 
with which to compare US. Histological analysis is the ideal, but requires an 
invasive procedure and for detecting synovitis MRI may be the most practical 
modality. For outcome, validated functional endpoints such as HAQ and RAQOL 
may be appropriate or otherwise pragmatic investigations may use specific 
outcomes such as work instability, unemployment or arthroplasty. 
9.3.5 Prediction of outcome 
There are limited data on the US findings as a predictor of future outcome. 
A study comparing US-detected synovitis with findings at arthroscopy in patients 
undergoing arthroscopic synovectomy, demonstrated that US joint effusion at 
baseline was significantly increased in patients who relapsed, suggesting US could 
be used to predict relapse following synovectomy (Fiocco, Cozzi et at. 1996). In 
another study in early RA (Taylor, Steuer et al. 2004), baseline US measurements of 
synovial thickening and vascularity in MCP joints correlated with degree of x-ray 
joint damage 1 year later. There have been interesting developments in the arena of 
sites of pain with US findings in knee OA correlating with severity of pain (Naredo, 
Cabero et al. 2005). 
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9.3.6 Reliability 
A charge that is often made against US is that it is user dependent and 
outcome will depend on the level of skill of the operator. In response to this there 
are an increasing number of reliability studies in the literature. As with the findings 
of our study discussed in chapter 6, good levels of inter- and intra- observer 
reliability have been demonstrated for assessing synovitis in the wrist and small 
joints of the hands and feet (Ostergaard, Klarlund et al. 200 I; Qvistgaard, Rogind et 
al. 2001; Ribbens, Andre et al. 2003; Szkudlarek, Court-Payen et at. 2003) as well 
as another study only assessing intra-observer reliability again with good correlation 
(Backhaus, Burmester et al. 2002). Two of these studies (Qvistgaard, Rogind et al. 
2001; Szkudlarek, Court-Payen et at. 2003) assessed PD US. We have already 
described, in chapter 3, using gray-scale US with good inter-and intra-observer 
reliability. Using PD US good levels of inter-observer agreement for PD synovitis 
have also been demonstrated (Schmidt, Volker et at. 2000; Fiocco, Ferro et at. 
2003). 
Likewise for erosIons in the hand there has been good correlation 
demonstrated for inter- and intra-observer reliability (Wake field, Gibbon et al. 2000) 
and also for intra-observer reliability only (Backhaus, Burmester et al. 2002). In 
enthesitis good intra-observer reliability has been demonstrated (Balint, Kane et al. 
2002), whereas in the shoulder for cuff tears agreement has varied depending on the 
degree of expertise in one study (O'Connor, Rankine et at. 2005), but with good 
inter-observer reliability in another study (Swen, Jacobs et at. 1999). Future work 
should improve the general reliability of US assessment and improve standardisation 
of assessment techniques, setting out agreed definitions of pathology as well as 
using standard US scoring criteria. 
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9.3.7 US pathology 
Ultrasonography is not only demonstrating signs better than clinical 
assessment, but the technology being applied is also giving insight into pathogenesis 
of disease. One example is in a study of plantar fasciitis where hyperaemia was 
found with PD US in the plantar fascia and the surrounding soft tissue along the first 
cm distally from the insertion in patients not present in controls (Walther, Radke et 
a1. 2004). A separate study demonstrated increased thickness and reduced 
echogenicity of the plantar fascia in symptomatic heels compared with 
asymptomatic heels (Kane, Greaney et a1. 1998) giving some indication as to the 
underlying vascular and inflammatory component of the condition. 
With the ever increasing improvements in resolution visualising the qualities 
of tendon, and nerve as well as the measurement of skin thickness are becoming a 
reality. 
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9.4 Future directions 
While US has thus far demonstrated much promise in rheumatology practice, 
there are still many areas that require further investigation. 
9.4.1 Standardised image acquisition, definitions of pathology 
Key advances in this area were made when the EULAR working group 
published guidelines on set assessment techniques for US in Rheumatology 
addressing technical issues, training, and standardisation of image acquisition 
(Backhaus, Burmester et aI. 2001). The OMERACT US specialist interest group 
have recently proposed for the first time a consensus set of US definitions for 
common pathological lesions seen in Rheumatology practice, which in conjunction 
with the EULAR assessment guidelines provide a template for future studies 
assessing these standardisations (Wake field, Balint et aI. 2005). 
In the quest for ongoing training, standardisation of assessment techniques, 
and defining pathology, the EULAR working group for musculoskeletal US have 
been meeting and recently used a method of scoring stored images independent of 
each other, thereafter meeting and discussing scoring methods to develop consensus 
(Naredo, Moller et aI. 2006). This allows standardisation of techniques at an expert 
level, hopefully allowing this to be disseminated as those experts return to their 
particular bases. 
More needs to be done to ensure that methods of image acquisition are 
uniform, and of the highest quality. This requires an understanding of the physical 
principles of US, standardised assessment techniques and even standardised 
machine settings for specific assessments. The definitions that have only recently 
been agreed will no doubt require further modification with time, particularly after 
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more reliability data becomes available. Working groups like OMERACT are 
essential in ensuring that as more rheumatologists take on perfonning US that 
assessment techniques remain standardised and that widely accepted definitions are 
used. This will not only provide for more consistent diagnosis, but also allow easier 
comparison between studies. 
9.4.2 Validation of new technologies 
Newer techniques will require validation, preferably with histological 
analysis to detennine the validity of US detected synovitis. A potential limitation of 
gray-scale US is that it primarily detects synovial hypertrophy which although 
reversible in early disease may not be so in established disease when the synovial 
membrane may become chronically thickened and fibrotic. For this reason, gray-
scale US changes alone may not necessarily reflect active inflammation i.e. 
synovitis. The presence of increased PO signal signifies increased vascularity 
associated with active inflammation and may be more representative of true 
synovitis making it potentially more useful in established RA. 
It remains to be seen whether the specificity of US for synovitis III 
established disease may be improved by perfonning simultaneous PD assessment. 
Longitudinal studies including reliability assessments are required to assess the 
sensitivity of US to small changes in activity, providing a true reflection of the 
discriminant validity of the combination of the US machine with technology like PD 
with bubble-contrast enhancement. Ideally machines would undergo a standardised 
assessment to detennine the reliability of detecting the pathology in question which 
would then be documented as a feature of the machine much like axial resolution is 
currently noted. 
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9.4.3 Reliability of US machines 
One of the key difficulties facing US is the many different types of 
equipment with very little data comparing ability to detect pathology and assessing 
reliability between machines. This is a problem facing most advancing technologies 
and with a profit driven industry it will be difficult to get companies to submit to 
truly independent standardised assessments. 
9.4.4 How much synovitis does it take to damage? 
The role of US in predicting sub-clinical synovitis has already been 
discussed in this thesis and is potentially one of the areas that US may have a big 
impact. The predictive ability of US in cohorts not dissimilar to ours, centred on 
synovitis and early erosion detection needs to be further evaluated. In practice we 
are now seeing that at every level of clinical inflammation US seems to be more 
sensitive, from patients with inflammatory hand pain, to clinical oligoarthritis being 
reclassified to polyarthritis with US assessment, to significant levels of synovitis 
detected in clinical remission. The question that needs answering is how much of 
this synovitis matters and if so, is there a particular cut off above which disease 
progression is likely, or below which this is unlikely. These are questions that only 
well planned longitudinal studies have the ability to answer. 
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9.4.5 Are the requirements for US the same for different conditions? 
One of the issues that requires further clarification is whether the technical 
requirements and impact are similar in different conditions. A simple example is RA 
where pathology is primarily synovial and as such requires a small footprint 
transducer that can provide good access to the smaller joints as opposed to assessing 
patients with hip OA where a larger curvilinear probe maybe more appropriate. In 
early disease gray-scale detected synovitis is likely to be specific, although perhaps 
less sensitive than PD with or without contrast, whereas in established disease gray-
scale has difficulty differentiating between fibrotic (inactive) and active pannus and 
should benefit from the addition of PD. 
Being able to ascertain what the main function of the equipment is going to 
be is helpful in determining the type of equipment required; for ward work primarily 
used to detect and guide aspiration of effusion for example a portable machine with 
only moderate quality Doppler ability (to avoid vascular structures) is acceptable, 
but this is likely to be inadequate for monitoring small joints in inflammatory 
arthritis. 
In oligoarthritis our group has already demonstrated that US alters the 
diagnosis to a polyarthritis in over a third of patients. This suggests that US is a 
useful standardised method for assessing this patient group (Wakefield, Green et at. 
2004). 
Likewise there are similar assessment techniques for monitoring disease 
activity in the hand (Walther, Radke et at. 2004) and overall disease in RA with a 12 
joint US count representative of a 60 joint US count (Naredo, Gamero et at. 2005), 
as well as measures in SpA (Balint, Kane et at. 2002). Further studies are required to 
validate all these measures. 
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9.4.6 Are the requirements for US the same in clinical practice and research? 
The same applies to different working environments. A rheumatologist 
working in a small group will find it difficult to use US routinely in their clinical 
setting unless consideration of the time this takes is made. The practical solution 
would be to have a set clinic for performing US which maximises the usefulness of 
the machine, and also allows sharing of equipment with other departments. The 
obvious disadvantage of this is that patients have to return for this investigation. 
In a large academic unit it would be easier to have one operator using the 
machine while the rest of the team perform their outpatient work, and if clinical 
trials are part of the units' workload then specific time will need to be set aside for 
this bearing in mind clinical research assessments are usually longer. The technical 
requirement of the machine will also differ in this setting requiring a 'top-end' 
machine which in practice means a cost greater than £50, 000. 
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9.4.7 Other advances: what is the opposition? 
Advances in technology are not limited to US and the last few years have 
seen massive advances in MRI technology with low-field MRI units becoming 
available. These usually are in the range of 0.2 -0.5 Tesla, compared with standard 
high field MRI of 1.5 Tesla. These have the advantage over high-field MRI of 
patient comfort (high-field MRI of MCP requires the patient lying prone in 
'superman position' for up to 45 minutes ), less noise, less contraindications, less 
space and shielding required, less maintenance, not to mention less cost! 
The drawback of low field MRI is its low MR signal because the signal-to-
noise ratio is proportional to the field strength; the stronger the field, the stronger the 
signal. Other disadvantages are reduced field of view (for example the 'Magnaview' 
can image only 2-3 MCPs), and less resolution. 
As with US, improvements in technology are such that, usmg a high 
sensitivity radio frequency coil with high-temperature superconductors (better 
receiver) the problem of a weak signal can be overcome. This new technology can 
result in an increased signal to noise ratio of more than 100%. It is not unrealistic to 
expect that in a few years low-field units will be seen in outpatient departments in 
theUK. 
Improvements in technology of another kind are likely to have an impact on 
US soon. Portable machines are improving all the time and with better technology 
transducer elements that 'plug and play' in modified laptops are not far away. The 
question regarding the future of US is not so much about competition from other 
modalities rather how much US itself will adapt to these changes in technology. 
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9.4.8 Who should perform US? 
In the last decade there has been a trend towards earlier more aggressive 
therapy for inflammatory arthritis using the adage that inflammation over time 
causes damage. This requires the assessing physician to be confident that they have 
made a reliable initial diagnosis prior to starting long-term potentially harmful 
treatment. This has inevitably led to physicians becoming interested in any 
modality, imaging or otherwise, that can be used to detect a condition and then 
monitor response to therapy. 
The specific role of US in standard rheumatological practice is increasing as 
a result of easier access due to portable US machines, lack of ionising radiation, 
relatively low costs and improved technology making US more amenable to assess 
smaller joints. Direct visualisation of the area of interest with US is extremely 
valuable for both diagnostic and therapeutic reasons. As the use of US becomes 
more widespread and machines become more portable, and interest, particularly in 
academic units increases, more rheumatologists are taking on the role of performing 
US themselves . 
. The technical requIrements for US have already been discussed, but it is 
important to point out that in conjunction with quality US equipment, a good US 
assessment requires knowledge of the anatomy at the site of interest to avoid 
misinterpretation of normal anatomy, as well as understanding of the clinical 
scenario. This has lead to clinicians claiming that they, rather than an independent 
radiologist are best suited to do this. 
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In the shoulder there is evidence that US perfonned by an experienced 
radiologist and rheumatologist is reliable in assessing the rotator cuff (Swen, Jacobs 
et al. 1999), although another study amongst radiologists suggests that experience is 
important for maintaining good reliability (O'Connor, Rankine et al. 2005); while in 
the small joints there is good reliability between an experienced radiologist and a 
rheumatologist with limited training, but working to predetennined definitions 
(Szkudlarek, Court-Payen et al. 2003) . 
This confinns what is really important is not who should do it, but rather 
whether an individual is competent to perfonn US. Again standardised assessment 
and definitions seem to produce good results, even in a relatively inexperienced 
operator. 
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9.4.9 Training 
As a result of the increasing use of US in rheumatology more 
Rheumatologists are requesting training (Wakefield, Goh et al. 2003) and 
organisations like the BSR and EULAR are now providing teaching programmes 
differentiated by operator expertise. Different training techniques have been 
suggested ranging from a self taught programme after a 2 hour introduction 
(Filippucci, Unlu et al. 2003) or an informal team approach (Taggart, Filippucci et 
al. 2006), to a more didactic focused system (D'Agostino, Maillefert et al. 2004). 
The study described in the previous paragraph is significant, and highlights the need 
for standardised assessment and clear definitions. One novel training programme 
involved the use of remote assistance to train non physician crew members how to 
perform US of the shoulder in space (Fincke, Padalka et al. 2005). 
There have also been increasing efforts to determine exact requirements for 
rheumatology US training with collaboration from world-wide experts (Brown, 
O'Connor P et al. 2005) leading to the design of specific competency based 
educational outcomes (Brown, O'Connor et al. 2006). This takes into account 
criteria that all experts agree are a requirement for competency to be demonstrated. 
The next important phase of this work is to develop better clinical governance with 
means of certification, ongoing training, assessment and accountability. 
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9.5 Conclusion 
In conclusion, the studies discussed in this thesis provide new insights into 
the role of US in the investigation and management of rheumatic conditions. This 
thesis explores different potential roles for US, from establishing criterion and 
construct validity to reproducibility and predictive validity of the technique. This 
thesis demonstrates that US, while still requiring further investigation, is important 
in the day to day running of a rheumatology practice. 
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